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Debt Counselling for Depression in Primary Care: an
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Background: Depression and debt are common in the UK. Debt Counselling for Depression in Primary
Care: an adaptive randomised controlled pilot trial (DeCoDer) aimed to assess the clinical effectiveness and
cost-effectiveness of the addition of a primary care debt counselling advice service to usual care for
patients with depression and debt. However, the study was terminated early during the internal pilot trial
phase because of recruitment delays. This report describes the rationale, methods and findings of the pilot
study, and implications for future research.
Objectives: The overarching aim of the internal pilot was to identify and resolve problems, thereby
assessing the feasibility of the main trial. The specific objectives were to confirm methods for practice
recruitment and the ability to recruit patients via the proposed approaches; to determine the acceptability
of the study interventions and outcome measures; to assess contamination; to confirm the randomisation
method for main trial and the level of participant attrition; and to check the robustness of data collection
systems.
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Design: An adaptive, parallel, two-group multicentre randomised controlled pilot trial with a nested
mixed-methods process and economic evaluation. Both individual- and cluster (general practice)-level
were was used in the pilot phase to assign participants to intervention or control groups.
Setting: General practices in England and Wales.
Participants: Individuals were included who were aged ≥ 18 years, scored ≥ 14 on the Beck Depression
Inventory II and self-identified as having debt worries. The main exclusion criteria were being actively
suicidal or psychotic and/or severely depressed and unresponsive to treatment; having a severe addiction to
alcohol/illicit drugs; being unable/unwilling to give written informed consent; currently participating in
other research including follow-up phases; having received Citizens Advice Bureau (CAB) debt advice in the
past year; and not wanting debt advice via a general practice.
Interventions: The participants in the intervention group were given debt advice provided by the CAB
and shared biopsychosocial assessment, in addition to treatment as usual (TAU) and two debt advice
leaflets. The participants in the control group were given advice leaflets provided by the general
practitioner and TAU only.
Main outcome measures: (1) Outcomes of the pilot trial – the proportion of eligible patients who
consented, the number of participants recruited compared with target, assessment of contamination,
and assessment of patient satisfaction with intervention and outcome measures. (2) Participant outcomes –
primary – Beck Depression Inventory II; secondary – psychological well-being, health and social care
utilisation, service satisfaction, substance misuse, record of priority/non-priority debts, life events and
difficulties, and explanatory measures. Outcomes were assessed at baseline (pre-randomisation) and at
4 months post randomisation. Other data sources – qualitative interviews were conducted with participants,
clinicians and CAB advisors.
Results: Of the 238 expressions of interest screened, 61 participants (26%) were recruited and
randomised (32 in the intervention group and 29 in the control group). All participants provided baseline
outcomes and 52 provided the primary outcome at 4 months’ follow-up (14.7% dropout). Seventeen
participants allocated to the intervention saw a CAB advisor. Descriptive statistics are reported for
participants with complete outcomes at baseline and 4 months’ follow-up. Our qualitative findings suggest
that the relationship between debt and depression is complex, and the impact of each on the other is
compounded by other psychological, social and contextual influences.
Conclusions: As a result of low recruitment, this trial was terminated at the internal pilot phase and was
too small for inferential statistical analysis. We recommend ways to reduce this risk when conducting
complex trials among vulnerable populations recruited in community settings. These cover trial design, the
design and delivery of interventions, recruitment strategies and support for sites.
Trial registration: Current Controlled Trials ISRCTN79705874.
Funding: This project was funded by the National Institute for Health Research (NIHR) Health Technology
Assessment programme and will be published in full in Health Technology Assessment; Vol. 21, No. 35.
See the NIHR Journals Library website for further project information. Mark Gabbay and Adele Ring are
part-funded by NIHR Collaborations for Leadership in Applied Health Research and Care (CLAHRC) North
West Coast and Richard Byng and Rod S Taylor, Vashti Berry and Elizabeth Shaw part-funded by NIHR
CLAHRC South West Peninsula.
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Plain English summary
What was the problem?
Depression (and associated anxiety) is common among general practice patients, with many patients
reporting financial worries. This project explored the effectiveness and acceptability of different forms of
support within general practice for such patients.
What did we do?
A total of 61 adults with depression and debt worries from 10 practices in England and Wales participated.
Individuals were allocated to one of the following:
l usual general practitioner (GP) care plus two debt advice leaflets
l usual GP care, two debt advice leaflets, a shared assessment between a GP and a debt advisor, and
debt counselling provided by the Citizens Advice Bureau (CAB).
What did we find?
Because of the early closure of the project and small sample, we are not able to compare outcomes.
After 4 months we were able to collect results from 52 of the original 61 adults who participated.
We explored individuals’ experiences through interviews with 23 participants. Participants’ situations are
complex, with debt often contributing to anxiety and depression and vice versa. The impact of debt and
depression on individuals’ lives was complicated by other influences, including participants’ experiences
with debt collection organisations and obtaining welfare.
Although employment was a common goal, considerable barriers to this were identified.
What does this mean?
Although it was possible to recruit and retain vulnerable patients to our primary care study, this required
intensive resources. Positive aspects of debt advice included:
l providing support in debt negotiations
l identifying sources of financial support.
Interviews with clinicians and CAB advisors explored the practicalities of the intervention. The CAB service
was welcomed by GPs and CAB advisors, but regular communication was challenging.
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Scientific summary
Background
Depression is estimated to affect 5–19% of adults at any one time, is a common presentation to primary
care and, as part of the mild to moderate mental health problems category, is a major contribution to
absenteeism. It is estimated that 16% of the UK population is struggling with debt, and debt is particularly
common among people with depression. The pilot trial reported here was the first phase of an adaptive
trial funded by the National Institute for Health Research (NIHR) Health Technology Assessment (HTA)
programme to investigate the clinical effectiveness and cost-effectiveness of specialist debt counselling
in primary care over usual care for adults with depression and debt. As the study failed to reach its
recruitment target, it was terminated early during the internal pilot phase and, therefore, did not progress
to the main trial. This report describes the study rationale, methods and findings of the pilot phase of this
study, and implications for future research in this area.
Objectives
The aim of the pilot trial was to test the procedures, recruitment processes and operational strategies that
were planned for use in the main trial: identifying and resolving any problems, and thereby assessing the
feasibility of continuing with the main trial. The specific objectives of the pilot trial were:
1. to confirm methods for recruitment of practices
2. to confirm the ability to recruit patients via the proposed approaches
3. to confirm the acceptability of the study interventions
4. to confirm the acceptability of data collection (outcome measures)
5. to assess contamination and confirm the randomisation method for the main trial
6. to assess the level of participant attrition
7. to check the robustness of data collection systems
8. to identify and resolve potential difficulties in implementing the shared assessment
9. to assess intervention fidelity.
Methods
We conducted an adaptive, parallel, two-group, pragmatic randomised controlled pilot trial with 1 : 1
allocation to intervention or control treatment as usual (TAU). The participants allocated to the intervention
received a shared biopsychosocial assessment from the general practitioner (GP) and Citizens Advice
Bureau (CAB) advisor, debt advice leaflets and debt counselling from a CAB specialist debt advisor based
in the practice. The control participants received TAU and debt advice leaflets only at a GP appointment.
A nested mixed-methods process and economic evaluations were undertaken.
Patients who had current depression and were worried about debt were recruited through general
practices in three regions of the UK (north-west England, south-west England and south Wales).
Participants were recruited to the study via two approaches: (1) waiting room recruitment – publicity
posters displayed in the waiting rooms of participating general practices and flyers with attached
expressions of interest forms placed around the waiting room and handed out by study research assistants
and practice staff; and (2) practice database searches and mail-outs – patients’ records were screened for
current depression or depression-related treatment in the last 12 months. GPs reviewed lists to exclude
patients with other significant conditions that, in their opinion, made them unsuitable for invitation to the
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study. Those remaining on the list were sent an introductory pack that comprised an explanatory letter
from the practice, an expression of interest form and a freepost envelope.
Patients were eligible for the study if they were aged ≥ 18 years, scored ≥ 14 on the Beck Depression
Inventory II (BDI-II) and self-identified as having worries about debt. The main exclusion criteria were being
actively suicidal or psychotic and/or severely depressed and unresponsive to treatment; having severe
problems with addiction to alcohol or illicit drugs; being unable or unwilling to give written informed
consent; currently participating in another research study including a follow-up data collection phase;
having received CAB debt advice in the past 12 months; or not wanting to receive support about debt or
money worries provided via the general practice.
Outcomes of the pilot trial included the proportion of eligible patients who consented, the number of
participants recruited during the recruitment stage of pilot compared with the target, an assessment of
contamination, and an assessment of patient satisfaction with intervention and outcome measures.
The primary participant outcome was BDI-II score. Secondary outcomes included psychological well-being,
health-related quality of life, health and social care utilisation and employment factors, and substance
misuse at 4 months. Life events and difficulties data, service satisfaction, hopelessness, shame and
rumination were also reported. Outcomes were collected at baseline (pre randomisation) and at 4 months
post randomisation.
Quantitative data analysis
Given that the study did not progress to a full trial and achieved a reduced sample size in the pilot trial
phase, we were not powered to undertake an inferential statistical comparison of outcomes between
intervention and control groups. Instead, outcomes findings are reported descriptively (means and standard
deviation, or numbers and percentages) for primary and secondary outcomes for the two groups at
baseline and at 4 and 12 months post randomisation.
Health economic data analysis
As with the quantitative data analysis, given that the study did not progress to a full trial and achieved
a reduced sample size in the pilot trial phase, we were not able to undertake an inferential statistical
comparison of health-related quality of life or service use between the intervention and control groups, or
to undertake an economic evaluation. Instead, the findings are reported descriptively (means and standard
deviation, or numbers and percentages) for the two groups at baseline and at 4 and 12 months post
randomisation.
Qualitative data collection and analysis
In-depth, semistructured, topic-guided interviews were completed with a subset of consenting participants.
Baseline qualitative interviews explored the participant’s narrative biographies of depression, anxiety and
debt, focusing on impacts on the participant’s life and their perceptions of practical aspects of debt.
A further qualitative interview at 4 months enquired about developments since the participant’s entry into
the trial, exploring the possible psychological, social and economic factors involved in recovery (or not)
from debt and depression. The 4-month interviews also assessed concordance with trial protocols,
acceptability of intervention and assessment measures, and the participant’s experience of participating in
the trial.
Results
Sixty-seven practices were approached about the study; 12 were recruited as study sites but two were not
able to recruit participants before the pilot closed. A total of 7874 patients were identified on practice
computer systems as having markers of depression. In some practices, when > 300 patients were identified
who were potentially suitable for the trial, mail-outs were limited by random sampling from the total
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population. Consequently, 4121 letters were sent out after screening by GPs, resulting in 138 expressions of
interest. Researchers spent 170 hours in waiting room recruitment and 3367 leaflets were left in practices,
resulting in 100 expressions of interest. From the 238 expressions of interest screened, 61 participants
(26%) were recruited and randomised across the three research sites. Of those randomised, 18 were
recruited from the waiting room and 43 were recruited from database searches. Of the 61 participants
recruited, 32 were allocated to the intervention arm of the study and 29 were allocated to the control arm,
and 28 and 24, respectively, completed the 4-month follow-up. When the pilot was stopped, only
22 participants had completed the 12-month follow-up.
In sites where participants were individually randomised, we found no evidence that participants in the
TAU arm were accessing CAB debt advice more often than participants in cluster control (TAU) sites.
As a result of the small sample size, we can report only descriptive data. The groups were relatively well
balanced, but > 50% of the recruitment was at one of the three sites. Most participants scored > 28 on
the BDI-II (severe depression) at baseline, with an overall mean score of 35.2. The intervention group
contained a higher proportion of dependent drinkers as classified by the Alcohol Use Disorders
Identification Test.
We undertook in-depth, semistructured interviews with 23 participants (12 in the intervention arm and
11 in the control arm) and 11 professionals (GPs and CAB advisors). Participants’ experiences of the
intervention were largely positive, with those receiving CAB debt advice identifying two main benefits of
advice: first, support in engaging with a range of agencies about debt issues and, second, identifying
sources of additional financial support.
Participants also indicated benefits of participating in the research process. A number described the
opportunity to discuss their lived experience during interviews with research staff as a kind of therapy.
Although participants’ experiences of involvement in the research were, therefore, largely positive, there
were aspects of the research that participants highlighted as requiring further consideration. These
included the form and content of questionnaires, the length of interviews and the complexity of language
in some questionnaires, with the ‘force choice’ response style coming under criticism from some
respondents. Both the complexity of language and the sheer number of questionnaires to be completed
resulted in some overly long interviews; therefore, it was not surprising that some participants highlighted
the need for interviews to be shortened.
The intervention process evaluation (using the normalisation process theory approach) with GPs and CAB
advisors found that the co-location of the CAB service within primary care was viewed as beneficial and
workable by both GPs and CAB advisors. However, there were caveats to some elements of the intervention.
Although the psychosocial assessment undertaken by GPs as part of the shared comprehensive assessment
was normalised within usual clinical practice, the time required to collect detailed information for sharing
with CAB advisors was viewed as potentially prohibitive by GPs. A key element of the intervention was
collaborative care through opportunities for informal communication, facilitated by the co-location of
services. However, there was little evidence of any opportunities for such communication. This was thought,
in part, to reflect the sporadic nature of CAB attendance at practices due to the small number of
participants, but also working practices and competing workload priorities within general practice.
Participant stories of debt and depression reflected considerable complexity. These highlighted the myriad
of concomitant psychological, social and contextual difficulties that acted and interacted to influence
individual experiences of psychological distress in the context of unmanageable debt. Contextual influences
included participants’ experiences with debt collection organisations and benefits agencies and their
systems and processes. Although employment was highlighted as a potential route out of debt and
associated worry, considerable barriers to employment were also identified. These included, in particular,
the current employment climate, the poverty trap (due to loss of benefits once in work), and physical and
psychological health difficulties.
DOI: 10.3310/hta21350 HEALTH TECHNOLOGY ASSESSMENT 2017 VOL. 21 NO. 35
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Gabbay et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xxiii
Conclusions
The relationship between debt and depression is highly complex. A multitude of psychological, social and
contextual influences acted and interacted to influence participants’ experiences of psychological distress in
the context of unmanageable debt. The contribution of debt and benefit organisations, through their
systems and processes, to some participants’ psychological distress, highlights the need to widen the focus
of research investigation to determine the mechanisms of psychological distress in the context of debt. A
number of participants highlighted specific benefits of debt advice, including helping them to engage with
agencies about debt issues and providing additional financial support. Although a collaborative approach
to care between GPs and CAB advisors for patients with debt and depression may be advocated, achieving
this requires more than simple co-location of services. Some of the challenges we experienced reflect the
difficulties of utilising an adaptive design in the tight time frame of a pilot trial, where the requirement for
a sequential pathway of permissions for protocol amendments prohibits immediate adaptations. It is likely
that the slow recruitment was at least partly a result of the complexity of psychosocial problems, making it
harder for participants to engage with the research. Our internal pilot trial indicates, therefore, that it is
likely that randomised controlled trials involving groups with complex social problems, including debt, are
likely to be feasible within the current primary care environment in England and Wales (in the face of
significant NHS reorganisations and stretched resources) only if additional investment is available to
support and sustain participant and site recruitment.
Trial registration
This trial is registered as ISRCTN79705874.
Funding
Funding for this study was provided by the HTA programme of the NIHR. Mark Gabbay and Adele Ring are
part-funded by NIHR Collaborations for Leadership in Applied Health Research and Care (CLAHRC) North
West Coast and Richard Byng and Rod S Taylor, Vashti Berry and Elizabeth Shaw part-funded by NIHR
CLAHRC South West Peninsula.
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Chapter 1 Introduction
In 2012, the National Institute for Health Research (NIHR) Health Technology Assessment (HTA)programme invited research teams to submit proposals to evaluate the clinical effectiveness and
cost-effectiveness of an intervention to integrate debt counselling and advice within a primary care setting
(HTA commission call number 11/148). The research question set out in the commissioning brief was ‘Does
the provision of debt counselling and advice in primary care improve the health and well-being of people
with depression and related debt problems compared with usual GP care?’.1
In response to this call, we designed an adaptive, parallel, two-group, multicentre randomised controlled
trial [Debt Counselling for Depression in Primary Care: an adaptive randomised controlled pilot trial
(DeCoDer)] with a nested mixed-methods process and economic evaluation.
The purpose of our trial was to deliver an intervention for patients with depression and worries about
debt within a primary care setting. The intervention was debt advice from a Citizens Advice Bureau (CAB)
advisor that incorporated a shared biopsychosocial assessment by a general practitioner (GP) and debt advisor.
We planned to evaluate this intervention in terms of its clinical effectiveness and cost-effectiveness, collecting
data at baseline and at 4 and 12 months, to compare mental health, well-being and cost-effectiveness
outcomes. We also planned to assess the acceptability and accessibility of the intervention, and facilitators of
and barriers to recovery through both quantitative and qualitative data collection. We conducted an internal
pilot trial to test the procedures, recruitment processes and operational strategies planned for use in the main
trial, so that we could identify and resolve any problems and thereby assess the feasibility of continuing with
the main trial. As a result of issues related to practice recruitment, trial set-up and participant recruitment, the
target sample size for the pilot trial was not achieved according to the pre-defined stopping rules. After
consultation with the NIHR HTA, the trial was stopped and data collection was completed at 4 months for
those already recruited at that stage.
Given that the study failed to reach its recruitment target and was terminated early during the internal
pilot phase, and therefore did not progress to main trial, we report here the findings of the pilot trial
including descriptive statistics [mean and standard deviation (SD)] for the primary, secondary and economic
outcomes by group, at baseline, and at 4- and 12-month follow-up (when available). We also present the
findings of our qualitative analyses concerning participants’ experiences of debt and depression, the
intervention and their involvement in the trial. Using the normalisation process theory (NPT) approach,2 we
report some of the potential barriers to and facilitators of implementing the intervention in practice.
We also report in detail the recruitment process and outcomes, our comparison of cluster versus individual
randomisation and the various challenges we faced in trial set-up and in recruiting general practices and
participants to the study. Our account provides key learning points that will be particularly beneficial to
future researchers planning randomised controlled trials with hard-to-reach and vulnerable groups in
primary care. This group of patients is typically those who are suffering the greatest health inequalities and
it is, therefore, important for the future of research design to understand how we can access such patients
and maximise data collection in these populations.
We note at this point that by the time the current study had been approved for funding and was ready to
commence recruitment, an advice service provided by CAB had already been commissioned by the Clinical
Commissioning Group in one of the three study sites. In April 2012, the Clinical Commissioning Group in
this site agreed to pilot as part of their primary mental health care strategy, a CAB service called the
‘Advice on Prescription Programme’. The proposed model, new for primary mental health care, included a
‘practical offer’ of advice based in primary care aimed at the most vulnerable patients. This service offered
quality-assured advice on benefits, debt, housing and employment support. The service was originally
piloted in nine GP surgeries from April 2012 to March 2013 and then rolled out across all practices from
April 2013, following independent evaluation.3
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The service continued throughout the current pilot trial period and was aimed at people who were at risk
of developing mental health problems as a result of their circumstances. Although this service differed
from that proposed in the pilot trial, it is evidently possible that the availability of this service within general
practices might have contributed to the difficulties we encountered recruiting general practices to the
study in this particular research site.
Scientific background
History of the problem
Depression is estimated to affect 5–19% of adults at any one time.4,5 Depression is a common presentation
in primary care.6 However, research suggests that only around 2.5% of patients are formally recorded by
GPs as having active depression or depressive symptoms.7,8 Alongside anxiety and stress, depression is
considered the most common cause of prolonged work absenteeism,9 as well as presenteeism (working
below normal capacity when unwell). Recent work on the cause of sickness absence indicates that the
proportion of absence due to mild to moderate mental health problems is increasing.10 Mental ill health is
estimated to cost the UK economy £40B per year overall.11,12
Around 16% of the UK population is estimated to be struggling with personal debt,13 and there is increasing
evidence of a link between debt and poor mental health.14,15 In a recent study on the association between
suicide and the 2008–10 economic recession in England, Barr et al.16 identified a link between rising
episodes of suicide and rising debts.
The changing composition of debt and the rise of debt problems
Indebtedness and poverty are endemic in Great Britain,17 particularly in areas of deprivation and high
unemployment, and the economic downturn has only further exacerbated these problems. A report by
Lucchino and Morelli18 found that the difference in consumption growth and income growth was largest
among those on the lowest incomes. The authors concluded that people in the lowest income decile
appeared to be reliant on credit to maintain consumption. Similarly, a UK study that analysed data from
clients seen by the then Consumer Credit Counselling Service (now called StepChange) found high
debt-to-income ratios in households with incomes of up to £13,500. These households held unsecured
debts worth 20% more than their annual net income.19
In a recent study examining the relationship between the increasing number of food banks across the UK
and current austerity, it was found that food banks were more likely to open up in areas of higher
unemployment and those most affected by welfare cuts and benefits sanctions.20
Summary of management of depression in primary care
Most episodes of depression are managed in primary care, following the National Institute for Health and
Care Excellence-recommended four-step approach.7 This involves a range of low-intensity interventions
including social prescribing to support lifestyle changes (e.g. for exercise), short-term talking therapies and
antidepressants for more persistent symptoms. However, a recent HTA trial21 found a marginal benefit of
selective serotonin reuptake inhibitors (antidepressants) for new cases of mild to moderate depression
managed in primary care over treatment as usual (TAU). Consequently, many questions remain about the
most cost-effective ways to manage depression.7
Current debt advice services: issues and gaps
In 2013, the Money Advice Service reported that nearly one in five adults in the UK was affected by
problem debt.22 There has been a sharp rise in demand for debt advice. A recent survey found a 56%
increase in demand for debt advice in the 3 years since 2012.23 The last few years have seen an increase in
the number of ‘priority’ debts, including housing, utilities and government debts (issues about benefits
and tax credit overpayments, social fund debts, child support arrears and magistrate court fines), and a
decrease in non-priority debts.24 Between 2005–6 and 2014–15, the number of priority debts that CAB
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provided advice for more than doubled, whereas personal loan and credit card debt (non-priority debts)
over the same period more than halved since their peak in 2008.24
Recognising the increasing burden of indebtedness and the link between debt and mental ill health
outlined in the Foresight Report,25 the UK government now provides web-based advice and guides on debt
management, highlighting a range of providers.26 Debt advice services are, therefore, now freely available
from commercial, public and third-sector providers. Topping this list is CAB, a charity-based service that is
widely available across the UK in > 3500 locations and provides support to > 2.5 million people per year.27
Its principal online recommended site is provided by the government, funded by a statutory levy from the
financial services industry and backed by a national advertising campaign (the Money Advice Service;
www.moneyadviceservice.org.uk/). However, currently there is no robust evidence regarding the impact of
these services on mental health outcomes or their cost-effectiveness. Furthermore, those with depression,
especially those from socioeconomically deprived groups, may be particularly likely to find such online
services insufficient or inaccessible (because of travel cost, low mood, poor information technology skills and
no/low access to information technology and telephone); therefore, a locally accessible, nationally provided
advice service was thought, at the time of our application submission, to be a potentially important way to
provide easier access to those with the greatest need. Debt is more common among poorer populations,
and is a problem in around one in four of those experiencing mental health problems. This group with
mental health problems make up 50% of those with debt overall.28,29 The strategic economic case for
providing debt advice for people experiencing mental health problems has been made in recent influential
reports, and the intervention we proposed in the current study fell within the suggested service provision
costs and model.30,31
Relationship between debt and depression
A clinical knowledge summary on assessing people with depression advises recording psychosocial factors
‘contributing to the development of depression’;32 at the top of the list are employment and financial
worries. In discussing the relationship between debt and depression, it is important to stress that the debt
relates to financial liability that is large in relation to income and is difficult or impossible to repay.33
Social surveys have consistently found a negative correlation between unsecured personal debt and
subjective measures of happiness and life satisfaction.34,35 One debt charity found that debt affected
people’s sleep and concentration at work, and put a strain on family relationships.23 Another debt charity,
Citizens Advice, released data suggesting that 60% of its clients had received a mental health diagnosis
within the previous 6 months and that in 56% of cases its debt advisors felt that their clients’ mental state
had a negative impact on their ability to make ‘reasonable decisions’ about credit.36
A survey by Mind37 identified an increase in rates of debt among people with mental health problems.
This report suggests that a two-way relationship can exist between debt and mental health. Of those
people surveyed, nearly three-quarters thought that their mental health problems had made their debt
worse. This rose to more than four-fifths among those in problem debt, which was defined as occurring
‘where an individual is two or more consecutive payments behind with a bill or repayment’ (p. 1).37 In
addition, almost 9 out of 10 of those in problem debt said that they thought that their financial difficulties
had made their mental health problem(s) worse.
A recent meta-analysis on the relationship between personal unsecured debt and health38 found a
significant relationship between debt and depression. The authors identified psychological elements,
such as worry and stress, hopelessness, and locus of control, as potentially playing a role in mediating
the relationship.
In a large household survey, Bridges and Disney39 found a strong association between depression and
self-reported indebtedness and financial stress. They also found a weaker link between the onset of
depression and subsequent financial difficulties. Although they found no direct association between
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objective measures of depression and debt, the authors did find an indirect association via subjective
indicators of financial well-being.
Fitch et al.40 conducted a systematic narrative analysis of peer-reviewed literature on the relationship
between personal debt and mental health. They found that indebtedness may contribute to the
development of mental health difficulties and mediate accepted relationships between those difficulties
and poverty and low income.
Drawing on data from a national household survey, Gathergood41 has explored some of the causal links
between problem debt and depression and has introduced the idea of social norm effects. He concluded
that exogenous factors, such as the level of social stigma in relation to debt, may have both positive and
negative effects on the links between debt and depression.
In conclusion, the literature suggests that social and psychological factors may mediate the relationship
between debt and depression, in either direction. Longitudinal research is needed to explore aspects of the
relationship between debt and depression further, such as (the direction of) causality and the specific
mechanisms and mediators that are involved. This may help in developing appropriate policies and
practices to help (depressed) people avoid and manage problem debt, and to prevent and treat depression
in those with debt. Research would also help identify which type of intervention works best for whom.
Aims and objectives of the main trial
As reported above, the early termination of this study in the pilot phase precluded statistical evaluation of
the clinical effectiveness and cost-effectiveness of the intervention. However, we were able to address
most of key objectives of the main trial in a modified form, as detailed below in italics.
The objectives of the main trial were:
1. to compare depression between intervention and control groups – we report descriptive statistics
(mean and SD) at baseline and at 4 and 12 months, when available
2. to compare anxiety, mental well-being, debt/financial status, satisfaction, health-related quality of life
and societal costs between intervention and control groups – we report descriptive statistics (mean
and SD) at baseline and at 4 and 12 months, when available
3. to explore outcomes referred to in (1) and (2) in terms of the following potential predictors –
substance misuse problems, self-esteem, life events and difficulties, hope, optimism, resilience and
attribution style – we report descriptive statistics only
4. to determine core outcome domains and measures using the Core Outcome Measures in Effectiveness
Trials initiative approach to define a standard outcome measure for mental health trials in deprived
and hard-to-reach groups in primary care, adapted to this specific study – we make tentative
recommendations only
5. to manualise debt assessment, joint comprehensive assessment (GP/patient/CAB) and counselling
intervention for use within the intervention – we undertook limited testing
6. to recruit new and chronic/recurrent cases from a variety of practices and populations to enhance
generalisability – we could not address
7. to undertake a mixed-methods process evaluation to assess fidelity of intervention (using NPT) and
explore reasons for observed outcome differences and relationships between depression, anxiety,
debt, stigma, shame and psychosocioeconomic factors; triangulating economic, psychological factors
analysis and qualitative interview data – we have partially addressed
8. to undertake knowledge exchange events to inform adoption into care pathways (implementation) –
we will undertake a reduced dissemination plan
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9. to work closely with service users in research/patient and public involvement (PPI) groups across the
study sites to inform trial methodology, intervention development, aspects of analysis and the
implementation of preparatory work – we addressed in full
10. to recruit a virtual group of commissioners, providers and health and well-being board members to check
willingness to commission the intervention and advise on domains and measures – we undertook a
modified activity
11. to work with CAB leads, GPs and PPI advisors on developing the intervention and comprehensive
assessment, qualitative topic guides and aspects of data analysis – we addressed in full.
Aims and objectives of the pilot trial
The aim of the pilot trial was to test the procedures, recruitment processes and operational strategies that
were planned for use in the main trial and to identify and resolve any problems in continuing with the
main trial. We addressed this aim and all of the following objectives of the pilot trial:
1. to confirm methods for recruitment of practices
2. to test the ability to recruit patients via the proposed approaches
3. to confirm the acceptability of the study interventions
4. to confirm acceptability of data collection (outcome measures)
5. to assess contamination and confirm the randomisation method for the main trial
6. to assess the level of participant attrition
7. to check the robustness of data collection systems
8. to identify and resolve potential difficulties in implementing the shared assessment
9. to assess intervention fidelity.
Intervention: theory and development
Our intervention was informed by the principles of collaborative care.42,43 The principles of collaborative
care include (1) adopting a multiprofessional approach (e.g. a GP plus at least one other professional),
(2) a structured management plan, (3) scheduled patient follow-up and (4) enhanced interprofessional
communication. A collaborative approach to patient care has been shown to improve quality of life,
healthy behaviours, self-efficacy and other health outcomes.44 In addition, our intervention aimed to
redress inequalities and promote social inclusion of marginalised groups.45 Our intervention was based
on the assumption that social context plays an important role for mental illness onset and recovery,
particularly in the case of debt and depression.40
Our intervention brought together two existing services: (1) primary care mental health services provided
by general practices, supplemented by Improving Access to Psychological Therapies (IAPT) services in
England, and in Wales a variety of counselling and psychological therapies services; and (2) debt
counselling provided by third-sector providers, such as CAB (see Figure 1).
Our model of debt advice – debt advice provided by CAB advisors – was distinct from many of the
commercially available offers of debt consolidation as the focus of our intervention was on face-to-face
debt advice, assessing the level and urgency of debts and arrears, and then triaging clients to specific
detailed advice on debt or money management.
Liaison has been shown to be an important element of collaborative care and shared care more generally.46
In developing the intervention we considered that communication would be enhanced through a
comprehensive assessment that was cocreated by, and shared among, the patient, CAB advisor and GP.
The purpose of the shared comprehensive assessment (SCA) was to combine social, psychological,
environmental, economic and medical perspectives with personal goals, in the production of a
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biopsychosocial management plan. We developed a SCA form for sharing of information between GPs and
CAB advisors with input from GPs, CAB advisors and managers and service users (see Appendix 1).
The active parts of our intervention as a whole were the combining of primary care treatment of depression
with the addition of debt counselling and a comprehensive shared assessment, supported by the co-location
of GP and debt advisor in primary care; the additional pathways of care; enhanced communication between
the GP and debt advisor; and case management for participants (see Appendix 2). Figure 1 summarises
all the aspects of the intervention and TAU options, whereas Table 1 summarises and compares the
contributions of the GP and CAB advisor within the intervention. Figure 2 maps the key components of this
approach: co-location, shared assessment and enhanced interdisciplinary communication.
Process evaluation
We used semistructured interviews with participants, GPs and CAB staff to evaluate the process of
integrating the intervention within primary care. We adopted a NPT approach2 to data analysis, which
focuses on the various actors, objects and context of the intervention (see Chapter 2, Intervention process
evaluation, Data analysis, for more detail of this approach).
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TABLE 1 Summary of GP and CAB debt advisor roles within intervention
GP CAB advisor
Undertake initial part of shared assessment and complete
form (estimated to take up to 20 minutes – double
appointment slot)
Undertake CAB section of shared assessment
Commitment to share care and decisions with the CAB
advisor, with patient at the centre of care
Commitment to share care and decisions with the GP,
with patient at the centre of care, sharing information
with GP as part of structured agreed plan, plus informal
case liaison as required
Share additional information with CAB advisor as appropriate
(using shared comprehensive GP follow-up form) as part of
structured management plan and enhanced communication
between GP/CAB
Case manage patient and work with GP team to
encourage engagement and retention within the planned
intervention taking account of contexts of shame, stigma
and chaotic life circumstances, the patient and their
attendances during intervention
Work with patient and CAB advisor to encourage engagement
and retention within plan in contexts of shame, stigma and
chaotic life circumstances
Support patient to devise and deliver solutions to debt
problems sensitive to mental health contexts
Problem debt
IAPT and other 
evidence-based 
treatments
Collaborative care
CAB debt counselling
Co-location
Case management
Enhanced communication
Shared comprehensive assessment
GP care
Intervention
Other social problems Shame
Anxiety
Depression
Problem debt
FIGURE 2 Conceptual map of the intervention and potential impact for individuals.
INTRODUCTION
NIHR Journals Library www.journalslibrary.nihr.ac.uk
8
Chapter 2 Methods
Pilot trial design
We designed an adaptive, parallel, two-group, pragmatic randomised controlled trial with 1 : 1 allocation
to intervention or TAU control, with a planned mixed-methods process and economic evaluation. During
the pilot trial we assessed intervention fidelity and any implementation problems, seeking to resolve any
issues without change to the intervention so that data collected in the pilot trial could be used in the final
analysis at the end of the full trial. We used both individual and cluster randomisation methods in the pilot
trial to assign participants to the intervention or the control arm (see Table 1), with the aim of using
individual-level randomisation in the main trial (should it have gone ahead) if the pilot trial showed no
substantive evidence of contamination (crossover of the intervention between trial arms).
Changes to trial protocol and methods
We undertook several revisions of the protocol and study methods over the course of the pilot trial in
response to the differing issues we encountered. This was within the parameters of the adaptive design
within which we anticipated a degree of iterative protocol development in the internal pilot phase. The
changes to the protocol and methods (listed in this section) were approved by the NIHR HTA programme,
the University of Liverpool (research sponsor), Research Ethics Committee North West, in Preston, and the
local research management and governance offices [Clinical Research Network (CRN), North West Coast
(lead CRN), Royal Devon and Exeter NHS Foundation Trust and Abertawe Bro Morgannwg University
Health Board].
Changes to exclusion criteria
Following confirmation from CAB that participants could be visited in their own home by CAB advisors,
we removed ‘housebound’ from the exclusion criteria.
Following early contacts with interested patients, we made an addition to the study exclusion criteria to
exclude patients (prior to consent) who did not wish to take up support for debt/money worries provided
via the general practice. This was to ensure that potential participants were clear about what their
participation might involve, and that we consented into the study only those who were interested in
receiving support for their money worries through this route.
Changes to participant recruitment procedures
Our original intention was that CRN staff would support research assistants (RAs) in handing out flyers
(advertising the study) and expression of interest (EOI) forms to patients in general practice waiting rooms.
As a result of resource issues, CRNs were unable to support these activities, so we approached general
practices to ask if their staff would be willing to hand out flyers/EOI forms; following necessary approvals,
general practice staff (including reception staff) in some practices did this. The potential benefits of this
change were twofold: first, if all patients were simply handed the flyer at reception, patients would not
feel like they were being singled out in the waiting room; and, second, patients would still be able to
receive information about the research when RAs were not in the practice, ensuring that as many patients
as possible were given the opportunity to be made aware of the study and register their interest. We also
made a change to the information pack sent out to patients by post, namely adding the advertisement
flyer. This meant that patients could read the brief summary information in the flyer and decide whether
or not they were interested in the study before they went on to read through the much more detailed
participant information sheet.
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Change to requirement for general practitioners to check identified patient lists
Towards the end of the pilot trial we changed the directive for GPs to check patient lists generated from
practice database searches to a neutral suggestion that GPs may choose whether or not to check the
patient list. The reasons for this change were twofold. First, although all GPs received similarly worded
advice, our experience showed that individual GPs were checking patient lists in very different ways. Some
were looking at records in great detail and excluding substantial numbers of potential participants, some of
whom might have been eligible to participate and were potentially being denied the opportunity. Other
GPs adopted much narrower exclusion criteria, simply confirming no errors in coding and that a patient’s
participation was not impractical (e.g. because they were recently bereaved, terminally ill or sleeping rough).
We considered the ethical issues regarding this change, and felt that, although the original protocol was
based on the idea that GPs should exclude those patients whom they deemed unsuitable for us to
approach, it was also equally valid that patients make this choice for themselves on reading the flyer and
letter of invitation. Second, based on recruitment rates at that time, we needed to increase considerably the
number of patients approached by letter, at least doubling the number of patients we had originally
planned to approach in each practice. We were already aware that some GPs were struggling to find time
to check the number of patients originally planned, resulting in delays to patient recruitment. This difficulty
would have been further compounded by increasing numbers of patients for review. In the event, this
change was introduced just before the trial was closed, so only one practice was recruited after the change
came into effect, and it was not possible to judge the impact of this change on recruitment delays.
Change to mail-out procedure
Following a request from one practice, we introduced the option for practices to use the Docmail® v2.0
(CFH Docmail Ltd, Radstock, UK) service for sending out the information pack to patients, but this practice
was the only one to adopt this method. It did not result in any important delays or additional complexities
to recruitment.
Practice identification, recruitment and training
In the pilot trial, we planned to recruit 12 general practices across the three research centres (with an
average of approximately 10,000 patients per practice). Two of these practices were to be those in which
GP members of the research team were based. Using these two sites early in the pilot enabled the GP
academics on the study team to closely monitor how the systems worked within their practices. This
facilitated feedback from colleagues about problems, enablers and barriers to delivering the study, thus
informing team discussions about adaptations during the pilot. The remaining practices were randomly
selected (by the study statistician) from the full list of practices at each site. All practices were matched
according to whether situated in high- or low-deprivation communities and practice size (large/medium/small).
Identified practices were initially approached by CRN staff (and in one centre by research staff) and sent
an invitation letter with brief information about the study (see Appendix 3). We followed up this initial
communication with a telephone call (from the CRN officer or a member of the research team, if appropriate)
to ascertain if the practice was interested in the study. When a practice declined to participate, the study
statistician identified further matched practices.
When a practice registered interest in participating in the study, we arranged a meeting between
GPs/practice staff and members of the research team to discuss this. In some sites, CRN staff also attended
practice meetings to discuss the support they could provide to practices.
No financial incentives were offered to practices for taking part in the study. Service support costs were
reimbursed for meetings with the research team, for administrative activities carried out by practice staff
(e.g. practice database searches) and for a GP’s time spent checking patient lists, and excess treatment
costs were met for GPs delivering the shared assessment component of the intervention. Control GPs did
METHODS
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not receive any payment for providing TAU and handing out the two debt advice leaflets to participants in
the control arm of the trial.
Following paired practices’ agreement to take part, we informed practices of their allocation and asked
them to select the GPs and staff members who would be involved in the study. Principal investigators
and/or research managers arranged further meeting(s) with GPs and selected staff for the purposes of
training, and CAB staff met with GPs and practice staff (when appropriate) to explain the debt advice
process and what this would entail. We provided GPs with a study pack containing supporting documentation
including a participant pathway flow diagram (see Appendix 4), a protocol guidance sheet (relevant to
practice allocation) (see Appendices 5 and 6), a serious adverse events form (see Appendix 7), a copy of
the study debt advice leaflet (see Appendix 8), a copy of the Royal College of Psychiatrists’ debt advice
leaflet47 and the SCA form (see Appendix 1), when appropriate. For intervention practices we also
discussed the shared biopsychosocial assessment and stressed that this was an important component of
the intervention, intended to support case management by the CAB advisor and facilitate the sharing of
relevant key elements of the history and progress. We sent GPs and relevant practice staff a link and login
to the password-protected study website, and training was provided using test data. Research managers
and/or RAs provided ongoing support for GPs and practice staff via telephone calls, e-mail communications
and further visits to the practice.
Trial participants: selection and recruitment
Patients with a history of depression (with or without anxiety) within the last 12 months and who also had
worries about personal debt were identified through participating general practices at the study centres.
Inclusion and exclusion criteria
Patients were eligible to take part if they:
l were aged ≥ 18 years
l scored ≥ 14 on the Beck Depression Inventory II (BDI-II)
l had worries about personal debt.
Patients were excluded from taking part if they:
l were actively suicidal or psychotic and/or severely depressed and unresponsive to treatment
l were experiencing severe problems with addiction to alcohol or illicit drugs
l were unable or unwilling to give written informed consent to participate in study
l were currently participating in another research study including follow-up data collection phase
l had received CAB debt advice in the past 12 months
l did not want support about debt or money worries provided through the general practice.
Participant recruitment
We recruited patients to the study via two approaches.
1. GP database searches and letter mail-out: practice database searches were conducted by CRN officers
or practice staff to identify adult patients potentially with current depression or who had depression-
related treatment in the last 12 months. GPs subsequently screened generated patient lists to exclude
any patients they deemed inappropriate for the study (with one exception after a protocol amendment,
see Change to requirement for general practitioners to check identified patient lists). Practices sent a
standard introductory pack (including covering letter, advertisement flyer, participant information sheet,
EOI form and freepost envelope) (see Appendices 9–12) to potentially eligible patients.
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2. Waiting room recruitment: publicity posters (see Appendix 13) were displayed in the waiting rooms of
participating general practices and flyers with attached EOI forms (see Appendices 10–12) were placed
around the practice waiting room. Flyers/EOI forms were also handed out by study RAs in practice
waiting rooms, and in some practices by practice staff. Interested patients were able to either hand the
completed EOI form back to the RA or return it at a later date in the freepost envelope provided.
Participant eligibility checking and consent
On receipt of a completed EOI form, local RAs contacted the respondent by telephone to discuss the
study and assess initial eligibility (i.e. that the patient had worries about debt that they were personally
responsible for, was not currently taking part in any other research, had not received debt advice from the
CAB in the past 12 months and was interested in receiving support for money worries provided via their
general practice). If, after this, the patient was still interested in taking part in the study (and eligible at this
point), the RA arranged a date and time to meet with the patient to complete the formal consent to
participate process, including obtaining formal written consent (see Appendix 14), a final-stage eligibility
check (completing the BDI-ll) and the collection of baseline data (Table 2). Participants scoring < 14 on the
BDI-ll were advised that they were not eligible to take part in the study, thanked for their time and
willingness to participate, and given the same two debt advice leaflets as those given to study participants.
TABLE 2 Data collection schedule
Data/measure Baseline 4 months 12 months
Demographic (age, sex, deprivation score, etc.) ✓
BDI-II ✓ ✓ ✓
Alcohol Use Disorders Identification Test (AUDIT) ✓ ✓ ✓
Drug Abuse Screening Test (DAST) ✓ ✓ ✓
Beck Anxiety Inventory (BAI) ✓ ✓ ✓
Short Warwick–Edinburgh Mental Wellbeing Scale (SWEMWBS) ✓ ✓ ✓
Client Service Receipt Inventory (CSRI) (adapted for trial) ✓ ✓ ✓
EuroQol-5 Dimensions-5 levels (EQ-5D-5L) ✓ ✓ ✓
Manchester Short Assessment of Quality of Life questionnaire (MANSA) ✓ ✓ ✓
Stanford Presenteeism Scale ✓ ✓ ✓
CAB/Control Debt Assessment and Outcomes questionnaire ✓ ✓ ✓
General Satisfaction Questionnaire (GSQ) ✓
Hope Trait Scale ✓ ✓
Life Events and Difficulties Schedule-short (LED-S) ✓ ✓
Other as Shamer scale (OAS) ✓ ✓
Response Style Questionnaire-24 (RSQ-24) ✓ ✓
Qualitative interviews
Participant purposive sample ✓ ✓
Professional (GP/CAB staff) purposive sample Once all participant
consultations complete
METHODS
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Outcomes of pilot trial
Assessment of approach to practice recruitment
We assess our approach to practice recruitment by comparing figures for number of practices approached
versus number recruited (see Table 4), and we record the reasons why practices declined to participate (see
Table 5). We also evaluate our recruitment approach by recording the time (in days) from the initial contact
with each practice to the practice’s recruitment (see Table 6). We also report findings from a focus group
analysis on trial processes (barriers to and facilitators of recruitment of practices) and information recorded
by CRN staff and study team members.
Assessment of ability to recruit patients via proposed recruitment approaches
We assess the two approaches to participant recruitment (database search and letter mail-out vs. waiting
room recruitment) by comparing the number of participants recruited via each approach (see Table 9).
We report the number of participants recruited during the pilot stage of the trial compared with target
recruitment (see Table 12) and we report the conversion rate from participants returning an eligible EOI to
being randomised into the study (see Table 10). We report reasons for dropout, ineligibility and loss to
follow-up rates (Figure 3) and we compare the cost per returned EOI form between the two recruitment
approaches (see Table 11).
Assessment of contamination
We assessed contamination based on self-reported information about receipt of CAB advice provided by
participants at the 4- and 12-month follow-up visits. We report the proportion of control participants
within each site with an individual allocation receiving CAB advice versus those in cluster-allocated control
sites receiving CAB advice.
Assessment of patient satisfaction with intervention
We assessed participants’ satisfaction with the intervention based on data from the self-report General
Satisfaction Questionnaire (GSQ) collected at 4-month follow-up and from participants’ reported
experiences of the intervention during the qualitative interview.
Assessment of acceptability of data collection (outcome measures)
We assessed acceptability of data collection (outcome) measures based on participants’ reported
experiences (from qualitative data) of data collection measures and from RAs’ feedback about comments
of participants at the time of the assessment.
Assessment of intervention fidelity
Intervention fidelity was assessed based on information from the clinician and CAB advisor qualitative
interviews.
Assessment of data collection systems and data completeness
Data collection and entry systems
Data were collected using paper-based participant booklets and researcher-completed case report forms
(CRFs). Paper documents were sent to Peninsula Clinical Trials Unit (PenCTU) so that the data could be
entered into a password-protected database. Data were double entered (by two independent staff
members) and then compared by standard scripts for any errors. All errors were checked back to the
original forms or queried with sites and then corrected. Data were centrally tracked using a web-based trial
management system. Microsoft SQL Server 2014 (Microsoft Corporation, Redmond, WA, USA) was used
as the database software behind the websites.
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Identify practices
Select four (matching) in each of three sites
(repeat through recruitment until sample size achieved)
Randomise to cluster or individual in phase 1
Then continue either cluster or individually randomised in phase 2
Ongoing care (intervention or TAU) and follow-up by researchers at 4/12 months
Ongoing care (intervention or TAU) and follow-up by researchers at 1 year
Recruit patients (waiting room 
recruitment and letter mailout)
and randomise after collection 
of baseline data
Individually 
randomised
practice 1
Individually 
randomised
practice 2
Invite to GP review (and 
information concerning
debt counselling) = TAU
Invite to GP review 
and debt
counselling = intervention
Recruit patients (waiting room 
recruitment and letter mailout; 
collection of baseline data)
Cluster 
practice 1
Cluster 
practice 2
At 4/12 months 
follow-up
(n)
At 4/12 months 
follow-up
(n)
At 4/12 months
(n)
At 4/12 months
(n)
Interim analysis at end of phase 1 on 4-month process data to check for contamination – if minimal 
continue individual randomisation only, if not cluster randomise only
Also to recalculate sample size depending on SD and retention estimate
At 12 months
(n)
At 12 months
(n)
At 12 months
(n)
At 12 months
(n)
Randomise clusters 
(by minimisation if ongoing)
Cluster 1
patients
Cluster 2
patients
TAU Intervention TAU InterventionCluster (TAU)
Cluster 
(intervention)
Invite to GP review (and 
information concerning
debt counselling) = TAU
Invite to GP and debt
counselling = intervention
FIGURE 3 Trial flow diagram.
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Data completeness
Data that were ‘missed’ were chased when appropriate and, if still missing, were marked as such.
Pre-defined rules (as recommended in the relevant literature and supporting documentation) were
employed for dealing with missing data; for example, for the main outcome (BDI-II), if the missing count
of items was ≥ 10 the total score was computed.
Data exports
Various reports for study management were created in Microsoft Access® v15.0 (Microsoft Corporation,
Redmond, WA, USA) and Microsoft Excel® v15.0 (Microsoft Corporation, Redmond, WA, USA) using tables
linked directly to the website data. These links were read only. Data were extracted from the website using
Microsoft Access. The data were complemented by an export dictionary, which listed all the fields and
their possible values and meanings.
Participant outcomes
Primary outcome and measurement
The primary outcome was severity of depression measured using the 21-item self-report BDI-II.48 All
measures of mood are essentially self-reported; although a person’s demeanour, dress and behaviour can
tell us something about their internal emotional status, their mood cannot be directly observed. It can be
argued, therefore, that instruments such as the Hamilton Rating Scale for Depression, which are applied by
professionals, are no more valid than those that are completed directly by patients. Furthermore, it has been
shown that a professional rating of a person’s emotional state adds nothing of value over and above a
self-report.49 Thus, the BDI-II is commonly used to assess depression in primary care mental health studies.
The BDI-II was completed by participants at baseline and at the 4- and 12-month (for participants
completing their participation before the trial was closed down) follow-up assessments. Participants were
classified according to the following categories: 14–19 points (mild depression), 20–28 points (moderate
depression) and > 28 points (severe depression).
Secondary outcomes and measurement
The secondary outcomes included psychological well-being, health-related quality of life, cost-effectiveness,
participant satisfaction and explanatory factors. For data collection time points for secondary outcome
measures, see Table 2. We discussed the proposed data collection plan with a panel of NHS commissioners
to ensure that the types of data we were planning to collect were considered relevant to influencing
commissioning decisions, and to confirm that a positive trial result had the potential to positively influence
service commissioning (as per the HTA brief).
Measures of psychological well-being
l The Beck Anxiety Inventory (BAI),50 a 21-item self-report measure, was used to assess severity of
anxiety. The BAI was chosen for consistency with the BDI-II.
l The Short Warwick–Edinburgh Mental Wellbeing Scale (SWEMWBS)51 was used to measure aspects
of positive psychological function, covering both hedonic (e.g. positive feelings and emotions) and
eudaimonic (e.g. positive functioning) aspects. The SWEMWBS is a shortened version consisting of
seven of the original 14 items. The SWEMWBS was chosen for inclusion in the North West Mental
Wellbeing survey and identified as the psychological well-being indicator in the government’s Public
Health Outcomes Framework.52
Measures of health-related quality of life
l The EuroQol-5 Dimensions-5 levels (EQ-5D-5L)53 is a well-known and commonly used generic measure
of health status. It is used to measure outcomes in clinical effectiveness, cost-effectiveness and
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population health studies.54 It is a patient-reported outcome measure in the Patient Reported Outcome
Measures programme run by NHS England.55 A key feature of the EQ-5D-5L is the ability to generate
‘utilities’ for health states (reflecting the preferences of the general public), which can be used to
estimate quality-adjusted life-years (QALYs).
l The Manchester Short Assessment of Quality of Life questionnaire (MANSA)56 was chosen because it is
preferred by service users, is more specific for mental health studies and has good reliability and validity.56
Measures of health and social care utilisation
l A version of the Client Service Receipt Inventory,57 together with a comprehensive ‘guide’ describing all
the resource use items, was adapted for this study population and used to measure NHS and social
services resource use, and also contact with criminal justice services.
Employment factors
l Work-related issues were measured by self-report (absence and partial work). We decided against a
primary care records ‘Fitnote’ search, as the Medical Certificate of Fitness for Work (MED 3s) is a
recommendation not a measure of actual absence, with modified or partial work subject to
employer agreement.
l Impact of health problems on work performance was measured using the Stanford Presenteeism
Scale-6 items (SPS-6).58
Record of personal debt issues
We recorded priority and non-priority debts in participants’ CRFs at all three assessment points (baseline,
4 months and 12 months). Priority debts are those that must be dealt with first because of the sanctions
available to priority creditors in the event of non-payment; such debts include mortgage or rent arrears,
secured loans, council tax, gas/electricity, child support, income tax, fines, value-added tax, hire purchase
and telephone arrears. Non-priority debts are those debts for which the only course of recovery action is to
sue the client in the county court. They do not involve the legal sanctions that are available in response
to priority debts, such as eviction or service disconnection. Generally speaking, therefore, all other types
of debt are non-priority and include, but are not limted to, credit cards, personal loans, charge cards,
catalogues, personal debts to family and friends, doorstep-collected loans, credit sale agreements, trading
cheques and vouchers.
We chose to record priority and non-priority debts as opposed to absolute amount of debt because
comparing the absolute amount of debt at baseline and outcome is less important than comparing the
extent of arrears and priority debts. The risks from debt may be reduced, alongside the associated worries,
without the absolute amount necessarily also reducing; it is the potentially serious consequences that often
provoke distress and the resolution of these that provides relief, even though the outstanding amounts may
remain. Study RAs were provided with guidance from the CAB in recording priority and non-priority debts.
Service satisfaction
Service satisfaction was measured with the GSQ.59 The GSQ was chosen because it is a brief measure with
good psychometric properties and has been used before in studies of people with mental health problems.
Measures of substance misuse
l Alcohol use was measured with the self-report version of the Alcohol Use Disorders Identification Test
(AUDIT).60 We chose to use the AUDIT because it is a well-recognised and widely adopted measure of
alcohol consumption in primary care, and its reliability and validity have been established.
l Illicit drug use was measured with an adapted version of the Drug Abuse Screening Test.61 We chose
this measure because it is simple and relevant, and widely used in the USA; there is no UK-specific
equivalent.
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Record of life events and difficulties
Life events and difficulties were assessed using the Life Events and Difficulties Schedule-short (LED-S).62 The
LED-S is a researcher-led semistructured interview schedule that has been widely used and acknowledges
the difference between the respondent’s personal reported actual reaction to a stressor and the ‘contextual’
severity of that stressor, namely how severely most people in the respondent’s biographical circumstances
(or ‘context’) would be expected to react to an event with those same ramifications. Raters have to undergo
detailed training and lengthy manuals of examples of various types of events and ongoing difficulties to
inform their ratings of the tape-recorded interviews. It pays special attention to dating of stressors in
relation to symptoms, and can be used in both quantitative and qualitative research.
Life events and difficulties were assessed for the 12 months prior to baseline assessment and for the period
between baseline and the 4-month follow-up assessment.
Research assistants received extensive training in LED-S from Tirril Harris, one of the authors of this
monograph and co-applicant on the grant, who is an original author of the LED-S. All RAs attended an
initial intensive training session with Tirril Harris and had the opportunity to undertake practise LED-S
interviews with members of the public with a history of depression and debt. Tirril Harris also conducted
consensus meetings with RAs throughout the data collection period to discuss and advise on coding of
LED-S data. Further guidance and support was provided by Tirril Harris via telephone and e-mail to support
RAs in coding of LED-S data.
Explanatory measures
Research on the relationship between debt and psychological distress consistently suggests that the
relationship between distress and subjective measures of debt severity is stronger than that with objective
measures. For example, Drentea and Reynolds63 analysed data from a large two-wave panel survey in the
USA. Their analysis found that although debt (uniquely among the socioeconomic variables studied) was
significantly related to a clinically valid measure of depression, the strength of the relationship did not vary
as a function of individuals’ financial position; that is, being in debt was experienced as bad irrespective of
its objective severity. In a British study, Bridges and Disney39 analysed the UK Families and Children Survey.
They identified a strong positive association between subjective debt problems and self-reported mental
health difficulties in the family, which persisted when objective financial circumstances were controlled for;
hence, they concluded that ‘only a weak link exists between “objective” measures of the financial position
of the household and psychological stress’.39
Given these and other findings, it was felt important to include measures of psychological factors that
might plausibly mediate the debt–distress relationship within the DeCoDer study, because this would offer
the possibility of exploring within-group variability in outcomes. However, research evidence bearing
directly on the question of which constructs might be most significant to perceptions of debt severity was
limited. Hypotheses were therefore generated on the basis of psychological mechanisms known to be
implicated in depression in other settings.
We had planned to assess three psychological constructs, each having been strongly associated with
depression in previous work and that might reasonably be hypothesised to mediate the debt–depression
relationship. As a result of the early closure of the trial and smaller than anticipated sample size, mediational
analyses were not possible, but we report instead descriptive data for the following three constructs.
1. Hopelessness: the feeling of little or no hope for the future has long been associated with both depression
and suicide. An analysis of the British National Survey of Psychiatric Morbidity in 2011 suggested that
hope/hopelessness may be a strong mediating factor in the relationship between self-reported debt
problems and suicidal ideation.64 A positive association between suicidal ideation and self-reported
indebtedness and a ‘strong indirect effect through hopelessness’ has been described previously.64 There
are two widely used psychometric instruments to measure hope: the Adult Hope Scale65 and the Beck
Hopelessness Inventory.66 These measures conceptualise hope in slightly different ways. The latter
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measures hopelessness in terms of just negative expectations about the future, whereas the former
conceptualises hope in terms of a sense of agency (feeling that it is possible to effect change in one’s life)
and a pathway (having the ability to find a solution to the problem). The Adult Hope Scale was, therefore,
better suited to the current trial, as a central aspect of the intervention was helping people to see practical
ways to better manage their finances.
2. Shame: depression has been associated with the experience of negative social comparison, such as
comparing oneself unfavourably to someone else or imagining their judgement.67 There is evidence
that debt problems may cause people to judge themselves negatively compared with others. For
example, Gathergood41 found that people in debt were more likely to experience mental health
problems if they lived in areas where the wider prevalence of debt problems was low. We used the
Other as Shamer scale (OAS)68 (a psychometric instrument developed in order to measure external
shame) to assess a participant’s beliefs about how others evaluate the self. The OAS is conceptualised
as a trait measure, reflecting an individual’s characteristic and global beliefs about how they are viewed.
We decided to use this measure, instead of the originally proposed Attributional Style Questionnaire,
because the OAS appeared to capture more accurately the experience of being judged negatively by
other people – hypothesised as a mediating factor in the debt–depression relationship.
3. Rumination: rumination is defined as ‘repetitively focusing on one’s symptoms of distress and the
circumstances surrounding these symptoms’.69 Rumination is strongly associated with depression70 and
impairs problem-solving ability.71 Ruminating on debt is likely to increase negative affect and limit the
extent to which individuals are able to conceive ways to improve their financial situation. We assessed
rumination with the Response Style Questionnaire-24,72 the most commonly used measure of
depressive rumination.73
Sample size
For the full trial we estimated that we would require 135 patients per arm in order to have 90% power to
detect a clinically meaningful difference in the primary outcome of 3.5 BDI-II units between groups at 5%
two-sided alpha (based on a SD of 9).74 To allow for a cluster (practice-level) allocation of patients, we
inflated the sample size by a design effect of 1.45 (assuming an intracluster correlation coefficient of 0.05
and an average cluster size of 10).75 Based on this proposed sample size for the full trial, we proposed a
sample size of 120 patients for the pilot trial, randomised to intervention and control (TAU) arms, nested
by individual or cluster randomisation. Given its early termination, the study did not progress to a full trial
and achieved a recruited patient sample size of 61 patients (32 in the intervention group and 29 in the
TAU group) in the pilot phase.
Trial interventions
Treatment as usual plus two debt advice leaflets
Following randomisation, participants assigned to TAU were contacted by their general practice to arrange
an initial consultation with the GP participating in the study. We asked practices to arrange this initial GP
assessment within 1 week of the participant being randomised, whenever possible. During this initial
appointment, GPs managed participants in line with their trial arm allocation, conducting an initial assessment
(or review for those already in treatment) of both anxiety and depression, discussing treatment options and/or
progress (medication/psychological therapy) and negotiating an ongoing management plan. We advised GPs
that TAU could include a referral to the local IAPT service and might normally include up to 12 further GP
contacts; they were also free to refer participants to other treatment/services as they deemed appropriate (see
Appendices 5 and 6). We also asked TAU GPs to hand out the study debt advice leaflet (see Appendix 8) and
the Royal College of Psychiatrists’ debt advice leaflet.47 GPs were asked to record all non-attendances in the
password-protected study website and to make reasonable attempts to recontact patients to check if they
wished to rebook their appointment with the GP.
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Intervention: treatment as usual plus primary care-based Citizens Advice Bureau debt
advice plus two debt advice leaflets
Following randomisation, participants assigned to the intervention arm of the trial were contacted by
their general practice to arrange an initial consultation with the GP participating in the study. We asked
practices to arrange this initial GP assessment within 1 week of the participant being randomised
whenever possible. During this initial trial appointment, GPs conducted the same patient assessment and
review as for TAU participants. In addition, intervention GPs were asked to confirm the participant’s
willingness to continue in the trial and obtain their written consent for completion of the SCA form
(see Appendix 1), sharing of information with CAB advisor and referral for an appointment with a CAB
advisor. The signed SCA form was retained by the practice and participants were offered a printed copy.
As in the TAU arm, we asked intervention GPs to hand out the two debt advice leaflets to participants
during the consultation (see Appendices 5 and 6 for intervention GP protocol). We asked GPs to record all
non-attendances on the password-protected study website and to make reasonable attempts to recontact
participants to check if they wished to rebook the GP appointment.
When participants agreed to CAB referral, CAB advisors contacted participants to arrange an initial
assessment appointment. We asked CAB advisors to arrange the initial appointment within 2 weeks of
receipt of the referral whenever possible. The advisors were asked to case manage the participants and
send them appointment reminders as required.
The aim of the initial CAB appointment was to assess the severity of debt and other social problems, and
to draw up a management plan. At the end of the assessment there was an agreement regarding whether
the participant required a higher-level debt counselling intervention or the basic debt counselling provision.
The CAB intervention was implemented utilising protocols (see Appendix 15 for the CAB advisor protocol),
manuals, training and organisational agreements. Appointments between the CAB advisor and participant
usually took place at the participant’s own general practice (to facilitate liaison between GP and CAB
services), although CAB advisors visited some participants at alternative venues at the request of the
participant. More detailed information about the CAB advisor and GP roles is provided in section 4.1 of the
protocol (see Appendix 2).
We followed up all participants who were still willing to participate in the study but did not wish to be
contacted by a CAB advisor, as planned per protocol. We asked GPs (or agreed member of practice
staff) and CAB advisors to access the password-protected study website following appointments with
participants to record study-specific information (e.g. dates of scheduled appointments, and if and when
participants attended).
Randomisation
Demographic information (size and deprivation index score) for all general practices in the three study
localities was sent to the study statistician (RST). General practices in each locality were matched on their
size (‘small’, < 3500 patients; ‘medium’, 3500–8000 patients; ‘large’, > 8000 patients) and deprivation
index score76 (‘not deprived’ indices of multiple deprivation score of ≤ 21.7, ‘deprived’ score of > 21.7,
where 21.7 is the UK 2010 average score) before being randomised to intervention or control arms either
at the cluster (practice) or individual (patient) level (see Table 1).
The randomisation sequences and matching was computer generated and undertaken by the study statistician.
In practices allocated to individual patient allocation, a member of the research team (usually the RA)
gained informed consent and then accessed the password-protected randomisation website developed
by PenCTU and entered participant details. Once data entry was complete, participant allocation was
automatically generated by the computer but did not appear on the screen, thereby maintaining RA
blinding.
DOI: 10.3310/hta21350 HEALTH TECHNOLOGY ASSESSMENT 2017 VOL. 21 NO. 35
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Gabbay et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
19
When a general practice dropped out post randomisation, we replaced it with a practice of similar size and
deprivation index by matching it with practices on a waiting list. Practice staff in the cluster randomisation
arms were not informed about their allocation before they agreed to participate in the trial.
Individual randomisation procedure
Following the obtaining of informed consent and the completion of the baseline assessment, RAs accessed
the password-protected study website (designed by PenCTU) and entered the required participant details
(including general practice and participating GP’s e-mail address) in order to generate the participant’s
allocation and study number. The participant’s study number was visible to the RA on the database screen
but the participant’s allocation was not, thereby maintaining blinding of the RA who was conducting the
participant assessments. This randomisation procedure triggered an automatic e-mail to an identified
member of the practice staff, informing them of the participant’s allocation. This e-mail identified the
participant by their initials and unique trial number. Based on this information, the practice staff (and study
GP) were able to identify the participant when they accessed the web-based password-protected study
database.
We maintained separation between GPs seeing TAU and intervention participants within individual
randomisation sites in an effort to reduce the risk of contamination. A member of the practice staff
forwarded the automatic e-mail to the appropriate study GP (intervention or control GP), and the
participant’s personal details were retrieved from the password-protected study website so that practice
staff could call the patient to arrange an appointment with that GP at the practice.
Cluster randomisation procedure
Participants recruited from cluster-randomised practices were registered into the study as soon as
possible after giving their written consent and completing the baseline assessment. The RA accessed the
password-protected study website and entered the required participant details (including general practice
and participating GP’s e-mail address) in order to register the participant on the trial. This process triggered
an automatic e-mail to the relevant member of the practice staff, confirming the participant’s consent and
registration. The same administrative process was undertaken as for individual randomised patients: a
member of practice staff accessed the web-based password-protected study database to retrieve the
participant’s personal details so that they could call the participant to arrange an appointment with a
named GP at the practice.
Blinding
In the pilot trial both researchers and participants were kept blind to practice and participant allocation.
Researcher blinding
Researchers conducting assessment interviews were not informed of participant allocation. RAs entered
the same information into the study website for all participants and were unaware which participants had
been individually randomised and which participants were from cluster practices. At the start of each
visit, RAs explained to participants that they did not know what type of debt advice the participant had
received and requested that this not be discussed during the visit to avoid RA unblinding. Instead,
participants self-completed a questionnaire about the debt advice they had received (see Appendix 16),
which they then placed in a sealed envelope so that the RA did not see the questionnaire. The sealed
envelope was sent to PenCTU along with the participant’s other data to be entered onto the study
database by PenCTU staff. If the RA was inadvertently made aware of the participant’s trial arm during the
assessment visit, ‘unblinding’ was recorded on the participant’s CRF at the time of the data collection visit.
Practices were advised that researchers carrying out the assessment interviews were blind to participant/
practice allocations and that they should refrain from referring to participants’ allocations in discussions
with RAs. Local research managers liaised with the practice on matters related to practice and participant
allocation (e.g. training about the referral process and use of the study database).
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Participant blinding
Participants were also blind to their allocation. The reason for not telling participants whether they were in
the intervention or TAU arm of the trial was the belief that there was genuine equipoise about the benefits
of the intervention versus GPs providing TAU plus signposting with advice leaflets about managing debt.
To maintain participant blinding, the participant information sheet explained that the study was evaluating
different ways of providing debt advice but did not refer to ‘intervention’ and ‘control’ groups. The
information sheet explained that participants would be ‘randomly allocated’ to a particular way of providing
debt advice. The information sheet made it clear that one type of debt advice was referral to a CAB advisor
and that this type of advice would not be available to all, but this was not identified as an ‘intervention’.
GPs told patients their trial allocation during their initial consultation, explaining that they had been
allocated to receive debt advice from a CAB advisor or that they were to receive two debt advice leaflets.
GPs were asked not to refer to ‘intervention’ or ‘control’ arms in discussions with participants.
Data collection
Participant assessment visits were undertaken at baseline and at 4 and 12 months (for some participants
who had reached this stage when the study was closed) (see Table 2). Data were collected through a
combination of participant self-report and researcher-led questioning. Booklets containing self-complete
measures were handed to participants at the start of each assessment visit. Researcher-administered
measures were entered into study-specific CRFs by the RAs. The order of completion of the measures was
predetermined, giving consideration to the sensitive nature of some questionnaires (see Appendix 17).
The original CRF pages and self-complete booklets were sent to PenCTU for double-data entry onto a
password-protected database. Double-entered data were compared for discrepancies using a stored
procedure, and discrepant data were checked and verified with RAs who retained a photocopied version of
the CRF. Participants were able to complete data measures (see Table 2) over more than one visit if they
preferred to do so. However, subsequent visits were required to be completed within 1 week of the first
assessment visit. Participants received a £10 voucher at the end of each assessment (baseline and 4 and
12 months) as a form of recognition of their participation in the study.
Baseline data collection
All participants (with consent) had the LED-S component of the baseline assessment visit audio-recorded.
The participant’s unique trial number was included on all parts of all participant data collection booklets
and CRFs.
Follow-up data collection
Further data collection visits (before the closure of data collection) were completed at 4 and 12 months
after the baseline assessment visit (see Table 2). Follow-up data collection visits were completed as close as
possible to the follow-up due date (generated by a computer). If participants did not want or were unable
to complete follow-up visits, we asked them if they would be willing to complete the primary outcome
measure (BDI-II) by telephone.
Quantitative data analysis
Statistical analysis
Given that the study did not progress to a full trial and achieved a reduced sample size in the pilot trial
phase, we were not powered to undertake an inferential statistical comparison of outcomes between
intervention and control groups. Instead, outcomes findings are reported descriptively (means and SDs,
or numbers and percentages) for primary and secondary outcomes for the two groups at baseline and at
4 and 12 months post randomisation. Using the Consolidated Standards of Reporting Trials (CONSORT)
framework, we provided a detailed summary of the flow of participants through the study from approach
to participation to 4- and 12-month follow-up for those completed before close-down.
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Health economics analysis
The ‘true’ cost of the intervention has been estimated using CAB standard rates for the NHS. The CAB also
provided their records to confirm the time taken to complete the intervention. Given the reduced sample
size in the pilot trial, the focus of the health economics analysis is descriptive: we present a summary of
mean QALYs, health-care utilisation and costs by group. No incremental cost per QALY analysis was
undertaken; instead, we have undertaken a disaggregated analysis of costs and consequences.
Participant qualitative data collection and analysis
Data collection
We originally planned to conduct two qualitative interviews (one at baseline and one 4 months later) with
30–45 participants (10–15 from each of the three research sites). As a result of early closure of the trial
and the smaller than anticipated sample size in the pilot trial, only 23 participants had been recruited for a
qualitative interview at the point of trial closure (see Table 39).
We selected participants for qualitative interview by first identifying participants who had registered their
interest in taking part in qualitative interviews on the main study consent form. As participant recruitment
was gradual and baseline qualitative interviews had a timeline for completion within 2–4 weeks of baseline
assessment visits, it was agreed with the qualitative research team that the first six participants registering
their interest in a qualitative interview would all be contacted for interview. Subsequently, participants
were purposively sampled based on their age, sex, BDI-II score and allocation. We also sought to ensure
that there was representation in the qualitative sample from each of the three study sites and, whenever
possible, at least one participant from each general practice. One of the three research sites started
participant recruitment much later than the other two sites; consequently, only five participants were
recruited from this site before the trial was closed down. All five participants registered their interest in a
qualitative interview and so all were approached by a study RA for interview.
Research assistants contacted participants by telephone, e-mail or letter to check if they were still interested
in taking part in a qualitative interview and, if they were, to arrange a date and time for the interview. Not
all participants who were contacted to participate in qualitative interviews actually completed an interview
(see Chapter 6, Participants). We asked participants taking part in qualitative interviews to complete a
further consent form specific to the qualitative interview that included providing consent for the use of
anonymised quotations (see Appendix 18). The qualitative interviews were conducted by different study RAs
from those conducting the assessment interviews to avoid unblinding. Interviews took place face to face
and in a setting convenient for the participant. Interviews were audio-recorded with the participant’s
consent and were anonymised during transcription. Transcripts were identified by the participant’s unique
trial number and each participant was assigned a pseudonym.
Baseline qualitative interview
We conducted the baseline qualitative interview with the aid of a topic guide (see Appendix 19). This topic
guide was developed by the qualitative team, including the service user lead, and refined iteratively. The
baseline interview adopted a semistructured approach, commencing with a broad opening question
inviting participants to tell their story about their experience of money worries. This was followed up with
additional prompts (as appropriate) to explore participants’ biographies of depression, anxiety and debt,
and the impact of these on their lives. The interview also explored participants’ experiences relating to the
practical aspects of debt (e.g. contact with creditors).
Four-month follow-up qualitative interview
We conducted a further topic-guided (see Appendix 19) interview with participants 4 months later.
The 4-month topic guide was developed using the same approach used to develop the baseline topic
guide. The follow-up interview was semistructured in form and enquired about developments since the
participant’s baseline interview, including any changes in debt and depression, and any possible influences
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on changes in mental distress. We also asked participants about their experiences of the intervention
(as appropriate) and involvement in the trial. We explored in particular each participant’s acceptability of
the intervention, assessment visits with the researcher and outcome measures, and views about costs in
terms of time and convenience with respect to study participation.
Data transcription and management
Digital audio-recordings were transcribed by an independent professional transcriber. The recordings were
transcribed verbatim, although it was agreed that brief pauses and verbal idiosyncrasies (e.g. ‘er’) would
not be transcribed. The reason for any significant pause in the interview (e.g. where participant left the
room for any reason or the audio-recording was paused) was recorded in brackets on the transcript. In
addition to participant identification number, participants’ age, sex and a pseudonym were added during
transcription. When participants referred to another individual by name, the other individual’s relationship
to the participant was inserted instead for purposes of anonymity. When direct reference was made to the
name of a service or place, this was replaced with a generic term such as ‘hospital’ or ‘GP’. Qualitative
RAs subsequently checked the transcripts against the audio-recording for accuracy and the recordings
were then deleted. For ease of management and coding, transcript data were imported into NVivo
version 10 (QSR International, Warrington, UK).
Data analysis
The first five transcripts were read and underwent open coding77 by members of the qualitative team, and
emerging concepts were discussed. We transformed the data through an iterative process of reading and
rereading transcripts, working actively with the data to develop a framework that enabled conceptual
development of the data. The framework included both in vivo concepts (concepts using the participants’
own words)77 and researcher-generated concepts. Through a further process of axial coding, a sense of the
relationships between concepts was developed.77
One member of the qualitative team conducted a subsample analysis focusing specifically on the
phenomenological experience of debt and the psychological mechanisms linking these to the experience
of distress.78
Intervention process evaluation
Data collection
In each of the three research centres we interviewed a number of GPs and CAB advisors about their
experiences of participating in the trial. GPs and CAB advisors were provided with an information sheet
(see Appendix 20) prior to the interview and completed a consent form (see Appendix 21) before the start
of the interview.
The interviews with GPs and CAB advisors were topic guided (see Appendix 19) and semistructured in
form. The topic guide was developed with the professional members of the team (CAB and GPs plus the
qualitative team and PPI lead) and followed the NPT framework approach. We explored clinicians’ and
CAB advisors’ experiences of implementing the intervention, their views about the processes involved and
their thoughts about the feasibility of integrating the intervention into everyday practice, including any
potential barriers to or facilitators of this.
Data analysis
The components of the intervention were analysed following the rationale of NPT.2 NPT underpinned the
exploration of the behavioural mechanisms that inhibit the routine incorporation of interventions in
everyday practice. It provides a rigorous conceptual framework to identify, describe and understand
interactions between participants’ contribution (i.e. the things that they do) and the capabilities offered by
the intervention. Most specifically, NPT pays attention to the intervention’s workability and integration
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within the workflow and context in which the intervention is undertaken. The analysis of the interviews
encompasses an interpretation based on the understanding of the wider research project.
Patient and public involvement
Service user involvement has been integral to the DeCoDer trial. In this section we detail the different ways in
which service users have contributed to the development and progression of the trial throughout its course.
Pre-funding preparation
The research team co-applicant leading on public involvement has been involved with the trial from the
outline bid stage. Early engagement and involvement of service users was facilitated through the NIHR
Research Design Service North West PPI fund. This fund supported our initial meetings with Liverpool
Mental Health Consortium and the chief investigator presented the proposed study to the former NIHR
North West Mental Health Research Network Service User Research Panel to discuss the trial and obtain
feedback on the potential value of such a service, and possible concerns individuals who had personal
experience of such difficulties might hold. Through the PPI lead co-applicant, contact was also made with
PPI groups in the other two research centres before funding. Feedback from these service users influenced
our intervention design, data collection protocol and recruitment strategy. Service users commented on
the proposed intervention, informed by their personal experiences of debt and mental health problems.
They reviewed the various proposed data collection instruments and options being considered, and
recommended alternatives based on their views on both the acceptability and relevance of various options
being suggested, and the overall burden of data completion.
Post-funding preparatory work
Our PPI lead co-applicant was involved in frequent communications (e-mail, teleconference and face-to-face
meetings) to develop study protocols (including the safety protocol) and participant documentation. Participant
information sheets and consent forms were based on templates provided by our PPI lead. Service user
representatives reviewed participant-related documentation (including, but not limited to, the advertisement
poster, flyer, debt advice leaflets, participant information sheet and assessment questionnaires). We amended
documentation in light of their comments, including making changes to the advertisement poster. The service
user group advised that, although they were happy with the assessment questionnaires for the pilot trial, any
opportunity to reduce the number of questionnaires for the full trial would be welcomed.
Service user representatives from the former Mental Health Research Network Service User Research Panel
were involved in training study RAs, namely by taking part in practice assessment interviews and meeting
with RAs to discuss the sensitivities involved in conducting interviews about depression and debt.
Our PPI lead co-applicant attended the research ethics committee review meeting along with the chief
investigator and the trial manager.
Throughout progression of the pilot trial
Throughout the course of the pilot trial changes to the study protocol and documentation were discussed
with the PPI lead co-applicant. Discussions included those concerning our close-down plan and our
proposal to complete 12-month follow-up assessment visits with all participants recruited to the pilot trial,
although the funder did not endorse this. Our PPI lead co-applicant has also contributed to the analysis of
participant qualitative data.
Report writing, academic paper preparation and dissemination
The PPI co-applicant on the team has been involved in the production of the final report to HTA, including
preparation of the Plain English summary and preparation of the end-of-study information sheet for
pilot trial participants (see Appendix 22). He will continue to be involved in dissemination activities and
preparation of academic papers.
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Ethics approval and research management and governance approval
The study was reviewed and approved by NHS Research Ethics Committee North West – Preston (reference
14/NW/0230). Site-specific assessments were completed by NIHR CRN – North West Coast, Royal Devon
and Exeter Foundation Trust, and Abertawe Bro Morgannwg University Health Board, and all of the
necessary approvals were granted. All substantial amendments were reviewed and approved by the above
bodies, and letters of assurance were provided.
Sponsorship
The study sponsor is the University of Liverpool.
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Chapter 3 Implementation of the pilot trial
Introduction
In this chapter we detail the challenges we faced in setting up the internal pilot trial, including the
recruitment and set-up of general practices and the recruitment of participants. We sought to recruit
general practices to the pilot trial during a time of considerable change and flux both at the practice level,
as it was a period of upheaval within general practice,79 and in terms of NIHR infrastructure support
systems, following the transition from primary care research networks to local CRNs, with considerable
staffing turnover and resource strain. The practices themselves were under particular stress as they were
largely situated in deprived areas and reflected the known imbalance between primary care demand and
resources.80,81 Our target population – people with depression who had worries about debt – is known
to be a vulnerable group in society who are often hard to reach and engage. We sought to recruit
representatives from this hard-to-reach group from deprived areas at a time when they were under
considerable personal stress (in debt and depressed/anxious).
Focus group analysis
Two focus groups were undertaken by a researcher in February 2015 as part of an independent
investigation of factors that had either hindered or enhanced the progress of the DeCoDer trial. The
focus groups were conducted with a sample of study team members from each of the three trial sites.
Semistructured qualitative interviews, informed by a topic guide, focused on key stages of study design:
recruitment of patients and general practices; progression from baseline visit/randomisation to intervention/
control; progression from baseline to 4- and 12-month follow-up; communication, within and across
research teams, and local CRN support; and causes of delays/barriers to trial progression and recruitment.
The overall aim of the focus groups was to access narrative voices of those involved in the design and
delivery of the trial, including the different roles played by each team member. Each focus group lasted
approximately 3 hours. Digitally recorded discussions were transcribed and coded to identify dominant
themes and areas of divergence. Group discussions were lively and informative. The data were analysed in
terms of discursive strands, but issues were intricately interwoven, capturing the multiple realities of
undertaking large-scale, collaborative projects.
Communication was identified as potentially problematic in the engagement, recruitment and retention
aspects of the trial. However, when effectively managed, and there was clear evidence of this, interpersonal
relations played a key role in progress. Mental health distress and financial stresses constructed the sample
group as a ‘hard-to-reach’ population: chaotic lives mediated by crisis and comorbidity. Health inequalities
impacted in poorer neighbourhoods where general practices, confronted by statutory requirements of
regulatory monitoring and target-driven services, were less likely to prioritise research. Time was lost in the
‘setting-up’ and ‘signing-up’ phases of general practice recruitment owing to contractual and higher-level
administrative issues, which for one site generated frustration and substantial delays. Staff acting as a
‘gatekeeper’ to individual GPs proved a significant impediment, as did staffing issues/workload and variable
levels of support from CRNs. In this context, ‘doctor-to-doctor talk’ proved helpful, and there was a feeling
that any disinclination of GPs to participate signalled powerlessness rather than lack of interest.
The recruitment of patients was compromised by a number of factors, such as the vulnerability of the client
group, the physical space of waiting rooms and the complexity of primary care services in which privatisation,
private finance initiatives and moves towards multiprovider facilities presented challenges. The period
between ‘expression of interest’ and ‘conversion’ was described as a process rather than procedure,
requiring sensitive management and flexibility. Similarly, baseline screening and home visit interviews had to
account for the often difficult circumstances of the individual. Overall, it was acknowledged that trial
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complexities were underestimated in the proposal but, despite slower than expected progress, commitment
and enthusiasm of participants was without question.
Pilot trial challenges and issues
We encountered a range of issues in setting up and delivering the pilot trial as we had originally envisaged.
These issues could be broadly categorised as (1) organisational- and governance-level issues, (2) study
design issues, (3) capacity issues and (4) participant engagement issues.
Organisational- and governance-level issues
Contractual processes
Delays in contracting for the study had a major impact on project start-up, particularly in one of the three
study sites. From the contract start date (1 March 2014) it took 33 days for the collaborative agreement to be
signed off by the funder and a further 134 days for the collaborative agreement to be signed off between the
host organisation and collaborating institutions. This had serious implications for one of the three research
sites in particular, as it was not permitted by its institution to proceed with research staff recruitment without
the finalised, fully executed collaborative agreement. Although locally based co-investigators were able to
make progress with site recruitment, further administrative delays at this site after collaborative agreement
sign-off, specifically local post-award administration processing and recruitment permissions, resulted in
essential research staff (local trial manager and RA) finally coming into post a full 12 months after the official
start date for the study. This left little time for recruitment of practices and participants at this site before the
trial was officially closed to recruitment, with the first trial participant being recruited at this site almost
6 months after the original timetabled end date for pilot trial recruitment.
Approval timelines for substantial amendments
Our study was funded as an ‘adaptive’ trial design, and we undertook a number of protocol and
documentary amendments (five in all) throughout the course of the pilot trial as we worked through the
various issues as they arose. These amendments required funder, sponsor, research ethics and research
governance approval. Although review processes are often described as running in ‘parallel’, in reality
approvals are sequential: the research sponsor requiring funder approval before proceeding, research
ethics committee requiring sponsor approval before proceeding and research governance offices requiring
research ethics committee approval before providing final approval. In our experience, research ethics
approval and lead CRN approval was expedited fairly swiftly; however, the timeline from initial approach to
the funder for review of the amendment to final local governance approval was variable. In one instance,
the timeline from submitting a substantial amendment to the funder, to the final local Research and
Development office approval was 49 days (Table 3). Consequently, implementing necessary changes in the
TABLE 3 Substantial amendment timeline, number of days to approvals
Amendment number
Approval (number of days)
Funder Sponsor NRES Final R&D received
1 –a 6 5 34
2 –b 12 11 34
3 14 4 7 39
4 –a 3 7 32
5 20 2 6 49
NRES, National Research Ethics Service; R&D, Research and Development.
a Not required.
b Advised.
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tight time frame of a pilot trial was not facilitated by the approval processes at the time. It is also of note
that the shorter timelines reported were only possible through constant monitoring and engagement with
the different review organisations, and a willingness on their part to expedite reviews in fewer than the
35 days that they are legitimately afforded for local site reviews.
Study design issues
Recruiting general practices to the pilot trial proved to be much more difficult than we had originally
envisaged. One of the factors that contributed to this difficulty and the extended time taken to recruit
(and then train) practices was the requirement to recruit pairs of matched practices. This requirement is
recommended to add robustness to intervention trial designs; in particular, it can help reduce baseline
difference between participants in cluster trials in which practices rather than participants are randomised.
Nevertheless, it led to substantial delays in undertaking necessary training and preparatory work in
practices before participant recruitment could begin. In one research site there was a 6-month delay
between a practice agreeing to take part and the arrangement of necessary (before participant
recruitment) practice-based activities, while we recruited a suitable matched practice (see Table 6). In fact,
recruitment to the trial was closed before this practice was actually able to get started. At a time when
practices face staff shortages, Care Quality Commission inspections and changing expectations as new
innovations in care and targets are being introduced, delays in progressing practice set-up would have
probably resulted in some practices becoming disengaged with the study had we progressed to full trial.
This design issue would have needed to be resolved to avoid practices withdrawing from the study before
they had even started recruitment.
A further issue concerned the size of the available practice pool in one research site, which was relatively
small and so quickly exhausted, requiring a substantial amendment to approach practices in neighbouring
areas. Given the aforementioned review timelines, this requirement was less than ideal.
Capacity issues
Further issues that hampered both practice recruitment and set-up concerned capacity within practices
and the CRN teams. Both practice staff and GPs had competing clinical and administrative workloads that
severely constrained their availability to complete required practice-based activities before participant
recruitment. This was further compounded by the limited resources (in terms of time and expertise) in
some local CRNs. These issues had serious implications for both recruitment and retention of practices, and
completion of practice-based activities (practice meetings, practice training, practice database searches,
GP list checks, mail merging/envelope stuffing) that were required to progress participant recruitment.
It is of note that practice capacity/staffing issues were also the reason most often cited by practices for
declining to participate in the trial (see Table 5). Current practice workload coupled with limited capacity was
also offered as an explanation for early withdrawal from the pilot trial by two participating practices, both of
which withdrew before reaching their target participant number. The timing of general practice recruitment
was identified as an important factor in terms of likely sign-up, recruitment of practices before Christmas being
less successful than after Easter owing to a combination of fluctuating workload and the aforementioned
constraints. Before the pilot trial was closed, we were planning to widen the recruitment areas and start to
sign up practices in advance of the full trial as an adaptation to the design. This was to ensure that we would
have sufficient practices signed up before opening up to the full-trial recruitment phase.
It was also evident that activities that were required to be undertaken by participating practices as part of
the letter mail-out approach to participant recruitment took much longer than anticipated because of
either research capacity issues or competing priorities within practices. For example, practice database
searches (required to identify potential participants for study pack mail-out) had to be completed by
practice or CRN staff. This was because research staff were not permitted to access patient records before
participant consent was obtained. Completing this activity was particularly problematic in one research site
where neither the practice staff nor the CRN had the capacity to conduct the database search, leading to
substantial delays in participant recruitment via the letter mail-out approach.
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Once patient lists had been generated through practice database searches, GPs were (prior to a substantial
amendment) required to check patient lists to exclude patients whom they deemed it would be
inappropriate to approach. The limited availability of GPs to check patient lists because of their clinical
workload meant that this activity took far longer than had been anticipated. Some GPs had to complete
the list check over a number of sessions because of the time taken in checking lists, with some GPs
undertaking extremely thorough reviews. The maximum number of days from an initial database search to
the completion of GP list check was 87, although the quickest GP managed this in 4 days (see Table 6).
Finally, letter mail-outs were also delayed in some practices as a result of limited availability of practice
administrative staff to undertake mail-merge and envelope stuffing, with the number of days from GP list
check to mail-out completion ranging from 5 in one practice to 56 in another. Overall time from initial
contact to first randomisation ranged from 89 to 320 days, with three of the practice sites never getting to
consent a participant before the trial closed (see Table 6).
Although local CRNs were supportive of the study and were involved in many initial approaches to general
practices and attending practice meetings in some centres, growing pressures on local CRN officers meant
that their availability to support the trial became increasingly limited. In particular, local CRNs were unable
to support recruitment of participants via the waiting room approach. This meant that recruitment from
practice waiting rooms was limited by the availability of local RAs, recruitment via the waiting room being
possible only when RAs were not busy contacting interested participants or undertaking assessment
interviews. In addition, in one site the CRN was unable to support practice or participant recruitment until
the first general practice had been recruited. This ‘rule’ delayed CRN support for the study in this site.
Participant engagement issues
We sought to offer flexibility in terms of the methods by which we contacted participants following their
initial register of interest from the letter mail-out or waiting room approach. The EOI form returned by
participants included a number of options for future contact (telephone/text/letter/e-mail) and patients
were also able to indicate a preferred time to be contacted (see Appendix 12). Nevertheless, researchers
experienced considerable difficulty in contacting some patients following an initial EOI, with 29 (13.4%) of
216 patients who returned eligible EOI forms being subsequently non-contactable (see Figure 4). There
were also some issues in completing assessment visits that had been arranged, with a number of patients
cancelling (some rebooking) or failing to be in/show up for the baseline assessment. These patients are
likely to be among the most vulnerable patients on a practice list and also, because of their debt, more
likely to avoid answering calls. Although these issues were not wholly surprising given the very difficult
circumstances that many people were probably experiencing, they did have an impact on participant
recruitment and lead to delays in entering patients into the study.
Remedial actions: did they have an impact?
In light of the challenges we faced in recruiting general practices and participants to the pilot trial, we
undertook a number of amendments to the protocol and methods for the study, as detailed previously in
Chapter 1. It is of note that not all of the changes that we proposed were implemented as anticipated
and, therefore, it is possible that not all were as successful as might have been expected. For example,
we had hoped that practice staff (in particular reception staff) would hand out study flyers to consecutive
adult patients at reception and that this would bolster the distribution of the flyers during periods
when the study RAs were not available to carry out waiting room recruitment. However, although this
amendment to recruitment processes had been approved, some practices were reluctant to engage in this
activity because of either competing task and time pressures or concerns regarding the sensitive nature
of the research and potential patient responses. Practices that did agree to distribute the flyers did
not consistently hand them out to all adult patients who approached the reception desk. Once these
inconsistencies had been identified, through conversations with staff or observation while recruiting on
site, this activity was withdrawn from practices in which it was an issue to avoid reception staff ‘cherry
picking’ ‘suitable’ patients to receive flyers.
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NIHR Journals Library www.journalslibrary.nihr.ac.uk
30
The removal of the requirement for GPs to check patient lists before mail-out was approved only shortly
before recruitment closed; it was not possible, therefore, to assess the impact of this change on participant
recruitment timelines.
Summary and recommendations for future research
We faced a number of challenges during the internal pilot trial that could be largely categorised into one
of four key areas: (1) organisational and governance-level issues, (2) study design issues, (3) capacity issues
and (4) participant engagement issues. Although some of these issues spanned all three research sites,
other issues were more site specific. We sought to address these issues through a number of protocol and
method amendments that were in and of themselves time-consuming in the tight time constraints of a
pilot trial. Our experiences of both practice and patient recruitment highlight the considerable challenges
of recruiting in a primary care setting within the current health-care and research funding climate.
In one site, CRNs provided training to administrative staff about the importance of taking part in research.
This was part of the CRN remit as they were seeking to offer training to support GPs in becoming more
research active. In light of the issues we experienced in some practices, we would fully endorse CRNs
providing such training to practices, in particular those practices that are new to research. It is likely that
where practices are new to research, so too will be their patients; thus, having practice staff (including
administrative staff) who are confident about responding to patient queries about research would be likely
to benefit patient recruitment to research.
The population of patients we sought to recruit face many and complex difficulties, indicated by our
quantitative and qualitative data (see Chapters 4 and 6, respectively). Consequently, these participants
required considerable flexibility in order to facilitate their participation in research. This flexibility, and the
extended timelines required to facilitate it, were not conducive with the constraints of a short pilot trial
time frame.
As we seek to build robust evidence on the impact of interventions among vulnerable populations who
may be harder to reach, consideration needs to be given to the complexity and additional time needed in
trial designs, and the associated cost implications. The risk is that underserved populations will continue to
be underserved by research as well, unless additional resources are granted to meet their additional needs
and complexities.
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Chapter 4 Pilot trial results: statistical analysis
Introduction
We report here our findings with regard to the pilot trial objectives.
Given that the study did not progress to a full trial and achieved a reduced sample size in the pilot trial phase,
outcomes findings are reported descriptively (means and SDs, or numbers and percentages) for primary
and secondary outcomes for the two groups at baseline and at 4 and 12 months post randomisation.
Practice recruitment
Recruitment process
Of 67 practices approached, 14 failed to respond to our invitation, 40 declined participation, one was
excluded and 12 were recruited to the trial (Table 4). The main reason given by practices for declining to
participate was current staffing/resource issues, with a number reporting staff absence due to sickness,
key staff leaving the practice or new staff having just joined (Table 5).
Arranging an initial meeting with practices to discuss the study was a protracted process, with the period
from initial letter/e-mail contact to practice meeting ranging from 22 to 135 days (Table 6).
TABLE 4 Number of practices recruited by research site
Site
Number of practices (%)
Approached
That did not
respond Declined Excluded Recruited
North-west England 16 7 (43.7) 5 (31.3) 0 (0.0) 4 (25.0)
South-west England 9 2 (22.2) 2 (22.2) 1 (11.1) 4 (44.4)
South Wales 42 5 (11.9) 33 (78.6) 0 (0.0) 4 (9.5)
Total 67 14 (20.9) 40 (59.7) 1 (1.5) 12 (17.9)
TABLE 5 Reasons given by general practices for declining participation by research site
Reason for decline
Site, n (%)
Total, n (%)
North-west
England
South-west
England South Wales
Staffing/resource issues 4 (80.0) 1 (50.0) 14 (42.4) 19 (47.5)
Too busy currently 1 (20.0) 0 (0.0) 4 (12.1) 5 (12.5)
Practice in a period of change 0 (0.0) 0 (0.0) 4 (12.1) 4 (10.0)
Not interested in the study 0 (0.0) 0 (0.0) 4 (12.1) 4 (10.0)
No reason given 0 (0.0) 1 (50.0) 7 (21.2) 8 (20.0)
Total 5 2 33 40
DOI: 10.3310/hta21350 HEALTH TECHNOLOGY ASSESSMENT 2017 VOL. 21 NO. 35
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Gabbay et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
33
TA
B
LE
6
Pr
ac
ti
ce
ac
ti
vi
ty
ti
m
el
in
e
in
d
ay
s:
le
tt
er
m
ai
l-
o
u
t
re
cr
u
it
m
en
t
ap
p
ro
ac
h
Si
te
/p
ra
ct
ic
e
In
it
ia
lc
o
n
ta
ct
to
p
ra
ct
ic
e
m
ee
ti
n
g
(d
ay
s)
Pr
ac
ti
ce
m
ee
ti
n
g
to
tr
ai
n
in
g
(d
ay
s)
Pr
ac
ti
ce
m
ee
ti
n
g
to
fi
rs
t
d
at
ab
as
e
se
ar
ch
(d
ay
s)
Fi
rs
t
d
at
ab
as
e
se
ar
ch
to
fi
rs
t
lis
t
ch
ec
k
(d
ay
s)
Fi
rs
t
lis
t
ch
ec
k
to
fi
rs
t
m
ai
l-
o
u
t
(d
ay
s)
M
ai
l-
o
u
t
to
fi
rs
t
ra
n
d
o
m
is
at
io
n
(m
in
im
u
m
)
(d
ay
s)
M
ai
l-
o
u
t
to
fi
rs
t
ra
n
d
o
m
is
at
io
n
(m
ax
im
u
m
)
(d
ay
s)
In
it
ia
l
co
n
ta
ct
to
fi
rs
t
ra
n
d
o
m
is
at
io
n
(d
ay
s)
10
1
28
65
57
4
10
14
20
11
3
10
2
53
62
55
0
24
14
14
14
6
10
7
85
30
30
–
a
–
a
20
34
21
3
10
8
70
29
20
8
30
13
20
14
1
20
3
64
18
9
10
8
87
56
13
13
31
5
20
4
64
18
9
10
8
–
b
–
c
–
c
–
c
–
c
20
5
29
90
56
26
8
35
35
26
4
20
6
13
5
13
7
75
86
3
15
21
32
0
20
9
64
39
5d
34
3
–
e
–
e
–
f
–
f
–
f
31
0
27
28
50
0
5
14
14
96
31
1
22
35
35
1
11
20
20
89
3g
44
N
C
42
0
–
f
–
f
–
f
–
f
3g
38
N
C
15
9h
–
f
–
f
–
f
–
f
–
f
N
C
,
no
t
co
m
m
en
ce
d.
a
D
at
e
of
lis
t
ch
ec
k
no
t
re
co
rd
ed
.
b
N
o
lis
t
ch
ec
k
co
m
pl
et
ed
.
c
N
o
le
tt
er
m
ai
l-o
ut
.
d
Re
pl
ac
em
en
t
pr
ac
tic
e
br
ou
gh
t
in
m
uc
h
la
te
r
af
te
r
in
iti
al
co
nt
ac
t.
e
Li
st
ch
ec
k
no
lo
ng
er
re
qu
ire
d.
f
Pa
rt
ic
ip
an
t
re
cr
ui
tm
en
t
cl
os
ed
.
g
Pr
ac
tic
es
re
cr
ui
te
d
bu
t
no
t
as
si
gn
ed
a
pr
ac
tic
e
id
en
tif
ic
at
io
n
nu
m
be
r
be
fo
re
re
cr
ui
tm
en
t
cl
os
ed
.
h
D
ay
s
to
‘s
ch
ed
ul
ed
’
pr
ac
tic
e
m
ee
tin
g.
PILOT TRIAL RESULTS: STATISTICAL ANALYSIS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
34
As noted previously, arranging necessary practice activities in advance of participant recruitment was not
without its difficulties. In the case of recruitment by letter mail-out, in addition to arranging an initial
meeting with the practices to discuss the study and completing practice training, there were challenges
in completing the database search to identify patients, the GP list check to exclude patients and the
administrative mail-out activities. These resulted in longer than anticipated timelines to participant
recruitment, with the number of days from practice meeting to the randomisation of the first patient by
letter mail-out ranging from 67 to 251 days across practices (see Table 6).
Practice and general practitioner demographics
Ten practices participated in the study. Of these, seven identified themselves as a city practice, two
identified as suburban and one identified as rural. Practice list size ranged from 2800 to 28,500, with a
mean of 9306.7 and a SD of 7194.5. All practices reported that they were training practices and seven
were registered as research ready or linked to a primary care network.
General practitioner characteristics
We asked the sites to identify a trial lead GP for cluster sites and a pair for individual randomisation sites
(one for intervention appointments, the other for TAU participants). Fourteen GPs had seen at least one
participant. This sample of GPs was generally older and there was a predominance of male GPs. The
majority of GPs were in full-time posts, were a principal/partner in the practice and had a Membership of
the Royal College of General Practitioners or a Fellowship of the Royal College of General Practitioners
qualification. Just over half had worked in a psychiatric post (Table 7).
Availability of services for treatment of depression
Practices were asked to record the availability of a number of services for depression for their practice
population. Interestingly, IAPT services were not considered to be readily available by any practice and four
practices failed to enter a response for that service (Table 8).
TABLE 7 Summary characteristics of GPs consulting with at least one participant
Characteristics GP sample (N= 14), n (%)
Age band (years)
20–30 1 (7.1)
31–40 2 (14.3)
41–50 5 (35.7)
51–60 6 (42.9)
Sex
Male 9 (64.3)
Female 5 (35.7)
Professional status
Full-time post 10 (71.4)
A principal/partner in the practice 11 (78.6)
Have MRCGP/FRCGP 12 (85.7)
Have worked in a psychiatric post 8 (57.1)
FRCGP, Fellowship of the Royal College of General Practitioners; MRCGP, Membership of the Royal College of General
Practitioners.
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Participant recruitment
Assessment of ability to recruit participants by recruitment approaches
We assessed the two recruitment approaches (letter mail-out vs. waiting room recruitment) by comparing
numbers of participants recruited to the study with costs of recruitment. Across the three research sites,
4121 letters were mailed out to potential participants, 127 eligible EOI forms were returned and 43
participants were randomised (Table 9). In comparison, across the three research sites 3367 flyers (with
attached EOI forms) were distributed in general practice waiting rooms, 89 eligible EOI forms were returned
and 18 participants were randomised (see Table 9). Conversion rate from eligible EOI to randomised
participants was greater from mail invitations than from waiting room recruitment, with 34% of eligible
EOIs from letter mail-out being converted to randomised participants versus 20% from waiting room
recruitment approaches (Table 10). Although letter mail-out yielded more randomised participants, this
approach was more expensive than waiting room recruitment in terms of cost per returned EOI (Table 11).
However, when comparing cost per randomised patient (rather than returned EOI), letter mail-out was
marginally cheaper than waiting room recruitment (see Table 11). It is also important to note that 33 EOIs
from mail-out approaches, compared with just three EOIs from waiting room recruitment, could not be
progressed owing to the early closure of the trial. These 36 EOIs had the potential to become randomised
patients and this ratio difference is likely to have further widened the difference in cost between the two
recruitment approaches.
We compared actual recruitment against target recruitment. Our planned target was to recruit 120
participants over a period of 6 months from July to December 2014. At the end of this 6-month
recruitment period we had randomised 19 patients, 15.8% of the target randomisation (Table 12). We
continued to recruit to the study through January to June 2015, when stopping rules were invoked
following a meeting with NIHR HTA. In discussion, it was agreed that patients who already had a baseline
assessment visit booked would be permitted to complete their assessment and recruited to the study. We
recruited our final participant in August 2015, giving a final sample size of 61 participants, 50.8% of our
original target randomisation figure for the internal pilot trial (see Table 12).
Participant flow
Figure 4 is the CONSORT diagram showing participant flow through the trial. The CONSORT diagram
provides summary figures for numbers of patients assessed for eligibility, declines, exclusions, allocation
and completion of 4-month follow-up data collection. Tables 13–15 provide a breakdown of reasons for
decline, reasons why patients did not meet inclusion criteria and reasons why patients did not participate
in the pilot trial, respectively.
TABLE 8 Availability of services for depression
Services for treatment of
depression
Availability, n (%)
Readily
available
Available with
some difficulty
Available with
great difficulty
Not
available
Not completed,
n (%)
Psychiatrist 0 (0) 6 (60) 2 (20) 1 (10) 1 (10)
Community psychiatric nurse 0 (0) 3 (30) 4 (40) 1 (10) 2 (10)
Psychologists 0 (0) 3 (30) 4 (40) 0 (0) 3 (30)
Psychiatric social worker 0 (0) 1 (10) 3 (30) 3 (30) 3 (30)
Counsellor 1 (10) 6 (60) 2 (20) 0 (0) 1 (10)
IAPT 0 (0) 3 (30) 1 (10) 2 (20) 4 (40)
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TABLE 10 Comparison of percentage randomisation from eligible EOIs by recruitment method
Site/practice
Recruitment method
Letter mail-out Waiting room
Eligible EOI returned,
(n)
Patients randomised,
n (%)
Eligible EOI returned
(n)
Patients randomised,
n (%)
101 30 11 (36.7) 13 3 (23.1)
102 12 7 (53.3) 8 1 (12.5)
107 11 4 (36.4) 12 6 (50.0)
108 4 3 (75.0) 9 1 (11.1)
203 8 2 (25.0) 7 1 (14.3)
204 –a –a 21 4 (19.1)
205 12 4 (33.3) 11 1 (9.1)
206 11 8 (72.7) 7 0
209 16 –b –b –b
310 18 1 (5.5) 1 1 (100)
311 5 3 (60.0) 0 0
Total 127 43 (33.9) 89 18 (20.2)
a No letter mail-out.
b Participant recruitment closed.
TABLE 11 Cost comparison: letter mail-out vs. waiting room recruitment
Recruitment method
Letter mail-out Waiting room
Item n Cost (£) Item n Cost (£)
Packs 3882 5127.04 Flyers 3367 208.75
Pre-paid envelopes 4121 235.76 EOIs 3367 208.75
Administrator time (hours) 38.82 446.43 Receptionist time (sessions) 3 195.00
Searches 11 385.98 Pre-paid envelopes 100 5.72
Patient list check 9 1040.00 Researcher time (hours) 170 2949.50
Mail merge 10 943.92 Returned envelopes 10 29.50
Docmail® 1 103.56 PIS 100 24.80
Returned envelopes 138 40.71
Total cost 8323.40 Total cost 3622.02
Number of EOIs 138 Number of EOIs 100
Cost per EOI 60.31 Cost per EOI 36.22
Patients randomised 43 Patients randomised 18
Cost per randomised patient 193.57 Cost per randomised patient 201.22
PIS, participant information sheet.
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Participant characteristics
Of 61 participants randomised into the study, 26 (42.6%) were male and 35 (57.4%) were female.
The mean age of the participants was 46 years (SD 12.8 years; range 21–79 years). Fifty-nine (96.8%)
participants reported their ethnicity as white and two (3.2%) reported it as ‘other’. Fourteen (23%)
participants were married, four (6%) were cohabiting, six (10%) were in a relationship, 31 (51%) were
single and six (10%) reported their marital status as ‘other’. Nine (14.8%) participants were in paid work,
two (3.3%) were in training/education, 29 (47.5%) were not working because of long-term illness or
disability, three (4.9%) were looking after the home, eight (13.1%) were unemployed and actively seeking
employment, four (6.6%) were retired and six (9.8%) recorded their employment status as ‘other’.
Severity of depression
Mean BDI-II score across participants at baseline was 35.2 (SD 8.1; range 14–53). The great majority of
participants recorded BDI-II scores in the severe range (Figure 5), with a score of 14–19 indicating mild
depression (two participants, 3%), a score of 20–28 indicating moderate depression (six participants, 10%)
and a score of > 28 indicating severe depression (53 participants, 87%).
Comparison of participant characteristics by recruitment approach: letter mail-out versus
waiting room recruitment
Table 16 provides a summary comparison of participant characteristics by the two recruitment methods.
Although equal numbers of male and female participants were recruited by the waiting room method,
61% of those recruited by letter mail-out were female. More single participants than cohabitees (72% vs.
67%) were recruited by letter mail-out, as were more participants who were not employed (84% vs.
78%). However, in light of the relatively small numbers, there is no evidence of significant sample skewing
between the two methods of recruitment.
TABLE 12 Comparison target randomisation vs. actual randomisation by month
Month Month number
Target
randomisation
(n)
Actual
randomisation
(n)
Target
cumulative
randomisation
(n)
Actual
cumulative
randomisation,
n (%)
June 2014 1 0 0 0 0 (0.0)
July 2014 2 6 0 6 0 (0.0)
August 2014 3 6 0 12 0 (0.0)
September 2014 4 18 2 30 2 (6.7)
October 2014 5 30 2 60 4 (6.7)
November 2014 6 30 7 90 11 (12.2)
December 2014 7 30 8 120 19 (15.8)
January 2015 8 – 5 120 24 (20.0)
February 2015 9 – 4 120 28 (23.3)
March 2015 10 – 7 120 35 (29.2)
April 2015 11 – 3 120 38 (31.7)
May 2015 12 – 9 120 47 (39.2)
June 2015 13 – 9 120 56 (46.7)
July 2015 14 – 4 120 60 (50.0)
August 2015 15 – 1 120 61 (50.8)
Bold denotes the month when recruitment was originally timed to be completed.
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Comparison of participant characteristics by allocation
Table 17 summarises participant characteristic by allocation. There was a greater proportion of female
participants in the control arm than in the intervention arm (69% vs. 47%). The mean ages of the groups
were similar [mean age in control arm, 45.5 (SD 15.0) years; mean age in intervention arm, 46.4 (SD 10.6)
years]. Of those participants who were employed, almost two-thirds were in the intervention arm of the
study, although these constituted only 18% of the whole sample. Although the majority of the sample
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(n = 238)
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• Because of missing information, n = 22
• Unable to contact, n = 29
• Declined to participate, n = 28
• Did not meet inclusion criteria, n = 52
• Other reasons, n = 46
Allocated to intervention
(n = 32)
• Practice unable to contact, n = 1
• Did not attend GP appointment, n = 7
• Referred to CAB, n = 24
Received intervention
(n = 17)
Allocated to control (TAU)
(n = 29)
• Practice unable to contact, n = 6
• Did not attend GP appointment, n = 3
• Attended GP appointment, n = 20
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p Lost to follow-up at 4 months
(n = 4)
• Formal withdrawal, n = 1
• Unable to contact/meet, n = 3
Lost to follow-up at 4 months
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is Primary outcome – BDI-II
• Analysed at baseline, n = 32
• Analysed at 4 months, n = 28
Primary outcome – BDI-II
• Analysed at baseline, n = 29
• Analysed at 4 months, n = 24
FIGURE 4 The CONSORT diagram showing participant flow from initial eligibility assessment through to 4-month
follow-up.
TABLE 13 Reasons given by respondents for declining participation in the trial
Reasons n
Does not want to take part in research 2
Unable to take part because of time commitment 5
Baseline cancelled/no show at baseline unable to recontact or decided no 13
Decided no longer interested 8
Total 28
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TABLE 14 Reasons why respondents did not meet inclusion criteria
Reasons n
Currently taking part in another research study 2
Debt advice form CAB in last 12 months 10
Does not have low mood/depression 9
Does not want debt advice via general practice 3
Not worried about debt or no debt 25
BDI-II score of < 14 at baseline assessment 3
Total 52
TABLE 15 Other reasons for non-participation in the trial
Reasons n
Baseline risk assessed then unable to recontact/did not wish to continue 3
Baseline split over more than one visit: unable to recontact to complete 1
Withdrawn by GP 1
General practice no longer able to take participants into the study 3
Change of location/general practice pre baseline 2
HTA decision to close trial: unable to progress to baseline 36
Total 46
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FIGURE 5 Severity of depression across the whole sample.
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TABLE 16 Participant characteristics at baseline by recruitment method
Baseline characteristic
Recruitment method
Letter mail-out Waiting room
Sex, n (%)
Male (N= 26) 17 (39.5) 9 (50.0)
Female (N= 35) 26 (60.5) 9 (50.0)
Age (years), mean (SD) 46.3 (13.2) 44.4 (11.9)
Ethnicity, n (%)
White (N= 59) 43 (100.0) 16 (88.9)
Other (N = 2) 0 (0.0) 2 (11.1)
Cohabiting status, n (%)
Cohabiting (N= 18) 12 (27.9) 6 (33.3)
Not cohabiting (N= 43) 31 (72.1) 12 (66.7)
Employment, n (%)
Employed (N = 11) 7 (16.3) 4 (22.2)
Not employed (N = 50) 36 (83.7) 14 (77.8)
Mean depression score (SD) 35.8 (8.3) 33.8 (8.1)
Severity of depression, n (%)
Mild (N = 2) 2 (4.7) 0 (0.0)
Moderate (N = 6) 2 (4.7) 4 (22.2)
Severe (N= 53) 39 (90.6) 14 (77.8)
TABLE 17 Participant characteristics at baseline by allocation
Baseline characteristic
Trial arm
Control (TAU) Intervention
Age (years), n [mean] (SD) 29 [45.5] (15.0) 32 [46.4] (10.6)
Sex, n (%)
Male (N= 26) 9 (31.0) 17 (53.1)
Female (N= 35) 20 (69.0) 15 (46.9)
Ethnicity, n (%)
White (N= 59) 29 (100.0) 30 (93.7)
Other (N = 2) 0 (0.0) 2 (6.3)
Cohabiting status, n (%)
Cohabiting (N= 18) 9 (31.0) 9 (28.1)
Not cohabiting (N= 43) 20 (69.0) 23 (71.9)
Employment, n (%)
Employed (N = 11) 4 (13.8) 7 (21.9)
Not employed (N = 50) 25 (86.2) 25 (78.1)
Severity of depression, n (%)
Mild (N = 2) 0 (0.0) 2 (6.3)
Moderate (N = 6) 3 (10.3) 3 (9.4)
Severe (N= 53) 26 (89.7) 27 (84.3)
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recorded their ethnicity as white, both of the participants who did not were in the intervention arm of the
trial. The vast majority of the sample recorded BDI-II scores at baseline that fell within the severe range;
however, both participants with scores that fell within the mild range were in the intervention arm of the
trial (see Table 17).
Assessment of contamination
We assessed contamination based on self-report information about receipt of debt advice provided by
participants at the 4- and 12-month assessment visits. The original criterion for determining evidence of
contamination was ‘10 or more of the individually randomised TAU participants from among the 30
individually randomised control participants seeking debt advice, providing this is at least twice as common
among individually versus cluster randomised controls’. At the time recruitment to the trial closed, only
29 participants had been allocated to the control arm of the trial, with 18 participants from cluster control
practices and 11 participants individually randomised. Of the 18 cluster controls, 13 completed the debt
advice question at 4-month follow-up, with one participant reporting having received debt advice. Of the
11 individually randomised controls, 10 completed the debt advice question at 4-month follow-up, with one
participant reporting having received debt advice. Only four control participants completed a 12-month
follow up, all were individually randomised controls. None reported receiving debt advice in the preceding
8 months. Although the figures are small, based on the definition above, there was no evidence of serious
contamination within the participants individually randomised to the control arm of the trial. We would
therefore have employed individual randomisation for the full trial.
Assessment of unblinding
Unblinding of RAs (when it occurred) was recorded on the participant CRF. There were four definite cases
(one control participant and three intervention participants) in which RAs were unblinded to participant
allocation at 4-month follow-up. There were also a further four cases (all intervention participants) in
which RAs were unsure whether or not they had been unblinded – either because there had been some
reference to practice allocation or because participants had referred to CAB – but it was unclear whether
this was for the study or if the participant was seeing CAB independently. No additional unblinding
occurred at the 12-month follow-up point.
Assessment of data collection systems and data completeness
We checked through the clinical trials unit for missing data in all files from baseline, 4- and 12-month
follow-up. In each case, although there were some missing answers in a few questionnaires, most were
fully completed where relevant (e.g. high ‘missing rate’ in Stanford presenteeism scale owing to low levels
of employment among participants).
Primary and secondary outcome analysis: descriptive statistics
Although we include available data for all three data collection points (baseline and 4- and 12-month
follow-up), we will not comment on the 12-month data because of the small imbalanced numbers of
participants at 12 months.
Primary outcome
Table 18 shows mean BDI-II scores in the control and intervention groups at both baseline and 4-month
follow-up. The mean scores in all groups at all time points continue to fall within the moderate (20–28) or
severe (> 28) depression range.
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Secondary outcomes
Psychological well-being
Anxiety and well-being were assessed using the BAI and the SWEMWBS, respectively. Table 19 shows the
mean anxiety scores for control and intervention groups at baseline and follow-up, and Table 20 shows
the mean SWEMWBS scores for control and intervention groups at baseline and follow-up.
Employment factors
Employment factors were assessed with participants’ self-reported absence from work due to sickness and
with the SPS-6 questionnaire assessing the impact of health problems on work. Table 21 shows the
percentage of participants in the control and intervention groups reporting a sickness absence at baseline
and follow-up. At both baseline and follow-up a greater percentage of the intervention group reported
sickness absence. Table 22 shows mean scores on the SPS-6 for control and intervention groups. The
possible presenteeism score ranges from 6 to 30, with lower scores indicating less presenteeism. Both
groups, thus, have moderate presenteeism average scores with little change at follow-up.
TABLE 18 Beck Depression Inventory-II at baseline and follow-up
Trial arm
Time point, n [mean] (SD)
Baseline 4 months 12 months
Control 29 [36.6] (7.9) 24 [29.0] (11.3) 4 [31.8] (20.3)
Intervention 32 [33.9] (8.4) 28 [25.7] (9.9) 18 [25.4] (8.8)
TABLE 19 Beck Anxiety Inventory at baseline and follow-up
Trial arm
Time point, n [mean] (SD)
Baseline 4 months 12 months
Control 27 [28.2] (13.0) 23 [22.4] (11.8) 4 [32.0] (19.9)
Intervention 31 [25.4] (13.3) 26 [24.9] (14.0) 18 [22.0] (14.1)
TABLE 20 Short Warwick–Edinburgh Mental Wellbeing Scale at baseline and follow-up
Trial arm
Time point, n [mean] (SD)
Baseline 4 months 12 months
Control 17 [16.3] (4.9) 22 [17.9] (4.3) 4 [14.5] (6.0)
Intervention 28 [17.6] (4.7) 25 [18.6] (4.3) 17 [20.1] (4.8)
TABLE 21 Percentage of participants reporting sickness absence at baseline and follow-up
Trial arm
Time point, n [mean] (SD)
Baseline 4 months 12 months
Control 5/10 (50.0) 4/11 (36.4) No data
Intervention 8/10 (80.0) 5/9 (55.6) 1/2 (50)
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Service satisfaction
Participant service satisfaction was assessed with the GSQ, with higher scores indicating greater
satisfaction. Table 23 shows mean scores between groups on the GSQ at 4-month follow-up, with little
difference in mean scores for control and intervention groups, suggesting no evidence of relatively lower
satisfaction with either approach.
Substance misuse
Alcohol and illicit drug use was assessed with the AUDIT questionnaire and Drug Use Questionnaire,
respectively. Table 24 presents mean scores for alcohol consumption. Clinically, those scoring 8–15 would
be offered advice on reducing hazardous drinking, those scoring 16–19 would be offered a more
structured brief intervention and those scoring ≥ 20 would be considered potentially dependent drinkers.
At all data collection points, the mean score in the intervention group is higher than in the control group;
indeed, the mean score of persistently > 20 in the intervention group who completed the full AUDIT score
suggests that many of these were dependent drinkers. The proportions of hazardous (or more) drinkers
were comparable between the control and intervention samples at baseline, dropping after 4 months
among controls (from 38% to 29%) but rising among the intervention group (from 34% to 50%).
TABLE 23 General Satisfaction Questionnaire at 4 months
Trial arm
Time point, n [mean] (SD)
4 months
Control 22 [47.4] (9.2)
Intervention 25 [46.0] (10.6)
TABLE 24 Alcohol Use Disorders Identification Test at baseline and follow-up
AUDIT score
Time point, n [mean] (SD)
Baseline 4 months 12 months
Control
Qu 1–3 18 [1.4] (1.6) 17 [1.4] (1.7) 2 [2.0] (2.8)
Qu 1–10 11 [13.6] (9.6) 7 [15.4] (9.8) 2 [11.5] (6.4)
All 29 [6.0] (8.4) 24 [5.5] (8.3) 4 [6.8] (6.8)
Intervention
Qu 1–3 21 [2.0] (1.7) 13 [1.9] (1.8) 9 [2.0] (1.7)
Qu 1–10 11 [21.7] (12.7) 13 [23.9] (10.1) 9 [21.3] (12.0)
All 32 [8.8] (12.0) 26 [12.9] (13.3) 18 [11.7] (13.0)
Qu, question.
TABLE 22 Stanford Presenteeism Scale-6 at baseline and follow-up
Trial arm
Time point, n [mean] (SD)
Baseline 4 months 12 months
Control 10 [18.2] (4.9) 11 [16.1] (5.5) No data
Intervention 17 [17.9] (5.0) 14 [17.0] (5.4) 6 [19.0] (4.5)
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Table 25 shows mean scores between groups for illicit drug use. The mean score for illicit drug use is
higher in the intervention group at all data collection points. Table 26 shows the comparison between the
control and intervention groups for illicit drug use by severity category. No participant in the control arm
scored within the severe range for illicit drug use, compared with two participants scoring within the
severe range at some point across the data collection points.
Quality of life
Quality of life was assessed with MANSA, with higher scores indicating better quality of life. Table 27
shows that at both time points there was some difference in mean quality-of-life scores between groups,
with the mean score at baseline being lower among the controls, but rising by 8.8 versus 3.3 in the
intervention group to give a higher mean score at 4 months.
TABLE 26 Severity of drug use at baseline and follow-up
Severity category
Time point, n/N (%)
Baseline 4 months 12 months
Control
Low 6/6 (100.0) 5/6 (83.3) 2/2 (100.0)
Moderate 0/6 (0.0) 1/6 (16.7) 0/2 (0.0)
Substantial 0/6 (0.0) 0/6 (0.0) 0/2 (0.0)
Severe 0/6 (0.0) 0/6 (0.0) 0/2 (0.0)
Intervention
Low 5/8 (62.5) 6/12 (50.0) 2/5 (40.0)
Moderate 1/8 (12.5) 4/12 (33.3) 1/5 (20.0)
Substantial 1/8 (12.5) 0/12 (0.0) 1/5 (20.0)
Severe 1/8 (12.5) 2/12 (16.7) 1/5 (20.0)
Severity categories: low 1–2; moderate 3–5; substantial 6–8; severe 9–10.
TABLE 25 Drug Use Questionnaire at baseline and follow-up
Treatment arm
Time point, n [mean] (SD)
Baseline 4 months 12 months
Control 6 [1.3] (0.5) 6 [1.8] (1.2) 2 [1.5] (0.7)
Intervention 8 [3.0] (3.0) 12 [3.6] (3.0) 5 [4.8] (3.9)
Severity categories: low 1–2; moderate 3–5; substantial 6–8; severe 9–10.
TABLE 27 Manchester Short Assessment of Quality of Life questionnaire at baseline and follow-up
Trial arm
Time point, n [mean] (SD)
Baseline 4 months 12 months
Control 29 [41.8] (13.1) 24 [50.6] (10.5) 4 [43.2] (11.6)
Intervention 32 [44.1] (11.6) 27 [47.4] (12.9) 18 [52.4] (11.6)
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Life events and difficulties
The presence of life events and difficulties known to be associated with depression, and positive events and
reduction in difficulties associated with improvement in psychological well-being, were assessed with the
LED-S. At baseline, there appeared to be some difference between groups in the reporting of life events and
difficulties, with a greater percentage of the intervention group reporting a severe event or severe financial
event in the 12 months prior to baseline. However, a greater percentage of the intervention group also
reported a fresh start event in the 12 months prior to baseline. A greater percentage of the control group
reported a financial fresh start event, a difficulty reduction, a financial difficulty reduction, a positive experience
and a positive financial experience in the 12 months prior to baseline (Table 28). At the 4-month follow-up a
greater percentage of the control group reported having experienced a severe event, a fresh start event and a
positive experience between baseline and 4-month follow-up, suggesting that the intervention had no effect
on experiences relieving stress. There was little difference between the groups on any other indices at 4-month
follow-up (see Table 28). Comparing the mean number of events and difficulties between groups, Table 29
shows little difference between the control and intervention groups in the mean number of events and
difficulties occurring in the 12 months prior to baseline and between baseline and 4-month follow-up.
TABLE 28 Participants reporting a severe event or difficulty
Events and difficulties
Severe event or difficulty occuring, n/N (%)
In the 12 months prior
to baseline
Between baseline and
4 months
Participants reporting a severe event
Control 16/29 (55.2) 12/24 (50.0)
Intervention 21/32 (65.6) 10/27 (37.0)
Participants reporting a severe financial event
Control 5/29 (17.2) 2/24 (8.3)
Intervention 8/32 (25.0) 2/27 (7.4)
Participants reporting a fresh start event
Control 9/29 (31.0) 9/24 (37.5)
Intervention 12/32 (37.5) 7/27 (25.9)
Participants reporting a financial fresh start
Control 2/29 (6.9) 0/24 (0.0)
Intervention 1/32 (3.1) 0/27 (0.0)
Participants reporting any difficulty reduction
Control 13/29 (44.8) 1/24 (4.1)
Intervention 8/32 (25.0) 1/27 (3.7)
Participants reporting any financial difficulty reduction
Control 13/29 (44.8) 1/24 (4.1)
Intervention 8/32 (25.0) 1/27 (3.7)
Participants reporting any positive experience
Control 18/29 (62.1) 9/24 (37.5)
Intervention 17/32 (53.1) 7/27 (25.9)
Participants reporting any positive financial experience
Control 3/29 (10.3) 2/24 (8.3)
Intervention 1/32 (3.1) 1/27 (3.7)
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The proportions of participants with severe financial events and difficulties in the past 12 months are
higher than in most studies, but this is unsurprising given that such an experience was a sample selection
criterion. Proportions with other types of severe events and difficulties are similar to those in other studies
with inner-city working-class participant samples.
Explanatory measures
Hopelessness
Table 30 shows some differences between the two groups in mean score, and agency and pathway
subscale, with controls recording lower mean scores (i.e. lower propensity to believe themselves able to
effect change in their lives and believe themselves able to find solutions to problems) at both time points
than the intervention group.
TABLE 29 Mean number of events or difficulties
Events and difficulties
Event or difficulties occuring, n [mean] (SD)
In the 12 months prior
to baseline
Between baseline and
4 months
Mean number of severe events
Control 29 [1.7] (2.7) 24 [1.1] (1.6)
Intervention 32 [1.6] (1.7) 27 [0.8] (1.7)
Mean number of severe financial events
Control 29 [0.3] (0.8) 24 [0.2] (0.7)
Intervention 32 [0.3] (0.5) 27 [0.1] (0.5)
Mean number of provoked difficulties
Control 29 [2.9] (1.3) 24 [2.4] (1.1)
Intervention 32 [2.7] (1.2) 27 [2.2] (1.2)
Mean number of financial provoked difficulties
Control 29 [0.7] (0.4) 24 [0.7] (0.5)
Intervention 32 [0.8] (0.4) 27 [0.8] (0.5)
Mean number of severe provoking events
Control 29 [4.6] (3.4) 24 [3.5] (2.6)
Intervention 32 [4.3] (2.4) 27 [3.0] (2.2)
Mean number of severe financial provoking events
Control 29 [1.0] (1.0) 24 [0.9] (0.9)
Intervention 32 [1.1] (0.6) 27 [0.9] (0.7)
Mean number of fresh starts
Control 29 [0.5] (0.8) 24 [0.5] (0.8)
Intervention 32 [0.5] (0.8) 27 [0.3] (0.6)
Mean number of financial fresh starts
Control 29 [0.4] (0.2) 24 [0.1] (0.3)
Intervention 32 [0.0] (0.0) 27 [0.04] (0.2)
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Shame
Table 31 shows some difference between the two groups in mean score on the OAS scale, with controls
recording higher mean scores (i.e. greater propensity to experience feelings of shame arising from the
perceived negative judgement of others) at both time points than those in the intervention group.
Rumination
Table 32 shows little difference between the two groups in mean Response Style Questionnaire-24 scores
for rumination at both baseline and 4-month follow-up.
Comparing perceptions between groups of debt contribution to low mood
and low mood contribution to debt
Participants completed a question asking whether or not they thought that their money difficulties
contributed to their experience of low mood/depression/anxiety and, conversely, whether or not they
thought that low mood/depression/anxiety had a negative impact on their money difficulties. If participants
answered affirmatively to the first question, they then rated, on a scale of 1–10 (where 1 was ‘hardly at
all’ and 10 was ‘completely’), the contribution of money difficulties to low mood/depression/anxiety and,
conversely, the contribution of low mood/depression/anxiety to money difficulties. Table 33 shows the
mean contribution scores by group. The means in all instances suggest that the majority of the sample
felt that debt contributed substantially to their low mood/anxiety and conversely that low mood/depression
contributed substantially to their money difficulties, with little difference between groups. This bidirectional
interaction reflects previous research (see Chapter 1, Relationship between debt and depression) and our
qualitative findings (see Chapter 6).
TABLE 31 Other as Shamer scale at baseline and follow-up
Trial arm
Time point, n [mean] (SD)
Baseline 4 months
Control 29 [37.5] (12.2) 24 [36.4] (14.6)
Intervention 31 [33.7] (15.5) 26 [31.3] (15.8)
TABLE 30 Hope Trait Scale Agency and Pathway variables at baseline and follow-up
Trial arm and variables
Time point, n [mean] (SD)
Baseline 4 months
Control
Agency 27 [14.2] (5.3) 24 [17.4] (6.8)
Pathway 27 [16.1] (5.6) 24 [19.4] (5.9)
Total 27 [55.3] (11.7) 24 [61.9] (13.0)
Intervention
Agency 32 [16.0] (6.5) 25 [16.1] (7.6)
Pathway 32 [18.5] (7.0) 26 [18.7] (7.1)
Total 32 [58.9] (12.3) 25 [58.5] (13.9)
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TABLE 33 Degree to which debt contributes to low mood and, conversely, low mood contributes to debt as
baseline and follow-up
Trial arm
Time point, n/N [mean] (SD)
Baseline 4 months 12 months
Debt contributes to low mood
Control 26/28 [7.6] (2.1) 21/24 [7.6] (1.8) 4/4 [6.5] (3.1)
Intervention 21/21 [7.6] (1.7) 24/27 [7.6] (1.5) 14/18 [7.3] (2.4)
Low mood contributes to debt
Control 25/28 [7.7] (2.3) 21/24 [7.1] (2.4) 3/4 [8.0] (1.0)
Intervention 19/21 [7.6] (1.9) 21/27 [8.0] (1.4) 13/18 [8.2] (1.8)
TABLE 32 Response Style Questionnaire-24 at baseline and follow-up
Trial arm
Time point, n [mean] (SD)
Baseline 4 months
Control 29 [29.0] (7.9) 23 [27.5] (8.1)
Intervention 32 [27.8] (8.0) 26 [27.9] (8.0)
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Chapter 5 Pilot trial results: health economics
analysis
Descriptive analysis: health and social care utilisation and personal debt
Given the small sample size and unbalanced 12-month follow-up samples, we comment mainly on the
data collected at baseline and 4-month follow-up.
Inpatient data
No participant listed any use of long-stay or rehabilitation inpatient hospital services over the 3 months
prior to study entry, or at either of the two follow-up time points. Overall, the number of participants with
use of inpatient hospital services was low; moreover, the number of inpatient contacts in the 3-month
period directly preceding baseline and each of the two follow-up data collection points was low within
both the control and intervention groups. Inpatient service use was reported mostly as acute and as
occurring prior to the baseline visit for all participants, with 10% of participants in the control group
reporting acute medical visits, compared with 6% of the intervention group. Acute surgical inpatient
contacts were reported by 7% of the control group, compared with 3% of the intervention group.
Only one person (3%) from the intervention group reported acute inpatient service use for mental
health services; this admission took place in the 3 months preceding baseline, with a reported number
of 41 inpatient days. A minority of the acute admissions were via the accident and emergency (A&E)
department, with 14% of admissions taking place via this route for the control group, compared with
11% of acute admissions for the intervention group. Only one participant from each group reported
inpatient service use in the 3 preceding months at 4-month follow-up; both were for acute service use of
medical or surgical nature, rather than for mental health services.
Outpatient (ambulatory) hospital services
As can be seen in Table 34, there is little difference in the percentage of participants attending for physical
health care from either the control or the intervention group. The number of participants reporting physical
health-care appointments was in both groups higher in the 3 months preceding the 12-month follow-up
assessment than at the 4-month follow-up, but the differences between baseline and 4-month follow-up
are small. At baseline, a greater percentage of participants from the intervention group (21%) than
from the control group (10%) report outpatient care for mental health. However, during the 3 months
preceding the 4-month follow-up, both groups’ use of outpatient care falls, the intervention group falls to
7% from 22%, compared with 8% from 10% among the control. Similarly, the percentage of participants
reporting A&E appointments changes between the groups at baseline and 4 months, with both groups
reporting a small rise, but the overall numbers are small (range 7–13%).
Community-based day services
Table 35 shows that at baseline and at 4-month follow-up a greater percentage of intervention group
participants than control group participants reported attending community-based services for mental
health care. A greater percentage of intervention group participants than control group participants
consistently reported attending community-based alcohol/substance misuse services at each data collection
point, but this falls substantially among the intervention participants at 4 months compared with baseline
or the 12-month follow-up (7% vs. 18% and 28%, respectively).
Primary care contacts
The percentage of participants reporting a primary care contact is similar between the control and
intervention groups at baseline and 4-month follow-up (Table 36), with nearly all participants reporting at
least one GP contact, as one might expect in view of the study design and population.
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TABLE 34 Participants with an outpatient appointment, for physical or mental health services care or A&E contacts,
and mean number of attendances in the 3 months preceding each data collection point
Type of appointment
Data collection point
Baseline (N= 61) 4 months (N= 51) 12 months (N= 22)
Control
(n= 29)
Intervention
(n= 32)
Control
(n= 24)
Intervention
(n= 27)
Control
(n= 4)
Intervention
(n= 18)
Physical
Participants with
appointments, n (%)
15 (51.7) 17 (53.1) 12 (50.0) 14 (51.9) 3 (75.0) 12 (66.7)
Number of appointments
across participants, mean (SD)
2.6 (2.5) 3.4 (5.1) 2.9 (2.8) 1.9 (1.7) 4.0 (1.7) 2.4 (1.9)
Mental health
Participants with
appointments, n (%)
3 (10.3) 7 (21.9) 2 (8.3) 2 (7.4) 1 (25.0) 1 (5.6)
Number of appointments
across participants, mean (SD)
3.0 (3.5) 4.0 (4.4) 2.0 (0.0) 1.0 (0.0) 1.0 (–) 2.0 (–)
A&E
Participants with
appointments, n (%)
2 (6.9) 3 (9.4) 3 (12.5) 3 (11.1) 1 (25.0) 3 (16.7)
Number of appointments
across participants, mean (SD)
4.0 (2.8) 1.3 (0.58) 1.0 (0.0) 1.7 (1.2) 1.0 (–) 1.0 (0.0)
TABLE 35 Participants attending community-based day services for mental health services or alcohol/substance
misuse, and mean number of appointments in the 3 months preceding each data collection point
Type of appointment
Data collection point
Baseline (N= 61) 4 months (N= 51) 12 months (N= 22)
Control
(n= 29)
Intervention
(n= 32)
Control
(n= 24)
Intervention
(n= 27)
Control
(n= 4)
Intervention
(n= 18)
Mental healtha
Participants with
appointments, n (%)
3 (10.3) 6 (18.8) 3 (12.5) 7 (25.9) 2 (50.0) 3 (16.7)
Number of appointments
across participants, mean (SD)
1.0 (0.0) 6.5 (3.6) 6.0 (4.0) 3.6 (4.2) 2.5 (2.1) 9.3 (14.4)
Alcohol/substance misuseb
Participants with
appointments, n (%)
1 (3.5) 6 (18.8) 0 (0.0) 2 (7.4) 0 (0.0) 5 (27.8)
Number of appointments
across participants, mean (SD)
2.0 (–) 21.2 (38.0) – 56 (62.2) – 20.2 (23.7)
a Mental health concerns community services denoted as ‘Case Worker – Mental Health’, ‘Community Mental Health
Centre’ or ‘IAPT’, ‘CBT’, ‘Psychotherapy’, ‘Psychiatrist’, ‘Mental health support service’ or any counselling.
b Alcohol/substance misuse concerns community services denoted as ‘Substance Misuse Service’, ‘Alcohol addiction
service’, ‘Alcoholics anonymous’ or ‘Narcotics addiction service’.
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Priority and non-priority debts
Table 37 shows the number of participants with priority and non-priority debts by allocation. Although
there is some variation between groups in the percentage of participants reporting priority debts at
baseline and 4-month follow-up, the average number of priority debts per participant is similar between
groups at each time point. At baseline and 4-month follow-up a greater percentage of participants in
the control group report having non-priority debts than in the intervention group. The proportion of
participants reporting a priority debt at 4 months falls more among control participants (from 72% to
50%) than among intervention participants (from 81% to 74%), although there is a greater reduction in
the mean number of priority debts (mean reduction at 4 months, intervention 0.8 vs. control 0.4).
Criminal justice system
Table 38 shows the number of participants who reported, via the Client Service Receipt Inventory, criminal
justice system contacts in the 3 months preceding each of the baseline, 4-month follow-up and 12-month
follow-up assessments. Only a small percentage of participants from both groups reported police contacts
at baseline and at 4-month follow-up. One participant from each group reported ‘spending the night in a
prison cell’ in the 3 months preceding baseline, but no further reports of such incidents were presented at
4-month follow-up in either group. A small percentage of participants in each group reported having civil
court appearances at baseline and at 4-month follow-up. No participant reported having any criminal court
appearances. Only one participant from the intervention group reported receiving a psychiatric assessment
‘in custody’; this took place in the 3 months preceding baseline and we have not included these data in
Table 38.
TABLE 36 Participants with primary care contacts, and mean number of contacts and time spent with a clinician in
the 3 months preceding each data collection point
Type of contact
Data collection point
Baseline (N= 61) 4 months (N= 51) 12 months (N= 22)
Control
(n= 29)
Intervention
(n= 32)
Control
(n= 24)
Intervention
(n= 27)
Control
(n= 4)
Intervention
(n= 18)
All primary care contacts
Participants with contact,
na (%)
27 (93.1) 31 (96.9) 23 (95.8) 24 (88.9) 4 (100.0) 15 (83.3)
Contacts, meanb,c (SD) 5.8 (4.5) 3.8 (2.3) 4.1 (3.1) 3.4 (2.7) 3.5 (1.3) 4.6 (3.6)
Time spent with clinician
across participants
(minutes), meanb,c (SD)
88.3 (81.7) 55.4 (43.2) 53.9 (42.2) 58.8 (58.4) 33.8 (14.9) 86.0 (89.1)
GP contacts
Participants with contact,
na (%)
27 (93.1) 31 (96.9) 23 (95.8) 24 (88.9) 4 (100.0) 15 (83.3)
Contacts, meanb,c (SD) 5.4 (4.4) 3.4 (2.0) 3.8 (2.8) 3.4 (2.7) 2.8 (1.3) 4.5 (3.5)
Time spent with GP
across participants
(minutes), meanb,c (SD)
79.6 (77.9) 48.0 (37.0) 50.3 (41.6) 58.8 (58.4) 26.3 (14.9) 79.3 (78.2)
a The count of participants with GP contacts is equal to the participant count with any primary care contact at all data
collection points.
b Mean calculations computed on only those who have clinical contact.
c Mean contacts/time skewed by extreme maximum values. At baseline maximum time values of 400 and 150 for control
and intervention, respectively, at 4-month values of 180 and 240, and at 12-month values of 50 and 270.
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Citizens Advice Bureau contacts
A total of 32 participants were allocated to the intervention arm to receive CAB debt advice. Of these, 19
had some form of communication with the CAB, two participants chose not to take up the service and 17
went on to receive CAB debt advice. Of the 17 participants receiving CAB advice, 10 (59%) had a single
CAB appointment, five (30%) had two appointments and a small number had three or four appointments
TABLE 37 Participants with priority or non-priority debts, and mean number of debts in the 3 months preceding
each data collection point
Type of debt
Data collection point
Baseline (N= 61) 4 months (N= 51) 12 months (N= 22)
Control
(n= 29)
Intervention
(n= 32)
Control
(n= 24)
Intervention
(n= 27)
Control
(n= 4)
Intervention
(n= 18)
Priority
Participants with priority debts,
n (%)
21 (72.4) 26 (81.3) 12 (50.0) 20 (74.1) 4 (100.0) 14 (77.8)
Number of priority debts
across participants, mean (SD)
3.5 (2.2) 3.2 (2.4) 3.9 (1.8) 3.1 (1.6) 3.3 (1.5) 2.6 (1.6)
Non-priority
Participants with non-priority
debts, n (%)
27 (93.1) 25 (78.1) 20 (83.3) 19 (70.4) 2 (50.0) 15 (83.3)
Number of non-priority debts
across participants, mean (SD)
3.6 (3.4) 2.7 (1.4) 2.3 (1.6) 2.5 (1.0) 1.0 (0.0) 2.6 (1.4)
TABLE 38 Participants in contact with the criminal justice system and mean number of contacts in the 3 months
preceding each data collection point
Type of contacta
Data collection point
Baseline (N= 61) 4 months (N= 51) 12 months (N= 22)
Control
(n= 29)
Intervention
(n= 32)
Control
(n= 24)
Intervention
(n= 27)
Control
(n= 4)
Intervention
(n= 18)
Police
Participants with contacts,
n (%)
1 (3.4) 2 (6.2) 1 (4.2) 3 (11.1) 1 (25.0) 3 (16.7)
Number of contacts across
participants, mean (SD)
1.0 (–) 2.0 (1.4) 2 (–) 3.7 (1.5) 1 (–) 2.3 (2.3)
Night in prison cell
Participants with contacts,
n (%)
1 (3.4) 1 (3.1) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Number of contacts across
participants, mean (SD)
1 (–) 1 (–) – (–) – (–) – (–) – (–)
Civil court appearance
Participants with contacts,
n (%)
2 (6.9) 2 (6.3) 0 (0.0) 1 (3.7) 1 (25.0) 2 (11.1)
Number of contacts across
participants, mean (SD)
1.5 (0.7) 1 (0.0) – (–) 1 (–) 1 (–) 1 (0.0)
a When data are missing, or if contact with criminal justice is ‘no’, data are imputed as zero.
PILOT TRIAL RESULTS: HEALTH ECONOMICS ANALYSIS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
54
(12% and 6%, respectively). Across the 17 participants, a total of 28 appointments took place. Most
appointments were completed face to face at the participant’s own general practice (71%), with four
appointments (14%) taking place at CAB premises. Appointments lasted an average of 57 minutes
(range 10–90 minutes).
Health-related quality of life
The data produced three samples of participants: those with baseline data (n = 61: control, n = 29;
intervention, n = 32), those who also had data from 4-month follow-up (n = 50: control, n = 24; intervention,
n = 26) and those who had complete-case data at 12 months (n = 22: control, n = 4; intervention, n = 18).
The data described later (see Figures 6 and 7) consider each sample (in isolation) at the three data collection
points. Results from all participants, as represented by group allocation of control and intervention,
are presented.
One data point was imputed for one participant to facilitate retention within the 12-month follow-up
sample; the data point was rescored using data from a participant with a similar pattern of response across
the EQ-5D-5L dimensions. Data at 4 months were spoiled for one participant and so only baseline data
were included.
The EQ-5D-5L Crosswalk Index Value Calculator (version 2) was used to calculate the EQ-5D-5L index
values and the following formula was used to calculate QALYs from the EQ-5D-5L administered at baseline
and at 4-month follow-up:
½(EQ-5D-5L score at baseline + EQ-5D-5L score at 4 months)=2
× (0:33 time since follow-up given as proportion of a year)). (1)
The formula was extended to calculate QALYs from the EQ-5D-5L administered at baseline and the two
follow-up time points (4 and 12 months):
f½(EQ-5D-5L score at baseline + EQ-5D-5L score at 4 months)=2
×(0:33 time since follow-up given as proportion of 1 year)g
+f½(EQ-5D-5L score at 4 months + EQ-5D-5L score at 12 months)=2
×(0:67 time since follow-up given as proportion of 1 year)g.
(2)
EurolQol-5 Dimensions UK population norms
In this study the EQ-5D-5L version was used; currently, there are no data for the UK population norms
from the five-level version, and the comparison made here is in reference to the EuroQol-5 Dimensions-3
levels (EQ-5D-3L). For the purposes of the comparisons shown here, the potential differences in values
from the three- and five-level versions are unlikely to lead the reader to draw erroneous conclusions about
the study population and UK norms. The norms were originally calculated by Kind et al.82 from a sample
of 3395 participants within the UK and recently reproduced in a study by Janssen and Szende.83 As the
number of people reporting severe problems is usually a small proportion of the general population,
it is common to sum the reported levels of problems.83 In the case of the EQ-5D-3L, this means that levels
2 and 3 are summed to create two categories of ‘no problems’ and ‘problems’ for each of the five
dimensions. As the opportunity to observe changes in the reported level of problems is more refined for
the EQ-5D-5L, no such categorising of ‘no problems’ relative to ‘problems’ has been conducted for the
DeCoDer sample in an effort to demonstrate the nuances of change that transpired across the three data
collection periods. For both the index values (total and by domain) and visual analogue scale (VAS) scores,
the study population can be seen to score substantially below UK norms.
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EurolQol-5 Dimensions health states by group allocation
As can be seen from Figure 6, across the two groups most participants at baseline reported some problems
(levels 2–5/’slight’ to ‘extreme’) in all five EurolQol-5 Dimensions (EQ-5D) dimensions of mobility (54.4%),
self-care (39.6%), usual activity (82.0%), pain/discomfort (73.8%) and anxiety/depression (98.4%).
Anxiety/depression was consistently reported at a higher level (‘moderate to extreme’) across groups
(78.7%), along with usual activity (55.8%) and pain/discomfort (49.2%). Self-care (60.7%) and mobility
(45.5%) were the dimensions in which most participants reported ‘no problems’. Similar patterns of
reporting were seen within both the control (n = 29) and intervention (n = 32) groups, although the
proportion of participants reporting higher levels (levels 4–5) of mobility problems was higher in the
control group (62.1%) than in the intervention group (43.7%), and similarly for usual activity (89.7% and
75.0%, respectively). Some variation in reported levels of problems can be seen across and within groups,
as well as between data collection points.
EurolQol-5 Dimensions visual analogue scale and index value by group allocation
The EQ-5D VAS scores (range 0–100) were rescaled for comparability with index values (range 0–1) by
dividing scores by 100 (e.g. a VAS score of 45 = 45/100 = 0.450).
As can be seen in Figure 7, at baseline the control group report marginally higher EQ-5D index values than
the intervention group (0.497 and 0.468, respectively), whereas the control group’s VAS scores are marginally
lower than those of the intervention group (0.450 and 0.522, respectively). Across both groups the index
value score and the VAS reports appear to be consistent in representing similar health-state valuations.
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Summary: health economics
The results are purely descriptive and, with such a small sample size, we are cautious about drawing
conclusions. However, it seems clear that at baseline the study population are ‘users’ of health services and
there is an imbalance at baseline. In a full randomised controlled trial, adjustment for baseline use and
other factors may be required. There were some participants who had contact with criminal justice
services, so in order for a full picture of impact on services to be captured, those conducting future studies
should be mindful of collecting these data as well as the health and social care contacts.
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The EQ-5D data reflect the impact on health-related quality of life that the study participants experienced
as a consequence of debt and depression; we see that, on the mental health domain, around 80% of the
study sample report ‘moderate’, ‘severe’ or ‘extreme’ problems with anxiety and depression. This is relative
to a UK norm of around 20% reporting some problems with anxiety and depression. We noted that 7%
of our participants reported that they had no problems with depression or anxiety at baseline, even though
all reached the BDI-II threshold for depression.
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Chapter 6 Qualitative findings
Introduction
Chapter 6 is divided into two main components. First, we provide summary information about the patient
participant sample and present findings from the analysis of patient participant interviews. Second, in
Intervention process evaluation we present the findings from the analysis of clinician and CAB advisor
participant interviews with regard to the intervention process evaluation component of the study.
Participants
Of the 61 participants recruited to the study, 57 (93.4%) registered their interest in taking part in the
qualitative component of the study. Of these 57 participants, 34 (59.6%) were selected for interview at
the time recruitment to the study was closed. Of the 34 participants selected, 23 (67.6%) actually went on
to complete a qualitative interview.
Of the 23 participants interviewed, just over half had been allocated to the intervention arm of the study,
and 65% were female. As with the overall sample, the majority of participants taking part in an interview
were categorised as having severe depression. The ages of participants ranged from 23 to 71 years, with
a mean age of 47 years. All participants taking part in a qualitative interview were given a pseudonym
(Table 39).
Of the 23 participants that took part in a baseline qualitative interview, 19 (82.6%) also completed a
4-month follow-up interview.
Introduction to findings
The purpose of undertaking participant interviews was threefold. First, we wanted to gain a better
understanding of participants’ lived experience of debt and depression, and the relationship between these
experiences. Second, we wanted to explore participants’ experience of the intervention. Third, we wanted
to explore participants’ experience of involvement in the trial, including the acceptability of trial processes
and outcome measures. We take each of these purposes in turn in presenting the findings of the
qualitative analysis.
The lived experience of debt and depression: a story of complexity
Participants’ biographies of debt and depression reflected the highly individualised and complex social,
psychological and contextual arena in which debt and depression was experienced.
Although each participant described a unique constellation of experience, important concepts and patterns
could be identified that spanned individualised experience.
Trajectories into unmanageable debt
Most participants were able to identify key trigger points/events that shifted them from a position of
financial security or manageable debt into a position of unmanageable debt: debts that participants
considered there to be little hope of them being able to address within the context of their circumstances
DOI: 10.3310/hta21350 HEALTH TECHNOLOGY ASSESSMENT 2017 VOL. 21 NO. 35
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Gabbay et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
61
at that time. Trigger events often heralded a loss or reduction in household income, as described by Anne
and Natalie:
Then he [partner] started with depression then he couldn’t work, so then I was paying everything and
then I started getting into debt again.
Anne
TABLE 39 Qualitative sample
Baseline depression severitya Age groupb Pseudonym
Intervention
Female
Severe Older Angela
Severe Older Natalie
Severe Older Anne
Severe Older Paula
Severe Older Laura
Severe Younger Karen
Severe Younger Lucy
Mild Older Jane
Male
Severe Older Mike
Severe Older Mark
Severe Older John
Severe Older James
Control
Female
Severe Older Emma
Severe Older Sophie
Severe Younger Amy
Severe Younger Emily
Moderate Older Alice
Moderate Older Jill
Moderate Younger Susan
Male
Severe Older Pete
Severe Older David
Severe Older Christopher
Severe Younger Steve
a Depression severity categories: 14–19, mild; 20–28, moderate; and > 28, severe.
b Age group categories: younger ≤ 39 years and older ≥ 40 years.
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Before I was divorced when I was married to him, he would buy the kids things you know, and help
them along and what have you, well after I was divorced I still tried to do that, and using the credit
card and that you know and buying stuff for the kids . . . that is how it started.
Natalie
Psychological impact of unmanageable debt
The psychologically damaging effects of unmanageable debt were clearly articulated by participants; these
included, but were not limited to, pervasive worry, threat and fear, a sense of entrapment, demotivation
and low mood/depression. It was apparent that these negative psychological experiences were intimately
entwined and compounded by other social and contextual influences. Pervasive worry, for example, was
linked by participants to their expressed feelings of low mood/depression:
It [debt] it worries you to the point where you know you are sitting here every day thinking am I going
to be here next week you know what I mean . . . debt was a killer it really was, I would sit here and
I would be in buckets all day all night.
Pete
Your central heating because you are worrying in case you put that on, you are worrying in case your
electricity, worrying in case and that is where the depression comes in on the financial side.
David
Many a day many a time I sat here . . . what are you going to do for food, what are you going to eat
today. And there will be no leccy [electricity] then what’s the point going out for work, or what is the
point [name] it is going to be the same, the same, the motivation, the self-esteem, it is just rock
bottom and then the depression sets in.
Mark
Contextual influences
The context of unmanageable debt contributed substantially to participants’ experience of unmanageable
debt and depression. In particular, participants’ social and life roles (and activities) featured heavily in their
descriptions of debt impact. Such activities appeared to be integral to participants’ psychological well-being
and the loss or severe limitation of these (due to lack of finances) was identified as a barrier to life
enjoyment and a key contributor to feelings of low mood and depression:
[Mates] are enjoying themselves . . . going to festivals whatever, enjoying themselves with their mates
. . . I can’t afford even just to even think about . . . that kind of stuff . . . debt is the wall and I can’t
climb over it and enjoy myself.
Steve
The financial depression or whatever you want to call it, money worries or that does revolve around
that. Where you pick your grandkids up, and or you don’t pick them up because you say to your lad
or your daughter or whatever, listen you make an excuse because you haven’t got the money
you know.
David
But it feels like so often I am having to sacrifice not even, not even big luxuries just kind of like little
bits of money just to you know for, to get by really so that is, that is depressing . . . waiting for your
life to actually begin in a way . . . I can’t afford to have fun.
Lucy
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Responses of others
How other individuals, in particular family members, responded to participants’ money difficulties also
influenced how participants felt about their current situation (and themselves), with negative responses
from others further compounding participants’ psychological distress:
. . . and this is why now I won’t tell my family because they can’t just go oh, right come here then
let’s, let’s help let’s have a look it is, well why didn’t you just ring them up, why didn’t you just fill it
in, why didn’t you just . . . and this is the bit that makes you feel even more inadequate, makes the
depression worse, and makes you put things off more.
Anne
Iatrogenic systems and processes
A subtheme that linked to ‘responses of others’ was the approaches taken by some creditors, debt
collection agencies and benefits agencies. Participants described the negative effects of being hounded by
debt collection agencies and experiencing what they perceived to be an uncaring approach of some
agencies. These negative experiences further compounded participants’ psychological distress in the
context of unmanageable debt:
I had horrible letters saying about coming here and they [debt collectors] did come here too which
was very disturbing.
Emma
It was a like a big black cloud that was over me . . . it was a nightmare you know what I mean that
was another one where I didn’t want to wake up of a morning . . . I was just getting hounded and I
kept thinking I am going to walk out the door here now and have these bailiffs on me.
Mike
It took 7 weeks before they could actually start processing the claim, and I thought, 7 weeks with not
a **** penny no gas, no electric . . . It was just a **** nightmare with all of them . . . and I was stuck
in the middle, suffering.
Pete
It feels like they [local authorities] don’t care . . . I was in hospital on my own, I don’t have a partner to
go for me, and when I came out of hospital I wasn’t well enough to go . . . how can I get the bus to
the one-stop shop . . . I am going to appeal it but then I think, when that [claim] gets rejected that is
going to knock me down again.
Amy
Multiple stigma
Also closely linked to others’ responses were participants’ perceptions of how others viewed them in
relation to the problems that they were experiencing. Having depression, being unemployed, being on
benefits and being in debt were all identified as stigmatising experiences by some participants:
I haven’t got a job and I am getting money from taxpayers so then again I am getting I feel like I am
scum almost because we’re stigmatised the unemployed aren’t we at the moment, so it is that doesn’t
make you feel good either.
Steve
A small number of participants were concerned about how they would be viewed in their parenting role
because of the stigma they believed to be associated with mental health, and this had implications for
accessing help:
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You get the mental health awareness days and stuff I am jumping on that a bit more now whereas I
used to ignore it because I didn’t want to class myself in that category because of the stigma . . . I was
always scared . . . I think that is why I haven’t even gone and told anyone the issues because I thought
the kids would get taken off me.
Jane
They put me for a referral for a mental health screening I didn’t go back . . . I don’t know it worries
me. Because I have got my daughter and I am on my own, I am worried they are going to label me as
incapable of parenting.
Emily
Concomitant difficulties
Other concurrent difficulties, for example physical health difficulties, relationship difficulties and addictions,
also contributed to participants’ distress, acting both independently of and in combination with money
difficulties to further compound feelings of worry and low mood:
My next big step is the finances the gambling that is hard, very, very hard . . . but other problems you
have like in not being able to put your heating on in the winter, not being able to go out because of
my ailments of my medical grounds . . . just an ongoing thing . . . it is depressing. Very depressing.
David
What am I going to do when the winter comes because it is cold then isn’t it. And I have got diabetes,
I am cold at the best of times. You know but, it is only the worrying, not having money to pay
my bills.
Angela
And then my depression following the breakup was about the breakup it wasn’t, well it didn’t help
with the fact I didn’t have any money.
Amy
Trapped and demotivated
Participants described how their experiences left them feeling trapped and demotivated. They further
described how demotivation, coupled with an expressed desire to escape (if only momentarily) from the
misery of debt, could, in turn, affect their engagement with debt issues:
It is like a vicious circle because I just can’t win and if I think I have found a solution, then it comes
down to the money and I don’t have the money and then to get money it means getting a loan and
no one is going to give me a loan because of my credit because I have never paid nothing back.
So there isn’t, I feel like . . . there is no answer, I can’t be bothered let’s just not bother.
Emily
And then you get more and more into the depression you just don’t think about money and then you
think about it, you get more upset and you just block it out it is like a, just it doesn’t matter, it is not
important, we will just pretend it doesn’t matter.
Amy
Linked to a sense of entrapment was a sense of dependency, which was closely aligned by a number of
participants to other negative experiences including feelings of embarrassment, guilt and shame:
Once the disability was lost I just, it was just I couldn’t really I had to borrow money and I was
embarrassed about it . . . Because I never asked money in my life.
John
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But food bank no it is not a good, I mean it is a good idea, for people who need the food you know
what I mean but, it made me feel worse knowing I had to go.
Pete
If I don’t get back to work I have no . . . I will have absolutely no option but to throw myself
upon somebody’s mercy and that feels horrible to me I don’t like it, it is not very good for my
self-esteem either.
Laura
Complexity and a vicious cycle of debt and depression
The overarching theme that encapsulated the myriad of experiences, influences and interactions reflected
in participants’ stories of debt and depression was that of complexity; complexity in terms of the
multiplicity of difficulties described by participants and the complexity of the interaction between these
difficulties and debt and psychological distress. For those participants experiencing the greatest complexity
in their lives, their experience was one that was characterised by a deeply entrenched vicious cycle of debt
and depression:
It [debt] has made me ill, it [debt] is like a disease like I have caught something and I can’t get shut of
it. You know what I mean it is going to be with me until the day that I die, it is not a debt I can see
me ever getting out of . . . the [tablets] are supposed to help with the stem of the thoughts, and they
are not working again at the minute but this is because the debt now is mounting . . . to deal with
debt you need to be healthy . . . my mind is not healthy, my body is not healthy.
Paula
Depression and loneliness, and the isolation thinking back to what I had and what I am doing now I
drink because of my past . . . there was times I would pack up the drinking and then but sitting in the
misery of basically getting by every fortnight . . . I am hoping that I can get back around the [work] but
at the moment I am just, continuing drinking as you can see . . . and then that is where my depression
comes in.
Mark
Priorities for change
For many participants, not having to worry about money was a key hope for the future and commonly
employment was seen as the favoured route out of money difficulties. However, participants also identified
a number of important barriers to achieving this, including (1) the current employment climate, (2) the
wage trap and (3) physical and mental health difficulties:
Yes and earning enough money that I don’t have to worry do you know what I mean, I am sick of it
. . . I would want a job that you think right [name] you know you are going to be working 10 hours a
day, 6 days a week 60 hours a week . . . don’t give me a job that is 20 hours a week, minimum wage
because I know I am going to be struggling.
Mark
I am trying for work you know, but you don’t know how hard it is . . . how many knockbacks I have
had now and it just disheartens you really bad.
Mike
So this is the longest I have ever been unemployed and I think because of the length of time now it is
making me a bit frightened about going back to work.
Anne
Although many participants identified having more money (and linked to that employment) as a key route
out of debt and psychological distress, it was clearly apparent from the issues participants raised that
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considerable support would be required in achieving this goal. It was also apparent that for those
participants experiencing a multitude of interconnected difficulties, a detailed and highly co-ordinated
package of support would be required if the vicious and debilitating cycle of debt and depression was to
be broken.
A number of participants pointed to the importance of an understanding and supportive approach to
addressing money difficulties in the context of mental health difficulties:
I went for my medical and they put me on the ESA [Employment and Support Allowance] so I am
still like kind of employment seeking but not as stressful as the job seekers yes. Just a bit more
understanding . . . they are dead helpful.
Jane
They [creditors] do burn your head up but it would be nice if they sat down with you, and spoke
about it like we are speaking about it now and come to some plan and then I wouldn’t be like that.
Mike
But the doctor can just sort of like send a letter to whoever, who it is because I don’t think they do
that, and just say to them you know this person is suffering at the moment, and what is happening
has made it worse. They accept that it is their fault, but could you just sort of ease up a little bit,
maybe give a bit of breathing space . . . I mean that would be a nice solution.
Christopher
Participant experience of the intervention
Although participants did not go into great detail about their experiences of the intervention, a number
provided examples of the ways in which they believed CAB advice had started to help them to address the
difficulties that they were experiencing with debt.
Engagement and information sharing
Two key concepts in this respect were engagement and being informed. Several participants described
how CAB advisors had engaged with creditors on their behalf and, as such, had started an important
dialogue so that participants could progress their engagement with debt issues:
Well I wouldn’t have got this point unless I had all the advice and doing the, and phone calls and all
ringing them up and things, I wouldn’t have got anywhere otherwise.
Emma
I think actually when I go to see [CAB advisor] next week, I think I am going to ask her to between us
draft a letter, maybe because this is where if I am left to do it myself I will keep putting it off and
putting it off.
Anne
The second way in which participants had found CAB advice beneficial was helping participants to identify
and access financial support or discretionary payments:
Yes a big help [CAB advice]. I wouldn’t have known anything about you know. Because they don’t tell
you what you’re entitled to in benefits or anything like that, if you’ve got depression.
Natalie
For increasing my money . . . the information they [CAB advisor] gave me was really useful like I said
and they started the ball rolling with the [organisation].
James
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[CAB advisor] filled in a [form] for me which is a discretionary housing benefit that you are, well some
people are entitled to and some aren’t basically and [CAB advisor] filled it in, explaining my mental
health issues and the trouble that I was facing financially and I got my [payment] through.
Paula
Psychological benefit of intervention
A small number of participants indicated some psychological benefit from their meeting(s) with
CAB advisors:
I don’t need, feel I need to yet [take advice] but I felt very reassured and hopeful. It lifted me up a bit
that there was, I wasn’t on my own and I didn’t have to struggle with it on my own. There was help.
Laura
See I haven’t paid it for years. So I am going to end up to here and she [CAB advisor] said no, she said
there is only so many years they can go back, so all this information was like, it took a weight off
my shoulders.
Jane
In a similar vein, participants who spoke about their consultation with GPs indicated that what was most
important about the consultation was that the GP was showing interest in, understanding of and concern
for their difficulties:
I think before if you owed money like I didn’t feel the GP would be interested in that particular reason
. . . feel that that has changed yes because [GP] did ask me . . . I felt better that he’d asked rather than
me just come and pour out all the information.
James
I think that was quite helpful. I think the fact that they [GP] were perhaps more receptive to debt and
depression going hand in hand and one feeding into the other.
Lucy
But she [GP] was nice and like she understood.
Jill
I could tell him [GP] anything, and I know it wouldn’t go any further. Which is sometimes a big help
. . . Makes me feel better. Because I always say well at least someone’s concerned at what is going on
in my life even though no one else is bothered.
Angela
However, one participant described how the consultation with the GP had provided an opportunity to
discuss a change in her antidepressant treatment, and another explained how it had led to progress in
investigating other concurrent health concerns:
I was a bit unsure about getting referred to my doctor but ended up what happened is I saw a
different doctor, who I originally registered with and the good thing that came out of that, is I am
changing my antidepressants.
Anne
They are keeping an eye on me anyway as well the general practitioner . . . well yes (what GP is doing
helpful), they arranged the X-ray . . . I have got to have a scan done because that was normal . . . he
[GP] said it is inside, in your bones probably arthritis like I had in my knee 12 months ago . . . so I want
to get that sorted.
Emma
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Participant experience of involvement in the trial
Opportunity to talk
A key theme in participants’ descriptions of their experience of involvement in the trial, and, in particular,
with regard to researcher interviews, was ‘unloading’. A number of participants described how talking
to the researcher had provided them with an opportunity to talk about the difficulties that they were
experiencing that they would be unlikely to feel able to discuss with known others:
But sometimes for me to try and unload some pressure from myself a lot of my gambling I tend to
bottle up because I find it is embarrassing. So being able to talk, about certain things and to maybe
relate openly to somebody like yourself and the other lady.
David
Just to get it off my, you know the guilt, because I feel guilty for owing this money to the banks . . .
it was total like this, relaxation you know, it was a bit of therapy for me to tell you the truth.
Mike
Engagement and reflection
For a number of participants, interviews with researchers also provided a space within which they
themselves could engage with and reflect on the difficulties that they were experiencing:
It has helped me work through things because you have to think about what impact has that had on
everything and it does, it has had a knock-on effect on, on everything.
Amy
It has helped, and it will help yes definitely because it helped, well one you know when I am talking
things through with you or just explaining, I am quite good at reflecting, and as I am talking it is like
therapy a bit.
Laura
Issues with involvement
Although the opportunity to engage with and reflect on difficulties was identified as beneficial by a
number of participants, for Paula there was a downside to the completion of some questionnaires, as she
describes in the following quotation:
That [questionnaires] irritates me . . . because it is a constant question of what I am like, what are my
thoughts, what is my emotions, how would you describe and that irritates me. Because then I have
got to think and then it is not a nice, that is not the nice part of the process to be honest with you
because that delves too deep, far too deep than sometimes I am prepared to go.
Paula
Forced choices
Both Anne and Paula reflected on the forced choice response of many questionnaires. Both considered this
to be problematic because it meant that their responses did not accurately reflect how they were feeling at
that time:
Not so much the questions that they are asking it is how you can answer them. There is never on
quite a few occasions there was never a tick box that I could have safely said well actually yes that is
how I am feeling.
Anne
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I just think on some of them [questionnaires] there is not the right answer there to answer it by you
can’t put it down in sometimes always never . . . it doesn’t tell you exactly, you can’t express exactly
how you are feeling on them.
Paula
Question relevance
Christopher questioned the relevance of some of the questions included in the context of a study about
debt and depression:
I think last time there was a sexual question, to do with partners or whether you have random
partners or something I can’t remember what the question was, it is irrelevant . . . I answered it but
then I thought, you know is that really necessary to do with debt.
Christopher
Language complexity
Several participants noted the complexity of the language used in some of the questionnaires, which was a
contributory factor to some overly long interviews:
For me it wasn’t [a struggle], but I did think there was, if you were . . . if reading wasn’t a real strong
point you would find it difficult. That is what I thought, some people might find it difficult because
and some of the questions were quite complex in some ways.
Laura
I didn’t understand a lot of the questions so she [researcher] was having to interpret them . . . and that
probably it probably went longer than what it should have done.
David
Interviews too long
As noted in the previous section, some interviews took longer than anticipated. Although many
participants did not consider time commitment an issue, several commented on interview length:
Yes they all right, they are fine. When they’re 3 hours it’s a bit . . .
Natalie
I just turned round to [researcher 1] and said is it OK that I am going this slow and she went yes but I
didn’t finish it. She had to come back the next day to finish it off.
Mike
Proposed changes
When invited to comment about possible changes for future research, participants suggested little change.
However, and not surprisingly, two participants advocated reducing the length of the data collection visit
and one indicated that the significant commitment required on the part of participants warranted greater
financial remuneration. Certainly participants appreciated the recognition of their involvement with the
receipt of a shopping voucher:
The shorter interviews are better . . . yes, perhaps shorter interviews but that’s all.
Natalie
I want to help, and everything else, but my advice, or my opinion is it is far better to have 2 or
3 × 2 hours.
David
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If I am being honest . . . if you want to go into somebody’s life so personally and in depth, in depth
I just think that you know maybe . . . probably more of a monetary encouragement if I am
being honest.
Christopher
I have enjoyed participating. Particularly like the £10 voucher . . . I saved the last ones, because I want
to buy myself something for my birthday.
Anne
I quite like the £10 voucher, only because I feel like I don’t get anything . . . Although it wouldn’t be
necessary for me I would have done it anyway. But it is nice.
Laura
Intervention process evaluation
The intervention process evaluation focused on the qualitative analysis of semistructured interviews with a
sample of seven GPs and four CAB advisors who participated in the trial. The purpose of the interviews
was to check fidelity to the model and the impact of participation on clinician and CAB advisor attitudes
and practices, using the framework of NPT.2
Analysis
The analysis focused on three specific components of the intervention as originally conceived (see Figure 7):
(1) co-location of CAB advisors in general practices, (2) GPs’ assessment of debt and depression, and
(3) enhanced communication between GPs and CAB advisors.
Co-location of Citizens Advice Bureau advisors in general practices
General practitioners and CAB advisors unanimously agreed that patients would benefit from having a
debt advisor based within general practices:
But there is no doubt that every general practice should have a debt advice service, you know, that is
an obvious place for them to be.
Interview 9, GP
Yes because you know the GP can pick up, you know, identify that the client has got debt, and we
are going to the surgery to see and we get all that side of it has worked well with the referrals coming
in, we contact the client, go to the surgery to see that has been quite seamless I think so I don’t see
why it couldn’t expand, we couldn’t see more clients in that way.
Interview 4, CAB advisor 1
This finding shows that the co-location of the CAB advisor in primary care is an intervention that is
normalised and, therefore, it could be integrated in the daily routine of general practices.
General practitioner’s biopsychosocial assessment of debt and depression
General practitioners conducted the assessment for debt and depression in the fashion of an ordinary
consultation for depression:
I asked to come in to talk about debt or something or, so, so from my point of view probably they
weren’t any different than what I normally do as a first depression kind of consultation. So it is quite a
long consultation, there is like you know 20 minutes probably maybe a bit longer, I put them at the
end of my list, so I could run over a bit more if I needed to rather than just have 10 minutes.
Interview 1, GP
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It was apparent, therefore, that although incorporating discussion of debt into the consultation was
feasible, addressing debt was time-consuming and not something that fitted easily within the constraints of
a single GP appointment slot. The issue of time was also raised by GPs when they provided feedback on the
SCA form, whose length and complexity was not considered helpful in keeping the consultation concise:
OK so, yes it was too long. And things like you know what are your three most important
individualised goals? That is hard for anyone to say, and then you know, in what, in what aspect of
my life and obviously you are talking about debt so actually, well get rid of the debt is going to be it
isn’t it but, but you know goals for everything in the future that just becomes a sort of like a, a game
they have to play so I didn’t find that helpful.
Interview 3, GP
The only barriers again you see there is a difference between running a study and running it in real
life, so the only big barrier for me would be (a) the form that I had to fill in that was too long, so that
needed to be refined to a one-sheet job.
Interview 9, GP
Although the inclusion of the SCA form raises the issue of time management, it was apparent that the
consultation per se followed the routine of a clinical assessment for depression, demonstrating that the
intervention was normalised within the GP’s usual practice:
[. . .] It is almost like a first depression consultation then isn’t it? The first time when you see them. So
it is more like a kind of, finding out how they are and going back to the beginning a bit of why they
were depressed and that could then lead on to talking about counselling if they had not thought
about it, and discussions about things like that rather than, just being on medication.
Interview 1, GP
No [the consultation was not different] but it was really nice for me to know that I had something that
I could offer you know because previously I just wasn’t aware of, or so much aware of, I would not, it
wasn’t on my radar so much to specifically ask about debt.
Interview 5, GP
Enhanced communication between general practitioners and Citizens Advice
Bureau advisors
A SCA form was developed in the start-up phase of the trial to facilitate sharing of information between
GPs and CAB advisors, with participant consent. Providing feedback on the form, GPs and CAB advisors
show a sense of uncertainty about what information should be shared and whether or not that
information was helpful:
Does it help them to know what this person’s medical problems are, it might do. That would be
interesting to know whether it helped them or made it harder sometimes you know. Because even if
you put the diagnosis down, does that help the CAB advisor deal with them in a better way I don’t
know. It might do.
Interview 3, GP
Encouraged the, you know the doctor to maybe write more and it might have encouraged us to write
a bit more on there as well. I think that might have been something that could have been useful to
have a look at in a little bit more depth.
Interview 4, CAB advisor
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It was, therefore, apparent that both GPs and CAB advisors were somewhat tentative about their input
into the shared assessment form and whether or not it facilitated collaborative care. One GP provided a
possible solution to this issue:
I guess there is probably training issues for the people that are doctors that are involved, the clinicians
that are involved as to what information is key on the forms and I guess the conversation with CAB
about like I said before, how useful, what bits are key that they really want and you know how much
is too much, how much is not enough a bit more of a conversation.
Interview 2, GP
The above statement indicated that some training and an ongoing dialogue between professionals
(i.e. GPs and CAB advisors) could facilitate collaborative care. However, it was apparent that CAB advisors
felt that there were no opportunities to engage in such a dialogue with GPs currently when attending
general practices:
So I know that they already have CAB advisors in some doctor’s surgeries, and I don’t think they have
any, any avenue of speaking to the doctors so there should be something in place.
Interview 10, CAB advisor
Following CAB advisors’ point of view, the issue of communication between GPs and CAB advisors was
informed by their individual experience in one site, of GP’s reservations about engaging in conversations
about depression:
I did feel like, the big, big stumbling block was I don’t necessarily feel like all the GPs were on board.
And I don’t necessarily feel like it was necessarily, I get they are busy and I get that, but obviously we
are busy as well, but I don’t think it was necessarily promoted in a way that was . . . when we go to
meetings and stuff there was a bit of hesitation I think in people saying I don’t necessarily want to ask
my client, my patient if they have anxiety or depression.
Interview 7, respondent 1, CAB advisor
As one CAB advisor suggested, the issue of communication between CAB advisors and GPs may have
arisen because the component of co-location was not embedded within the practice:
But I suppose if I was seeing three or four clients throughout the day I would spend the day in the
surgery and you would be in the kitchen making a, I am thinking of one surgery in particular where,
I have seen people milling about in and out of the kitchen you would be part of that I suppose you
could be part of that wouldn’t you and speak to people and get to know people. But because it has
only been in and out for one person, I haven’t actually met any GPs just reception staff really.
Interview 4, CAB advisor
Despite this barrier in communication, there was willingness among CAB advisors to move forward and
progress communication with GPs:
Let’s face it, we understand our topic a lot better than they do but then, they understand their topic a
lot better than we do [laughs] so you know and that, so I think there was a difficulty there really and
maybe having a bit more awareness of each other.
Interview 7, respondent 1, CAB advisor
It is almost like we are two pieces of a jigsaw and actually unless you are put together you can’t see
the whole picture.
Interview 7, respondent 2, CAB advisor
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Although CAB advisors addressed their concern about communication directly, this point appeared
somewhat overlooked by GPs. One GP did refer to collaborative care, suggesting that adopting a form of
communication familiar to GPs to raise awareness around mental health and as a reminder of services
would be beneficial:
I think for health professionals to be more aware from my bitter experience if you don’t keep
reminding them, and I put myself in this group, you forget, you forget that the service is there. So at
least bi-annually, at least every other year or yearly it would not harm for a short, sharp blast across
GP education systems, there is one once a month in this area . . . a short presentation, these are the
patients we saw last year, this number committed suicide, this number had depression but weren’t
seen for over 12 months . . . so really hard-hitting facts . . . there is nothing quite like a bit of peer
review, peer pressure, say oh flipping heck if that practice can do it [laughs] why aren’t we you know.
Interview 9, GP
Although CAB advisors are appreciative of liaising with GPs and co-location should facilitate planned
(i.e. telephone conversations, meetings, etc.) and written conversations (i.e. assessment form),
communication between these two professional groups is partial. This shows that the component of
enhanced communication was not normalised. The above statement highlights the importance of utilising
existing approaches to communication that are familiar to GPs, such as peer review communication that
is grounded in evidence, to remind GPs about available services and embed them within the everyday
general practice.
In summary, the analysis of GP and CAB advisor interviews showed that although co-location of CAB
advisors in general practices and GPs’ assessment for debt and depression were normalised, enhanced
verbal communication between GPs and CAB advisors was not. This is because communication between
these professionals is limited by a lack of co-location, small numbers of shared patients and a relative
unfamiliarity with each other and the ways of working.
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Chapter 7 Discussion and conclusions
The study failed to reach its recruitment target and was terminated early during the internal pilot phase,and, therefore, it did not progress to main trial. This report describes the study rationale, methods and
findings of the pilot phase of this study, and implications for future research in this area.
The following discussion focuses largely on a discussion of the challenges we faced in seeking to
implement the trial as originally envisaged and provides learning points for future researchers. We will, in
addition, discuss our qualitative data findings. These provide a valuable insight and points of learning both
for future research and for those seeking to support people living with debt and depression. Finally, we
briefly discuss the descriptive and health economics data.
Feasibility
Premature closure of trial at pilot stage
Ultimately, this trial ended prematurely because of the failure to recruit both practices and participants to
time and target. The view of NIHR was that the trial would ultimately fail to recruit sufficient participants
with the resources and time available. Although the requirement to recruit 50% of the target population
was ultimately achieved, the stopping rule for target recruitment was invoked because achieving this target
took twice as long as the intended time frame (12 months rather than 6 months). Below we discuss the
various challenges we faced that meant that the time frame for participant recruitment turned out,
ultimately, not to be realistic given the current funding and primary care climate, and that we sought to
recruit participants from a vulnerable and hard-to-reach group.
Research environment
In a multicentre trial, the lead organisation sets up the original agreements with the funder, and then
subcontractual arrangements are agreed with the other centres. We found that this protracted process
added many months to the time taken to finalise legal and financial agreements across all centres.
Finalising ethics and other governance arrangements, which could not be completed in individual sites until
the teams were set up (even if, theoretically, all centres can open once host sponsorship and permissions
are granted), further delayed participant recruitment. Research teams in each centre need to build working
relationships within their sites to run a trial effectively, liaising with the local research support and
governance teams covering their sites. All of these processes eat into the tight time frame of a pilot trial.
Unless organisations are prepared to employ staff in advance of finalisation of all contractual and financial
resources, significant delays in getting staff and other resources in place to set up and run a study can
occur. This was a particular issue in one of our three research centres, which was able to employ its full
complement of staff only once all financial systems were fully in place. This resulted in a 12-month delay in
that centre, such that it just started recruiting participants only as the pilot trial came to a close. We had
planned for 40 participants to be recruited from each of the three centres; in the end they achieved 36,
20 and 5. Near the closure, however, recruitment was accelerating. A further 36 EOI forms that were
submitted towards the end of the pilot phase could not be converted to randomised participants because
of the closure of participant recruitment. Almost half of these interested patients were from the delayed
set-up centre.
A further problem was the reorganisation of NIHR research networks between developing and delivering
the trial. This reorganisation meant that some of the anticipated practical network support that we had
envisaged was not available, which increased the hands-on recruitment expectations for the core team and
practice staff and, in particular, had implications for completing practice database searches and waiting
room recruitment activities.
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The challenge of recruiting general practitioner practices and completing
research-related tasks
With hindsight, this was not a good time to be conducting a trial among a hard-to-reach vulnerable group
through primary care, with general practice under pressure from external inspections being introduced
(Care Quality Commission), problems with staff recruitment and increasing expectations of target-driven
expanding service delivery, such as extended opening hours, intermediate care expansion and a new
contract. Fewer practices than anticipated offered to support the trial. Many practices required frequent
calls and reminders, and some failed to return calls or e-mails. In one, although the local staff were
interested, the parent company refused permission for the practice to become a site. Because of the
approach to practice recruitment (selected using random sampling by the study statistician in matched
pairs) new practices could be approached only once practices had refused, with some taking weeks to
provide a simple ‘no’, which delayed approach to further practices. We would have dropped the pairing of
practices in the main trial as any theoretical benefits were outweighed by fewer practices being available
to participate and additional delays. In many participating practices, the pressure of core NHS work and
the number and pace of practice changes, and the resulting pressure on meeting agendas, meant that
organising initial practice meetings to discuss the study, the necessary training and other research-related
activities (once practices had agreed to participate) took months rather than weeks. Once practices signed
up, the mode of participation varied significantly: some were highly co-operative, others failed to check
lists for months and one checked lists so assiduously (in order to organise care better for depression) that
delays were significant and many patients were excluded. The average time from initial practice contact to
first randomisation ranged from 8 to 46 weeks (mean 27 weeks), with three practices failing to recruit any
participants (one despite a large mail-out). One of the practices met with the study team only 7 weeks
before study closure.
It was important to keep in regular e-mail or telephone contact with practice research leads once they
expressed an interest, and weekly once we had held our initiating meeting to check for progress and to
troubleshoot any emerging problems and delays with them. GPs were not keen on receiving newsletters or
other formal updates as they felt that these would remain unread.
Adapting to change
An advantage of an adaptive design is that it enables adjustments to be made once a pilot has started,
linked to a priori agreed rules for changing the trial design as it proceeds. In DeCoDer this included
changes to trial information sheets, mechanisms for publicising the trial to patients and GP list searches,
determining the need for cluster or individual randomisation in a full trial. However, what works well in
some sites is less straightforward in others, and indeed within sites. This is particularly likely with large
practice teams who work differently and have varying individual beliefs and expectations, which have a
greater relative impact in non-routine work such as research recruitment and study support. There was a
wide variation in the interpretation of list checking by GPs, with some just excluding a tiny fraction and
others excluding far more, which introduces sample bias. For most practices, GPs struggled to find the
2–3 hours they needed to check the patient search lists before mail-outs, which took from 0 to 87 days,
the average delay being > 3 weeks, nearly one-third of the total time we had anticipated to spend
recruiting in each practice. On balance, we decided to allowed GPs to choose whether or not they needed
to check lists before mail-outs. One practice did receive a complaint from a patient who did not consider
themselves to be suffering from depression as described in the letter, so we made the wording in the
invitation letter more neutral to reduce the risk of causing inadvertent offence. However, every change in
trial design, even if small, needs to be approved, in sequence, by the funder, the sponsor, ethics and
governance, all of which require full paperwork including a revised protocol with marked changes. Even
with the most efficient systems, this takes at least 4–6 weeks from seeking permission to instigating
change across all sites.
Participant recruitment
The baseline data suggest that although we were able to recruit the target hard-to-reach vulnerable
patients with depression and debt, this took longer than anticipated. Most participants had severe
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depression as assessed by the BDI-II. It is not surprising that patients with debt and depression were difficult
to recruit, as they are less likely to respond to contacts – as highlighted during qualitative interviews. We
tested two main methods of recruitment, mail-outs signed by GPs from practice list searches and waiting
room recruitment. The return rates in terms of participants randomised were low for both methods at 1%
recruited per letter posted and 0.5% per leaflet distributed, respectively. Although the EOI return was
comparable at 3% for both methods, the conversion to consent rate was double within the letter method
compared with the waiting room method. This was not surprising as we anticipated a proportion of those
agreeing face to face in the waiting room, perhaps in an effort to please, would change their mind after
reflection. In terms of cost, this was around £200 per consented participant in both methods.
We anticipated a 20% dropout rate at 4 months; in the event this was 17% among controls but only
12.5% among intervention patients. However, the research team had to work hard to achieve this, with
many participants requiring frequent contacts and sometimes repeat visits to complete data collection.
People in debt tend to avoid communication by letter or telephone in case these are associated with their
debts, and this is exacerbated by the low motivation that occurs in depression. Although the 12-month
follow-up was incomplete due to early study closure, the indications were that dropout at 12 months
would be below 20% as well. We believe this was because of the relationship formed between
participants and researchers through the baseline assessment. Our belief in this respect was grounded in
data from qualitative interviews, with many participants expressing how they valued the contact and
interest in them and their lived experiences.
It is of note that after randomisation only 69% in TAU and 75% in the intervention group attended
a GP appointment for allocation. Of the latter, 71% actually received the intervention after allocation,
representing 53% of those allocated to see a CAB advisor. More than this proportion, however, continued
within the trial (83% in TAU and 88% in CAB intervention). This failure to make and attend appointments
reflects the difficulties faced by such patients during episodes of crisis and distress. Certainly our qualitative
findings demonstrate the sheer complexity of difficulties experienced by some participants. We did try to
mitigate this by adopting a case management approach for CAB advisors to support the participants
referred to them but, as described in Chapter 1, Intervention: theory and development, and Chapter 2,
Practice identification, recruitment and training, such patients are often shy of unknown contacts, fearing
that they relate to debts. It was not uncommon in qualitative interviews for participants to mention that
they avoid telephone calls and leave letters unopened. Some participants referred to pawning items in
times of particular hardship and this included, for one participant, their mobile phone. Other difficulties
and commitments also impacted some participants’ engagement with the research at one time or another.
The overall feasibility of a randomised controlled trial approach
Funding and time constraints
On reflection, the recruitment target for the pilot was overoptimistic in that, unless all our assumptions
about setting up times and site recruitment were realised, recruitment was always likely to fall below
target, despite the best efforts of the research team. This is probably true if it is expected that conducting
a complex intervention trial among vulnerable, hard-to-reach populations in primary care can be
undertaken without enhanced investment over other primary care trials. A higher rate of investment is
needed to widen the pool of sites to recruit from, and to account for, more intensive participant support
to engage with the study and maintain contact through to trial completion.
Constraints of trial design
In terms of trial design, the expectation of robust methods to achieve grant funding and ethical approval
(e.g. balanced matching, testing cluster vs. individual randomisation, list checking, complexity of approvals
for even minor protocol changes within an adaptive design) further add to delays in achieving recruitment.
Our experience was that many practices struggled to support the steps required for recruitment, not least
due to the rising workload for the NHS and problems recruiting clinical staff, particularly for practices in
inner-city areas, where more vulnerable and hard-to-reach patients are likely to be registered. Our current
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ethos demands that changes in service design and investment in new treatments will only take place if
robust research is available to support them. This means that if randomised controlled trials are not
undertaken in hard-to-reach populations, we risk further increasing the health inequalities gap, as trials will
focus on easier populations and problems.
Cluster versus individual randomisation
We did not find any evidence of contamination of the intervention between control and intervention
participants in practices where individuals were randomised, with only one participant in each control
group seeing a CAB advisor (which was one of the options outlined in the leaflets) during the study for
debt advice. There was no evidence of GPs recommending CAB to those in control groups. Thus, we
would not have recommended a cluster design for the full trial. Perhaps the additional costs associated
with this approach are better diverted to increasing the number of sites to improve the chances of
achieving recruitment to time and target. This pilot examination of cluster versus individual randomisation
was one of the successes of this trial. Cluster randomised trials are potentially weaker designs than those
in which participants are individually randomised, mainly because of the need to inflate the sample size
and the potential for imbalance in participants’ characteristics at baseline. Despite our slow recruitment,
we showed that an innovative examination of each method is possible at the outset of a trial and could
save funds in cases when a more expensive cluster randomised method can be avoided.
Summary qualitative findings
The debt–depression relationship
Participants’ stories of debt and depression highlighted the complexity of influences (psychological, social
and contextual) that contributed to both the impact of debt and the relationship between debt and
psychological distress. These influences compounded participants’ feelings of depression, contributed to
participants’ disengagement with debt issues and, ultimately, contributed to an ongoing cycle of debt
and depression. Participants’ stories of debt and depression indicated a bidirectional relationship, with
unmanageable debt contributing to negative feelings (including anxiety and depression) and psychological
distress impacting participants’ engagement with debt issues through psychological and behavioural
avoidance. Participants’ quantitative ratings of the contribution of debt to psychological distress and
psychological distress to money difficulties gave us more evidence on this relationship, with the majority
of participants indicating that debt contributed to anxiety and depression, and anxiety and depression
contributed to their debt problems.
It is of note that many of the psychological impacts reported by participants are also features of
depression. It was impossible to delineate psychological distress as a consequence of unmanageable debt
from the experience of depression per se, such was the complexity of participants’ lived experience of debt
and depression.
Evaluation of the intervention
Participants allocated to the intervention arm of the trial were largely positive about their experience.
Two aspects of CAB involvement were identified as particularly helpful. First, the CAB advisor role acting
as a conduit between the participants and other agencies, to facilitate communication and negotiation
about debt issues. Second, identifying possible sources of additional financial support and discretionary
payments. A small number of participants viewed their appointment with the GP as psychologically
supportive, providing validation for their concerns and evidence of GPs’ interest in their current difficulties.
General practitioner and CAB advisor experience and views about the intervention provided positive
feedback, but also a number of caveats concerning the feasibility of implementing the intervention, as
originally conceived, into day-to-day practice. Although co-location of services was welcomed on both
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sides, the anticipated benefit in terms of a collaborative approach to care through informal liaison between
GPs and CAB advisors was not realised. It was suggested that the sporadic nature of CAB advisor
attendance at GP surgeries (as a result of the small sample size and intermittent nature of participant
recruitment), coupled with current working practices in general practice, meant that the CAB service was
unable to become embedded within the fabric of the practice. Although the psychosocial assessment
conducted by all GPs was normalised within the consultation, it was noted that this extended appointment
duration, particularly in the intervention arm in which GPs were required to complete detailed information
for sharing with CAB advisors. Consequently, this particular aspect of the intervention was not considered
to be workable within the confines of a single GP appointment.
Participants’ experience of involvement in the trial
Participants were largely positive about their involvement in the trial. A particular benefit of involvement
was identified as the opportunity to talk to researchers about the difficulties that they were experiencing
(a possible confounder had the full trial gone ahead).
With regard to feasibility and acceptability of the outcome measures, it was apparent that the number
of outcome measures (and their form and content) was problematic for some participants – adding
considerably to the time taken for completion of interviews. Furthermore, several participants questioned
the forced choice responses of questionnaires, which did not capture the reality of their experience. Both
of these issues raise questions about the use of validated questionnaires that are often viewed as gold
standard approaches to the assessment of effectiveness in randomised controlled trials. Thus, there are
competing expectations of comprehensive data collection to maximise the opportunities to understand
not only if an intervention works (primary outcomes), but also why, and for whom, it does or does not
(secondary measures), versus caring for participants and reducing dropout by not overburdening them.
Outcomes
Summary of descriptive statistics
We have presented only descriptive analyses as a result of the small sample size. It is important to note
that, although a number of participants commented on the burden of data collection in our qualitative
interviews, the data collection was sufficiently comprehensive to be able to provide data for nearly all
participants for each of the measures at all time points, although we did have to impute some missing
values. However, we would have been likely to reduce the burden for the main trial, as data collection
usually took nearly 3 hours rather than the 2 hours we had anticipated. For example, although theoretically
we would have wanted to know about absenteeism and presenteeism, because this important outcome is
often ignored in randomised controlled trials, the low employment rates among the sample suggest this
was often irrelevant and confusing for participants who were in receipt of welfare (Job Seeker’s Allowance
or Employment and Support Allowance). We would probably have also undertaken only the explanatory
measures among a subsample (Hope Trait, Other as Shamer and Response Style Questionnaire).
Snyder et al.65 reported data from samples of US college students, outpatients receiving psychological
treatment and psychiatric inpatients of a state hospital. Mean agency, pathway and total scores for the
student group were A12.61, P12.61 and T25.24, respectively; for the outpatient sample these were
A11.27, P11.33 and T22.60, respectively; and for the inpatient sample were A11.25, P11.25 and T23.11,
respectively. However, these data are not directly comparable to scores in the present study because they
are based on the four-point response scale originally used in the Adult Hope Scale. This was later revised
to the eight-point format utilised in DeCoDer; however, no comparable studies of depressed populations
were found that also used this format.
Gilbert84 reported data on the OAS from a UK sample of students (screened as below the clinical threshold
for depression on the Centre for Epidemiological Studies Depression Scale) and patients who had been
hospitalised as a result of severe depression (mean BDI-II scores of 29). The mean OAS score for the
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student group was 22.5 and for the depressed group was 45.2. The group means in the present study
fall somewhere between these two, which would be consistent with participants in the DeCoDer trial
experiencing mild to moderate levels of depression. However, the mean BDI-II score at baseline and
4 months’ follow-up is higher than that for students with severe depression in the Gilbert study.84 Thus,
there is little evidence that debt is perceived as a particularly shameful state of affairs, as measured with
the OAS, as the mean scores are broadly similar to those seen in people who are experiencing similar levels
of depression. Nevertheless, shame remains a key cognitive concomitant of a depressed mood.
The group means for rumination are again broadly consistent with, or slightly lower than, comparable
scores in people experiencing a depressed mood.70 As with shame, there is little specific evidence of
rumination as a problematic element in the presentation of people in debt, over and above the levels of
rumination normally observed in depressed people. Nevertheless, rumination, like shame, remains a key
cognitive concomitant of a depressed mood. That is, both rumination and shame are commonly present in
depressed individuals, and are seen here. There is little evidence, however, that indebted depressed people
have higher levels of either shame or rumination than people who are depressed but are not in debt.
Our results do indicate that we were successful in recruiting the target group in terms of mental health
problems and life events being at the most severe end of a primary care population.
Summary of health economics data
The small sample limits the level of interpretation and analysis of the data collected to description only.
However, our findings did suggest that some adjustment would be required in a full trial to account for
resource use in the period prior to baseline, as these were imbalanced between the TAU and intervention
groups. We also suggest that any future study should account for criminal justice contacts as part of a
representative economic factor data collection within this type of population. Our EQ-5D data also support
the finding that we were recruiting our target vulnerable population with health-related quality-of-life
scores that matched against peer norms.
Lessons learned for future trials
l Take into account the barriers to and facilitators of trials for individuals with common mental health
problems and social disadvantage.
l Consider carefully the number of outcome measures beyond the primary outcome, balancing learning
against burden.
l Consider which outcome measures to use – not necessarily the ones that everyone else uses.
l Consider adding criminal justice contacts as an economic factor in such populations.
l Where it is unclear whether or not there is likely to be crossover of the intervention between
experimental and control participants (contamination), consider a pilot phase of cluster versus individual
randomisation in which this can be assessed.
l Ensure that trial centres are willing to recruit staff early, even if that is in advance of final subcontract
agreements being in place, to minimise delays in starting the trial.
Lessons learned for developing the intervention
l Needs to be clear expectations of each party/service in the collaboration – in this case what information
is considered helpful/required.
l Time commitment: the referral processes/information required needs to fit within the constraints of a
normal GP appointment.
l Raise awareness through usual channels of GP communication, embedding in general practice
consciousness.
l Alternative approaches to interventions for individuals with common mental health problems and social
disadvantage need to be considered.
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Implications
This pilot trial indicates that it is possible to recruit and retain vulnerable and stigmatised hard-to-reach
patients to a primary care trial. However, we suggest that the recruitment site base needs to be wider than
anticipated for other trials, and the population and inner-city practices they are registered with requires
more intense support and investment of time to achieve recruitment to time and target than is usually
required for complex intervention trials in primary care. The complexity of their problems suggests that a
more comprehensive intervention than debt advice alone is required to support the recovery of patients
with debt and depression.
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Appendix 1 Shared comprehensive assessment
forms
Shared comprehensive assessment form 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NHS Number: DOB:  
Name:  Address:  
Telephone number:  
Best way to contact if not on above number: 
Name of consulting GP: 
Date/timescale to next GP appointment: 
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GP ASSESSMENT 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NHS Number: 
Main concerns (Individual’s main worries/problems/concerns - debt and other - 
their words): 
 
 
Diagnoses (Ongoing/significant past): 
 
 
Anxiety/depression (severity): 
 
 
OCD/PTSD/phobia/panic:
 
 
Problematic substance use: 
 
Physical conditions: 
Psychological difficulties relevant to debt concerns/management: 
Tiredness/energy/apathy: 
Concentration/agitation: 
Anger/irritability: 
Fears (new people/opening post/going out/other): 
 
Hopelessness/suicide risk: 
         No thoughts of deliberate self-harm 
Some thoughts but no intent (low risk) 
Significant thoughts/plans but no intent (moderate risk) 
Significant thoughts/plans with intent (high risk – delay referral to CAB and refer to specialist 
mental health services 
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GP ASSESSMENT 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other social difficulties:
Housing: 
 
Work/study: 
 
Relationships: 
 
Current domestic violence emotional abuse: 
 
NHS Number: 
3 most important individualised goals for future: 
Immediate: 
Medium-term: 
Long-term:
 
Other treatment (ADs, therapy, exercise etc.): 
Ongoing treatment: 
 
Management decisions today: 
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Debts summary:   
Number of Priority debts: 
 
Number of secondary debts: 
 
Summary of imminent risk (e.g. eviction, loss of utilities etc.): 
 
 
 
 
 
 
Summary current/ongoing social difficulties: 
 
 
CAB ASSESSMENT 
 
NHS Number: 
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CAB ASSESSMENT 
NHS Number: 
Summary Action Plan 
Debt management plan: 
 
 
 
 
 
 
 
Sign posting (other services): 
 
 
 
 
Patient request (may require GP action e.g. requested referral to IAPT services): 
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Shared Comprehensive Assessment: GP Follow up Form 
  
 
NHS Number: DOB:  
Name:  
Date: 
Summary information of key changes (as appropriate): 
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Shared Comprehensive Assessment: CAB Follow up Form  
 
 
 
 
CAB Follow up appointment  
I agree to this information being sent to the GP   
Date appointment: 
Follow up appointment: [insert number - 1, 2 or 3] 
Case Update (Stage case is at and client engagement):  
Agreed Actions (what was discussed and agreed or next stage in brief e.g. 3 lines): 
Is this the client’s last appointment with CAB?     Yes / No   (circle as appropriate) 
NHS Number: DOB:  
Name:  
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Appendix 2 Intervention protocol
Debt Counselling for Depression in Primary Care: An Adaptive 
Randomised Controlled Trial  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Intervention Protocol 
 
- Theory, Practice and Delivery - 
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LIST OF ABBREVIATIONS 
CAB Citizens Advice Bureau 
 
DeCoDeR Debt Counselling for Depression: Randomised Controlled Trial 
 
IAPT Improving Access to Psychological Therapies 
 
NICE National Institute for Health and Clinical Excellence 
 
PTSD Post-Traumatic Stress Disorder 
 
SCA Shared Comprehensive Assessment 
 
TAU Treatment As Usual 
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1 RATIONALE FOR HAVING AN INTERVENTION PROTOCOL 
 
This protocol provides a description of the intervention as it is intended to be 
delivered by practitioners within general practice and CAB, the theory as to why it 
should make a difference, and the means for ensuring delivery: manuals, training and 
support. 
 
The protocol serves several purposes: 
• Provides a document stating what should be delivered for anyone to reference 
at a later stage 
• Provides a reference – along with manuals for practitioners to use if they wish 
• Provides a basis for assessing fidelity of actual delivery 
• Provides a document which supports the process evaluation (not included in 
this document) – to understand problems with delivery and how intervention 
has its effect, if any. 
 
 
2 BACKGROUND AND RATIONALE FOR THE INTERVENTION  
 
Depression is estimated to affect 5-10% of adults at any one time, and is a common 
presentation in Primary Care. However, research suggests that only around 2.5% of 
patients are formally recorded by GPs as having active depression or depressive 
symptoms1,2. Alongside anxiety and stress it is considered the commonest cause for 
prolonged work absenteeism3, as well as presenteeism (working below normal 
capacity when unwell). Mental ill health is estimated to cost the UK economy £40B 
per year overall4,5. Around 11% of the population are estimated to be struggling with 
personal debt, with evidence of increasing episodes of suicide associated with rising 
debt6,7. 
 
Most episodes of depression are managed in Primary Care, following the NICE 
recommended four-stepped approach1. This includes a range of low intensity 
interventions including short-term talking therapies, social prescribing to support 
lifestyle changes (e.g. for exercise), and antidepressants for more persistent 
symptoms. 
 
Recognising the increasing burden of indebtedness and the link between debt and 
mental illness in the Foresight Report8, the UK government provides web-based 
advice and guides on debt-management† highlighting a range of providers††.Topping 
this list is the Citizen’s Advice Bureau (CAB), a charity-based service which is widely 
available across the UK in over 3,500 locations, providing support to over 2M people 
per year. Their principal on-line recommended site is provided by government, 
                                                
† 
http://www.direct.gov.uk/en/MoneyTaxAndBenefits/ManagingDebt/PlanYourWayOu
tOfDebt/DG_10013291 
†† 
http://www.direct.gov.uk/en/MoneyTaxAndBenefits/ManagingDebt/PlanYourWayOu
tOfDebt/DG_187500 
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funded by statutory levy from the financial services industry, backed by a national 
advertising campaign: the Money Advice Service website at 
www.moneyadviceservice.org.uk/. However, those with depression, particularly if 
from socio-economically deprived groups, may be particularly likely to find on-line 
services insufficient or inaccessible (due to cost and/or low mood). Research suggests 
over 25% of depressed patients will have significant debt9, so a locally accessible, 
nationally provided, advice service may be an important alternative. Debt is 
commoner among poorer populations and around 1:4 among those experiencing 
mental health problems, who make up 50% of those with debt overall10,11. The 
strategic & economic cases for providing debt advice for people experiencing mental 
health problems have been made in recent influential reports; and the intervention 
being proposed here falls within the suggested service provision costs and model9,12.  
This study explores an intervention designed to provide enhanced access to timely 
support for people with depression and anxiety about indebtedness, and will provide 
robust information on its cost effectiveness and acceptability. 
 
2.1 Theoretical underpinnings of the intervention 
 
The intervention is informed by the principles of collaborative care13,14 which includes 
a multi-professional approach i.e. a GP plus at least one other, a structured 
management plan, scheduled patient follow ups and enhanced inter-professional 
communication.  
 
The proposed intervention brings together two existing services: 
 
1) debt counselling provided by third sector providers, such as the Citizens Advice 
Bureau   
2) primary care mental health services provided by general practices, supplemented 
by Improving Access to Psychological Therapies (IAPT) Services in England, and in 
Wales a variety of counselling and psychological therapies services.   
 
Collaborative care has been shown to improve quality of life, healthy behaviours, self -
efficacy and other health outcomes15. The intervention also aims to redress 
inequalities and promote social inclusion of marginalised groups16. It is based upon 
the assumption that social context plays an important role for mental illness onset 
and recovery, particularly in the case of debt and depression10,17. A shared 
comprehensive assessment will therefore combine social, psychological, 
environmental, economic and medical perspectives which will also incorporate 
personal goals and a bio-psycho-social management plan.  
 
Liaison has been shown to be an important element of collaborative care and shared 
care more generally18. Communication will be enhanced by the sharing of, and co-
creation between the patient, CAB worker and GP of the shared comprehensive 
assessment. 
 
The active parts of the intervention as a whole: combining primary care treatment of 
depression with the addition of debt counselling and the comprehensive shared 
assessment, are supported by the co-location of GP and debt advisor in primary care, 
the additional pathways of care, enhanced communication between GP and debt 
advisor and case management for participants.  
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3 PROTOCOL 
 
3.1 Debt counselling   
 
Debt counsellors will provide debt counselling as per national CAB protocols with the 
added responsibilities laid out in CAB advisor summary protocol. The CAB advice will 
be provided by specialist CAB debt advisors, supported and case-supervised by senior 
CAB staff. The CAB Service will accept the referral and arrange the 1st appointment 
which will take the form of an assessment of the extent of debt, income and other 
financial circumstances. Prior to the financial statement being prepared with the 
client, action will be taken in relation to any emergency action (bailiff action) and 
prioritising the priority and non-priority debts. The second stage will be to explore 
the options for dealing with the debts and agree an action plan with the client. Such 
options may include: challenging liability for debt, token offers for repayment, pro-
rata offers for repayment or legal remedies such as insolvency, debt relief orders or 
bankruptcy. Subsequent processes will include implementing or amending the action 
plan dependant on client circumstances. Those without ‘priority debts’ at assessment 
will be offered a session with a CAB money management advisor. The intervention is 
anticipated on average to consist of up to 3 post-assessment advice sessions plus case 
management support. 
 
Debt counselling provided by the CAB is intended to educate participants, teach them 
skills to manage their own short term debt, avoid a worsening of both debt and 
depression (i.e. a downward spiral) and raise confidence to manage longer term 
finances.  
 
3.2 GP Care 
GPs will provide treatment in line with NICE guidance for depression. In addition 
GPs will carry out a biopsychosocial shared comprehensive assessment and monitor 
the participant in line with the GP summary of the intervention protocol.  
 
3.3 Shared comprehensive assessment (see appendix SCA form) 
 
Assessment will be carried out following randomization to the intervention, through 
two key consultations. One assessment will be carried out by the general practitioner 
linked to the study within two weeks of consent to participate in the trial. This 
consultation will combine an assessment of both anxiety and depression, as 
recommended by NICE guidance1, and will include an assessment of need regarding 
medication and psychological therapy and agreement regarding further treatment 
which could include referrals to the local IAPT service.  
 
The shared comprehensive form has been developed to assist with the sharing of 
information in a structured way. It is split into 2 main parts, the first section is the GP 
assessment and the second is the CAB assessment. The GP assessment includes 
subsections including the main concerns of the individual in their own words and 
diagnoses; psychological difficulties relevant to debt, including suicide risk; other 
social difficulties including housing, work/study, relationships and domestic abuse 
and lastly a subsection identifying goals for the future and any other current 
treatment. 
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The CAB part of the shared comprehensive assessment incorporates assessments 
normally carried out in the Citizen’s Advice Bureau and will be further adapted and 
manualised to incorporate additional features. The primary aim is to assess severity 
of debt following initial engagement with the individual; the assessment will also 
incorporate an analysis of the individual’s other social problems, their strengths and 
their key social and emotional goals.  At the end of the consultation they will agree 
whether the individual requires a higher level debt counselling intervention, or the 
basic debt counselling provision. 
 
Each assessment section has an area for the participant to sign to consent for their 
information to be shared with the CAB and GP respectively. With the appropriate 
consent, information from the GP assessment and CAB assessment will be shared 
with the Citizen’s Advice Bureau advisor assigned to the patient’s own general 
practice and the study general practitioner. 
 
The shared comprehensive assessment is a protocolised system to share co-produced 
information between the GP, CAB advisor and patient in-line with the collaborative 
care model and shared decision making. It aims to improve communication between 
general practice and the CAB and facilitate continuity of care for the patient. It also 
aims to involve the patient in decisions about their care which has been shown to 
improve treatment adherence, self-efficacy and outcomes. The shared assessment 
also avoids the unnecessary burden of the patient having to tell what can sometimes 
be a painful story over and over again to staff and associated professionals19. 
 
Enhanced communication between primary care and CAB services is facilitated 
through the use of shared comprehensive assessment which is held on both the GP 
practice clinical notes and the CAB system and also by the patient.  
 
3.4 Co-location 
Co-location has been shown to improve liaison between the workers within services 
and can also help to improve access20,21. In this case the co-location of the CAB in 
primary care should enhance access to services21 by overcoming elements of stigma 
which may be present for those not usually accessing CAB services20,22.  
 
It is anticipated that where possible CAB workers will see patients within their own 
practice, but in some instances of small practices, and where accommodation is 
problematic CAB workers may see patients at other venues, including neighbouring 
practices or nearby health centres.  On occasions the more specialised intensive debt 
counselling services may be based within the usual CAB settings.   
 
3.5 Pathways 
The intervention incorporates two core pathways (3.1 and 3.2) as well as optional 
ones.  The core pathways include being seen initially by the General Practitioner and 
following this by the CAB advisor. On-going pathways of care include progress 
reviews by the GP and the CAB worker.  
 
Optional pathways include a) referral on to more intensive CAB debt counselling 
services, b) to other social inclusion services based on assessment of problems within 
comprehensive assessment and c) referral on to IAPT services for psychological 
therapy (NICE guidance for Depression ref).   
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3.6 Liaison 
Co-location is also anticipated to enhance the possibility of informal one-to-one 
discussion about individual cases. Organised formal liaison is encouraged between 
the GP and CAB worker in order to underpin enhanced communication where 
feasible, particularly for example where clients are more vulnerable and struggling to 
maintain contact with services and or having greater need and complexity. This 
enhanced liaison may include telephone catch-up calls between CAB advisor and GP, 
face-to-face meetings or occasional attendance at practice meetings by a CAB worker 
if appropriate.  
 
3.7 Case management 
Case management is an important part of the collaborative care approach . For this 
intervention, for the majority of cases, the case manager will be the CAB worker. 
After the initial Comprehensive Shared Assessment, the case manager will maintain 
contact with the patient according to the most convenient method for each 
individual. This may be by telephone, e-mail, text, face-to-face review or a 
combination. The aim will be to ensure that an individual’s progress is monitored and 
that individuals are enabled, prompted and empowered to attend appointments with 
the CAB workers, General Practice, IAPT and other social interventions as agreed in 
the management plan. If during the early stages of our feasibility trial attendance at 
appointments with CAB, GPs and other booked appointments remains low, we will 
enhance this aspect of our intervention. Case management, as a part of collaborative 
care, is an essential continuation of facilitating patient attendance, self-efficacy, 
patient-centred timing of progress and risk monitoring23. Care in a collaborative care 
model is a continuous process and not a one-off intervention that is responsive to 
changing needs and a changing evaluation of needs24. 
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4 IMPLEMENTATION 
 
Sections 2 and 3 have detailed how the intervention should be delivered in theory and in this 
research. However, changing existing practice requires a range of supportive mechanisms.  
 
To help with this, the delivery of the intervention will be supported by: 
• Training of GPs by the PI at each site arm (initial training) 
• DeCoDeR Manual and mini-manual for GPs (see appendices 
• Follow up review with GPs  
• Training of CAB workers by the lead CAB study co-applicant 
• Full manual and CAB summary protocol for CAB workers 
• Supervision of CAB 
• Fidelity review 
 
4.1 What new thinking and behaviour is required of GPs and Cab advisors? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GP 
1. Carry out part one of a Shared 
Comprehensive Assessment 
(this may take a double 
appointment slot, approx. 20 
minutes). 
2. Commitment to shared care 
with the CAB and shared 
decision making with the 
patient at the centre of care. 
3. Share additional information 
with the CAB advisor as 
appropriate (using the ‘Shared 
Comprehensive Assessment: 
GP Follow up Form’) as part 
of a structured plan and also 
informally as part of 
enhanced communication.   
4. Work with the patient and 
CAB advisor to encourage 
patient engagement and 
retention with CAB debt 
counselling in order to 
overcome shame, stigma or 
chaotic lives. 
CAB advisor 
1. Carry out the second part of the 
Shared Comprehensive Assessment.  
2. Commitment to shared care with the 
GP and shared decision making, with 
the patient at the centre of care. 
3. Working in a primary care location. 
4. Work with the patient towards their 
personal debt goals taking into 
account mental health issues. 
5. Share information with the GP 
practice as part of a structured plan 
(via CAB follow up form and 
arranged meetings) and informal 
liaison with GPs and practice staff as 
part of enhanced communication and 
colocation. 
6. Case manage the patient and work 
with the GP to encourage patient 
engagement and retention with CAB 
debt counselling in order to 
overcome shame, stigma or chaotic 
lives.  
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4.2 Fidelity review during internal pilot trial 
 
The proposed intervention is a complex intervention and will therefore need to be piloted. It is 
recognised that adaptations will be required and that a detailed implementation process will be 
needed to ensure the intervention is delivered optimally.   
 
Fidelity will be assessed and qualitative interviews with GP and CAB advisors will be used to 
assess implementation problems and facilitators. Problems will be resolved to ensure the 
intervention is implemented as closely to the model as possible.  
 
Refinements to training and the manual may be made to help ensure fidelity to the original 
model. During the main trial the intervention will continue to be implemented with any 
additional procedures developed in the pilot trial to ensure closer fidelity to the model. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fidelity Checklist 
 
• Carry out Shared Comprehensive Assessment and share 
• Provide participants with study debt leaflets 
• Offer CAB appointments 
• Provide an opportunity for co-location 
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Appendix 3 Invitation letter to general
practitioners
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Appendix 4 Participant pathway
Consent and assessment visit with 
study researcher (RA1)
Randomisation
Control
GP assessment appointment, hand 
out debt advice leaflets
2–4 weeks’ post randomisation
qualitative interview with researcher
(RA2) (sample of participants)
12-month follow-up assessment 
visit (RA1)
END OF PARTICIPATION
4-month follow-up 
qualitative interview RA2
4-month follow-up 
assessment visit RA1
Intervention
GP assessment appointment, hand 
out debt advice leaflets
Appointment(s) with CAB adviser
2–4 weeks’ post randomisation
qualitative interview with researcher
(RA2) (sample of participants)
12-month follow-up assessment 
visit (RA1)
END OF PARTICIPATION
4-month follow-up 
qualitative interview RA2
4-month follow-up 
assessment visit RA1
FIGURE 8 Pathway of participants through pilot trial.
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Appendix 5 Research protocols for general
practitioners in the control arm
Debt Counselling for Depression in Primary Care (DeCoDer): 
Research protocol for GPs in the Control arm 
Study Aim  
The aim is to determine the clinical and cost effectiveness of the addition of primary care based debt 
counselling (provided by Citizens Advice Bureau counsellors) to usual care, for patients with 
depression and debt.  
 
We hypothesise that outcomes can be improved by applying key principles of collaborative care: 
A shared understanding of how debt, depression and other problems relate to each other for 
each individual 
A plan agreed by patients, CAB and GP 
Structured communication between patients and the two main practitioners 
Proactive follow up to overcome shame, stigma or chaotic lives 
 
The control arm of the study will provide treatment as usual for participants in line with NICE 
guidance for depression. 
 
Pre GP assessment appointment 
Before seeing the GP, patients will have attended a research assessment and have been: 
Recruited to the study (via waiting room or record search, assessed as suitable, consented and 
baseline data collected) 
Allocated to control arm 
Phoned by practice staff to arrange an appointment to see a control GP (but they won’t know 
they are in the control arm) 
 
What happens at the GP assessment appointment? 
 
The GP will assess both anxiety and depression, and need regarding medication and psychological 
therapy. They will, in partnership with the patient, agree future treatment in line with NICE guidance. 
 
Advise patient that they have been allocated to receive debt advice leaflets 
 
If deemed appropriate, GP may refer patient to IAPT services and other interventions and 
arrange to review the patient at ongoing appointments as required 
The GP will provide the patient with the study–specific debt advice leaflet and Royal College 
of Psychiatrists’ Debt and Mental health leaflet 
 
Ongoing management of participants 
 
Ongoing care will be managed and co-ordinated by the GP and may include monthly progress reviews 
by the GP. On average this is likely to be 6 reviews, but could be up to 12 in line with NICE guidance.  
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Optional pathways include: 
 
a) Referral to other social inclusion services   
b) Referral to IAPT or other services for psychological therapy 
c) Sleep hygiene  
d) Active monitoring 
e) Structured Group Physical Activity  
f) Group Based Peer Support 
g) Community Mental Health Team 
h) Crisis resolution or Home Treatment teams 
i) Drug treatment e.g. SSRIs or other psychotropics 
j) Support for addiction e.g. alcohol, drugs, gambling, smoking  
 
Ongoing involvement in the research for participants 
 
Participants will continue to be followed up by researchers to collect outcome measures at 4 and 12 
months  
 
Adverse event reporting 
 
The following serious adverse events (SAE) should be reported to the Peninsula Clinical Trials Unit 
by faxing (                       ) the SAE form within 48 hours of becoming aware of the event: 
 
 Death 
 Immediately life-threatening illness 
 Hospitalisation or prolongation of hospitalisation (this may include hospitalisation for self-
harm/attempted suicide and depression) 
 An event which results in persistent or significant disability or incapacity 
 
 
 
 
 
If you have any queries about the study you can e-mail or call the research team: 
 
Local Researcher: 
Name: 
Telephone: 
e-mail: 
 
Local PI: 
Name: 
Phone: 
e-mail: 
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Appendix 6 Research protocol for general
practitioners in the intervention arm
Debt Counselling for Depression in Primary Care (DeCoDer): 
Research protocol for GPs in the Intervention arm 
Study Aim  
The aim is to determine the clinical and cost effectiveness of the addition of primary care based debt 
counselling (provided by Citizens Advice Bureau counsellors) to usual care, for patients with 
depression and debt.  
 
We hypothesise that outcomes can be improved by applying key principles of collaborative care: 
 A shared understanding of how debt, depression and other problems relate to each other for 
each individual 
 A plan agreed by patients, CAB and GP 
 Structured communication between patients and the two main practitioners 
 Proactive follow up to overcome shame, stigma or chaotic lives 
 
Pre GP assessment appointment 
 
Before seeing the GP, patients will have attended a research assessment and have been: 
 Recruited to the study (via waiting room or record search, assessed as suitable, consented and 
baseline data collected) 
 Allocated to treatment arm 
 Phoned by practice staff to arrange an appointment to see an intervention GP (but they won’t 
know they are in the intervention arm) 
 
What happens at the GP assessment appointment? 
 
The GP will assess both anxiety and depression, and need regarding medication and psychological 
therapy. They will, in partnership with the patient, agree future treatment in line with NICE guidance 
and also incorporate a psychosocial assessment and plan focused on debt and other social problems. 
  
 The GP will complete the study-specific CAB referral and shared assessment form, including: 
 Main concerns (in patient's own words) 
 Diagnoses (ongoing/significant past), including alcohol 
 Psychological difficulties and their relationship to debt for the individual (e.g. 
tiredness, concentration, anger, fears) 
 Other social difficulties (e.g. housing, work/study, relationships, domestic 
violence/emotional abuse, gambling) 
 Patient's goals (immediate, medium-term and long-term) 
 Assessment of hopelessness/suicide risk 
 Provisional treatment plan (e.g. psychological therapy, exercise referral etc.) 
 
 If deemed appropriate, GP may refer patient to IAPT services and other interventions and 
arrange to review the patient at ongoing appointments as required 
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The GP will advise the patient that they have been allocated to receive debt advice from a 
CAB advisor and will be contacted by a CAB advisor   
 
The GP will confirm the patient’s consent to CAB referral and their agreement to the sharing 
of their contact details and initial shared assessment with the CAB 
 
The GP will provide the patient with the study–specific debt advice leaflet and Royal College 
of Psychiatrists’ Debt and Mental health leaflet 
 
The participant’s written signed agreement to sharing contact details and specific information 
in the shared comprehensive assessment will be retained by the GP practice 
 
Ongoing management of participants 
 
The CAB advisor will complete the assessment, send back the completed form to the 
GP/practice and give a copy to the participant 
 
Ongoing care will usually be managed and co-ordinated by the CAB advisor (in a small 
minority of cases this may be the GP) for the period of the intervention  
 
Ongoing pathways of care will include monthly progress reviews by the GP. On average this 
is likely to be 6 reviews, but could be up to 12 in line with NICE guidance. Progress reviews 
may also include checking participant progress with CAB and prompting non-attenders to 
return if they appear to be dropping out or have dropped out of CAB care  
 
Ongoing communication between GP and CAB advisor includes: 1-2 line summaries in the 
patient electronic record after each contact and a short summary of significant events when 
appropriate. Further liaison is facilitated by the co-location of CAB advisors in GP practices  
  
Optional pathways include: 
k) referral to more intensive CAB debt counselling (if recommended and arranged by 
CAB advisor managing the case)  
l) referral to other social inclusion services   
m) referral to IAPT or other services for psychological therapy 
n) sleep hygiene  
o) active monitoring 
p) structured Group Physical Activity  
q) group Based Peer Support 
r) community Mental Health Team 
s) crisis resolution or Home Treatment teams 
t) drug treatment e.g. SSRIs or other psychotropics 
u) Support for addiction e.g. alcohol, drugs, gambling, smoking 
 
 
Ongoing involvement in the research for participants 
 
 Separately from the intervention, participants will continue to be followed up by researchers 
to collect outcome measures at 4 and 12 months  
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In the event that the participant refuses CAB referral: 
 
 The GP will complete the relevant tick box - informing the study team that the participant has 
declined CAB intervention 
  
 The GP may continue to have further follow up appointments with the patient as required 
 
Adverse event reporting 
The following serious adverse events (SAE) should be reported to the Peninsula Clinical Trials Unit 
by faxing (                       ) the SAE form within 48 hours of becoming aware of the event: 
 Death 
 Immediately life-threatening illness 
 Hospitalisation or prolongation of hospitalisation (this may include hospitalisation for self-
harm/attempted suicide and depression) 
 An event which results in persistent or significant disability or incapacity 
 
 
 
 
 If you have any queries about the study you can e-mail or call the research team: 
 
Local Researcher: 
Name: 
Telephone: 
e-mail:  
 
Local PI: 
Name: 
Phone: 
e-mail: 
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Appendix 7 Serious adverse events form
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Appendix 8 Debt advice leaflet
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Appendix 9 Patient letter
Letter to be written on practice headed notepaper. 
 
 
 
Insert date 
 
 
Insert name of patient 
Address 
 
 
Dear [Insert name of patient]   
 
We are writing to you to let you know about a research study taking place in this practice that 
you have the option to take part in. The research is testing out services to help people with 
both worries about debt and low mood. 
 
The study is being carried out by [Local University] and we have agreed to work with them. 
We are contacting patients identified from practice clinical records who may have 
experienced low mood in the past year, but we have not as yet informed the research project 
of any of your details. This is to give a wide range of people the opportunity of taking part but 
we are aware that this project may not be relevant to you so please accept our apologies if 
this is the case.     
 
If you are interested to know more about the study, please read the enclosed one page flyer 
and the more detailed information sheet to help you decide whether you would like to take 
part. 
 
If you would like to discuss the study in more detail, please complete, sign and return the 
enclosed ‘Expression of interest’ form in the freepost envelope provided so that a researcher 
from [Local University] can contact you. Alternatively, if you would prefer to contact the 
research team yourself to find out more about this study, please call [RA telephone number] 
and ask to speak to [RA name] or e-mail: [RA e-mail]. 
 
Taking part in the research is completely voluntary and if you choose not to take part in the 
study this will not affect your care from this practice or related services in any way. 
 
Thank you for your time. 
 
Yours sincerely 
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Appendix 10 General practitioner practice flyer
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Appendix 11 Participant information sheet
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Appendix 12 Expression of interest form
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Appendix 13 Publicity poster
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Appendix 14 Participant consent form
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Appendix 15 Citizens Advice Bureau advisor
protocol
DOI: 10.3310/hta21350 HEALTH TECHNOLOGY ASSESSMENT 2017 VOL. 21 NO. 35
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Gabbay et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
143
APPENDIX 15
NIHR Journals Library www.journalslibrary.nihr.ac.uk
144
Appendix 16 Debt advice questions
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Appendix 17 Baseline visit overview (from case
report form)
 
VISIT OVERVIEW 
Date visit started  
Date visit completed  
DOCUMENTS REQUIRED 
Participant information leaflet  
Participant consent form (x2)  
Debt advice leaflets 
Consent & Eligibility CRF  
BDI Questionnaire Booklet Baseline  
Questionnaire Booklet Baseline 
Case Report Form (CRF) 
EQUIPMENT REQUIRED 
Audio recorder 
ORDER OF COMPLETION (Green = Researcher led; Red = Self complete) 
Order Document Booklet Tick if complete 
1. Consent & Eligibility  Consent form and Consent and Eligibility CRF  
2. BDI    BDI Questionnaire Booklet Baseline  
3. BAI  Questionnaire Booklet Baseline  
4. SWEMWEBS  Questionnaire Booklet Baseline  
5. EQ-5D-5L  Questionnaire Booklet Baseline  
6. MANSA  Questionnaire Booklet Baseline  
7. CSRI  Case Report Form (CRF)  
8. Demographics LEDs & LEDs Schedule Case Report Form (CRF)  
9. Debt Summary  Case Report Form (CRF)  
10. Adult Hope Scale  Questionnaire Booklet Baseline  
11. OAS Scale Questionnaire Booklet Baseline  
12. Response Style Questionnaire – 24  Questionnaire Booklet Baseline  
13. Alcohol audit  Questionnaire Booklet Baseline  
14. Drug Screening Questionnaire  Questionnaire Booklet Baseline   
15. Stanford Presenteeism Scale  Questionnaire booklet Baseline  
If visit/measures only part complete, please give reason for part completion below: 
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Appendix 18 Participant qualitative interview
consent form
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Appendix 19 Qualitative interview topic guides
Participant topic guide (baseline) version 1.3
Topic Guide 1 
Baseline Qualitative interview (2-4 weeks after baseline interview) 
Opening remarks 
The researcher will:  
• Introduce him/herself and thank the participant for agreeing to take part in the 
interview 
• Go over the purpose of the interview, likely length of interview and answer 
any questions  
• Discuss use of the audio recorder 
• Discuss confidentiality and risk 
• Explain that the information they provide will not affect the quality of the care 
they receive from their doctor 
• Emphasise that participant can take a break(s) at any time in the interview – 
offer break if participant becomes fatigued/distressed 
• Advise the participant that they are free to terminate the interview at any time 
should they wish to do so 
• Go through consent form with participant 
Conversational prompts: Rather than a structured set of formal questions, the 
interview will follow the format of a focused conversation - beginning with an 
introductory question followed by the use of conversational prompts (CP) to facilitate 
further related discussion.  
Introduction: 
As you’re aware, our project is asking people about their experiences with difficulties 
they have had with money and how this has impacted upon their lives.   
Could I ask you to tell me your story about how you have come to have money 
worries? 
Prompts: 
 Recent issue or long term? 
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 Any specific events? 
 Circumstances – illness, bereavement, redundancy, unemployment 
 Family & home circumstances 
 Expected or unanticipated 
 Triggers- internet, gambling, bingo (NB: do not ask about these examples 
directly) 
Was there a time when you didn’t have money worries (transition)? 
• Anything in particular happened? 
• ‘Any change in what money is spent on?’ 
Can you tell me about how and when you became aware that you were having 
financial difficulties? 
People have different views of what is defined as debt, what do you think of it as? 
Do you know other people in a similar situation? 
Have you previously tried to sort out your difficulties with money? 
• If yes– what happened? 
• What did you do? 
How have your difficulties with money affected your life in both practical and 
emotional terms? 
Prompts: 
 relationships with close family, friends  
 work 
 Social life 
 Health 
How do you feel about dealing with creditors?  
• Why? 
What do you think would help you to deal with creditors? 
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What would you like to happen in the future, in relation to money difficulties in 
terms of your own experience and what might help others?  
DOI: 10.3310/hta21350 HEALTH TECHNOLOGY ASSESSMENT 2017 VOL. 21 NO. 35
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Gabbay et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
153
Participant topic guide (4-month follow-up) version 1.1
Draft Topic Guide 2 
Follow up Qualitative Interview (4 months into the trial) 
Opening remarks 
• Greetings and thank you to participant for agreeing to take part in a second 
interview with researcher 
• Discuss use of the audio recorder 
• Discuss confidentiality and risk 
• Advise participant that they are free to terminate the interview at any time 
should they wish to do so 
• Go through consent form with participant 
Introduction: 
When we last met, I asked you to tell me your story about the difficulties you were 
experiencing with money. In this second interview I will be asking you to tell me 
about what has been happening since we last spoke. I will also be asking you about 
your experiences of taking part in this research study.   
So perhaps I could start first by asking you tell me about what has happened 
since we last spoke? 
What has helped/not helped you to be in this position? 
 Influence of intervention (explore) 
o (GP 
o CAB 
o Leaflets 
o Other 
Do you feel that you are on the road to sorting it out, or not, from your 
difficulties with money?  
 If yes - why? 
 If no – why? 
How have your relationships changed or not since we last spoke? 
APPENDIX 19
NIHR Journals Library www.journalslibrary.nihr.ac.uk
154
 Family 
 Work, 
  Social, 
  Carer etc 
What hopes do you have for the future? 
In 12 months what do you hope life will be like? 
 Same/change (explore) 
Experience of research participation 
How are you finding your involvement in the trial? 
• Helping or not?   
• If helping, exactly how is it helping? 
 Practical support 
 Emotional support 
 Validation 
How are you finding the practical aspects of the trial? 
 time for being interviewed  
 asking to fill in questionnaires etc 
 Burden of assessment 
If a study like this was to be conducted again in the future what advice do you 
have about how things might be changed? 
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Topic guide for professionals (control arm)
DeCoDer Trial 
Qualitative Interview Topic Guide – Control GPs 
Opening remarks 
The researcher will:  
• Introduce him/herself and thank the GP for agreeing to take part in the 
interview 
• Go over the purpose of the interview and answer an questions  
• Discuss use of the audio recorder 
• Discuss confidentiality 
• Advise the participant that they are free to terminate the interview at any time 
should they wish to do so 
• Go through consent form 
Opening question:  
When you see patients from the control arm of the trial (when you gave them leaflets 
about debt and depression and discussed how their depression and debt were affecting 
them), how did those consultations go? 
• Do you think it was different to your usual consultation with such patients?  
o If so, in what ways? 
• What do you think are the best ways to help patients with depression and 
financial worries? 
• Who do you think is best placed to provide this, and if not you, how would 
you like them to link with you and your team if at all? 
• Have you any comments about the trial in general? 
o Organisation 
o Recruiting participants 
o Practical issues 
o Anything else 
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Topic guide for professionals (intervention arm) version 1.3
DeCoDer Trial 
THEORY BASED INTERVIEW SCHEDULE FOR PROFESSIONALS: 
COMPLEX INTERVENTION = SHARED COMPREHENSIVE ASSESSMENT 
AND DEBT ADVICE (SCADA) 
Opening remarks 
The researcher will:  
• Introduce him/herself and thank the Debt Counsellor/Health Professional for 
agreeing to take part in the interview 
• Go over the purpose of the interview and answer an questions  
• Discuss use of the audio recorder 
• Discuss confidentiality 
• Advise the participant that they are free to terminate the interview at any time 
should they wish to do so 
• Go through consent form 
Broad opening question 
How have you found the decoder debt advice intervention? 
Prompt: the intervention included debt advice provided by CAB, linked to GP 
care through: a shared comprehensive assessment, information sharing and 
follow up prompted by the CAB worker. 
 What was your experience of the individual parts? 
Has the intervention as a whole or in part worked or not for you and your work 
with these patients/clients? 
Why?   
 
Further questions/prompts: 
If the intervention were to prove effective, what do you think would need to change to 
be able to implement it into day to day practice? 
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How does/will the Intervention change what health professionals need to know (the 
knowledge base they draw on) to do their job? 
How does/will the Intervention change the everyday rules/care protocols that Health 
Professionals use/set to guide their practice? 
How does the operationalization of Intervention change the roles of Health 
professionals in primary care? (Changes to systems of organisation?) 
What sort of inter-professional co-operation and service co-ordination is needed to get 
the Intervention into practice? 
Do you think that the Intervention is workable in primary care - should it be 
integrated with other services? (If so, which?) 
Do you think that Intervention fits with the workflow in primary care - is it likely to 
add to the burden of work? (How?) 
Do you think this intervention is important and worth prioritising? If yes - why? If no 
- why? 
There’s a great deal of debate about the scope of healthcare provision at the moment, 
do you think that this Intervention to address debt through joint working is a 
legitimate use of resources? What about interventions to address other social 
problems such as employment, housing and relationships? 
How readily could practitioners use the shared assessment approach in practice? Is it 
useful beyond just this shared care with CAB? E.g. in other mental health/chronic 
conditions or for other social problems. 
How can you tell if it’s working? What do Health Professionals do to evaluate the 
effects of Intervention in particular patients? 
What have we missed - are their other barriers and facilitators to incorporating the 
Intervention in primary care that we need to take account of? 
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Appendix 20 Information sheet for professionals
Title of project: Debt Counselling for Depression in Primary Care: An 
Adaptive Randomised Controlled Trial 
  
We are inviting you to take part in an interview for the above research study. Before 
you decide, it is important for you to understand the purpose of the interview and 
what it will involve. Please take the time to read this information carefully. Please do 
not hesitate to ask us if there is anything that is not clear. Thank you for reading this. 
  
What is the purpose of the study? 
As you will be aware, the purpose of this study is to find out if debt advice for patients 
with debt & depression, accessed through general practices, makes a difference to 
their recovery. Part of the study is an evaluation of the processes undertaken by GPs 
and CAB advisors in order to deliver the intervention. As part of that evaluation we 
wish to conduct semi-structured interviews with a sample of general practitioners and 
CAB staff taking party in the study. The findings from the interviews will be 
triangulated with other data collected as part of the study.   
  
Why have I been asked to take part? 
You have been asked to take part in this study because you are either a general 
practitioner who has agreed to take part in this study or a CAB advisor providing debt 
advice to participants.    
  
Do I have to take part in an interview? 
No. It is up to you to decide whether or not you take part. If you decide to take part 
you will be given this information sheet to keep and be asked to sign a consent form.  
  
What happens next? 
If you agree to take part, you will be contacted by a researcher to arrange an 
appropriate time and place to meet for the interview. At the time of the interview you 
will be asked to complete a consent form. Everything you say during the interview will 
be treated confidentially. If you agree, your interview will be audio-recorded and 
transcribed later, allowing the researcher to fully concentrate on your interview. You 
will be free to withdraw from the interview at any point.  
  
Will my taking part in the study be kept confidential? 
Yes.  
We will follow ethical and legal practice and all information which is collected about 
you during the course of the research will be kept strictly confidential. During our 
reporting of the study, we may use quotations from your interview in reports, papers 
and presentations of the findings. However, any quotations will be anonymised and 
will not be attributable to you. 
 
How will my information be stored? 
Anonymised paper transcripts of the interview will be stored in locked filing cabinets 
within locked offices at local University sites. Anonymised electronic copies of 
transcripts will be stored on approved University computers at each site, which are 
password protected and virus checked. Data will only be stored on the University’s 
managed network server and not on the computer’s own hard drive. Original audio 
files will be destroyed after four months – once transcripts have been checked. 
Personal data will be stored under strict security and destroyed after the statutory 
time period.  Completely anonymous data may be retained for up to 10 years after 
the study. 
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What will happen to the results of the research study? 
Results of the study will be published in academic and professional journals and a 
report of the results will be sent to the funding organisation – the National Institute for 
Health Research. The study results will be fed back to members of the public through 
our service user group colleagues and contacts. We will also work with 
commissioners and GPs to explore how best to put the study findings in to practice.  
  
Who is organising and funding the research? 
This project was funded by the National Institute for Health Research HTA 
Programme (project number: 11/148/01).  The research is sponsored by the 
University of Liverpool. 
  
Who has reviewed the study? 
All research in the NHS is looked at by an independent group of people, called a 
Research Ethics Committee, to protect your safety, rights, wellbeing and dignity. This 
study has been reviewed and given a favourable opinion by: NRES Committee North 
West - Preston [Ref: 14/NW/0230]. 
  
Further information and contact details 
If you require any further information you can contact: 
  
Name Local PI [Local site name] 
Role in study 
Address 
Contact telephone no.  
E-mail 
  
Name Local site Research Assistant 
Role 
Name 
Address 
Contact telephone no. 
E-mail 
  
      
Chief Investigator/Principal Investigator  
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Appendix 21 Interview consent form
(professionals)
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Appendix 22 End of study participant
information sheet
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